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Vertebrate hematopoiesis is a highly conserved process that requires a series of cell 
specification, proliferation and differentiation. The underlying mechanisms governing 
these cellular events are, however, not fully understood. Recently, zebrafish (Danio 
rerio) has emerged as a good genetic model organism to study the early events of 
blood formation during vertebrate development. 
 
In order to study hematopoiesis, we carried out a whole-mount in situ hybridization 
(WISH) based forward genetic screen to isolate the rag1-deficient mutants. From 
screening 540 genomes, we identified 86 rag1-deficient mutants from 540 
mutagenized genomes. By observing blood circulation, wz260 mutant was identified 
as the only mutant that also had defects in primitive erythropoiesis. Therefore I 
selected wz260 for detailed characterization and found that it was a new allele (udusq1zl) 
of ugly duckling (udutu24), which was first isolated from the 1996 Tuebingen 
large-scale screen as a mutation affecting morphogenesis during gastrulation and tail 
formation. WISH to detect the hematopoietic markers indicated that both primitive 
erythropoiesis and myelopoiesis were impaired in udusq1zl homozygous mutants. Cell 
cycle, cytology, and transplantation analyses showed that the primitive erythroid cells 
in the udusq1zl homozygous mutants were severely defective in proliferation and 
differentiation in a cell-autonomous fashion. Positional cloning revealed that the udu 
gene encodes a novel protein of 2055 amino acids (aa) that contained several 
 vii
conserved regions, including two Paired Amphipathic-Helix like (PAH-L) repeats and 
a putative SW13, ADA2, N-Cor and TFIIIB-like (SANT-L) or a Myb-like DNA 
binding domain (This domain is referred as SANT-L thereafter). I further found that 
the Udu protein is predominantly localized in the nucleus and deletion of the putative 
SANT-L domain abolishes its function. Moreover, robust elevations of the tumor 
suppressor p53 expression as well as several p53 downstream targets were observed 
in the udu-/- mutant embryos. Knockdown of p53 protein expression by p53 antisense 
morpholino oligos (MO) could correct the mutant phenotype to the same extent as 
udu RNA injections in mutant embryos. Thus, these results indicate that the Udu 
protein plays a crucial role in regulating the proliferation and differentiation of 
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Chapter Ⅰ Introduction 
 
1.1 Hematopoiesis in mammals 
1.1.1 Hematopoiesis: definition and significance 
Hematopoiesis is the development of blood cells and other formed elements of blood. 
Hematopoietic cells consist of erythrocytes, monocytes, neutrophils, basophils, 
eosinophils, mast cells, magakaryocytes, nature killer (NK) cells, T and B 
lymphocytes. And they display distinctive functions, for example, erythrocytes deliver 
oxygen, platelets form blood clot, some myeloid cells scavenge debris as well as 
pathogens, and lymphocytes regulate the host specific immune reactions. Despite their 
wide functional diversities, all of the blood cells are derived from a common 
precursor cell — hematopoietic stem cell (HSC) (Kondo et al., 2003). So, 
hematopoiesis embraces two aspects: the development of the first HSCs from 
nonhematopoietic tissue in embryonic and fetal life, as well as differentiation of 
multipotent, self-renewing HSCs into all lineages of the blood.  
 
Hematopoiesis research has been always at the forefront of basic science, helping us 
to understand cell biology, molecular biology, genetics, and protein structure and 
formation. On the other hand, from the clinical point of view, a basic understanding of 
the biology of blood cells is essential for developing new therapeutic approaches for 
treatment of the hematopoietic diseases, such as thalassemia, immunodeficiency and 
leukemia. For instance, HSC or bone marrow transplantation has been used to treat 
the leukemia patients efficiently. Therefore, hematopoiesis study definitely provides a 
promising future for basic science as well as clinical medicine.   
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In the past few decades, studies in several species, including mammals, birds, and 
amphibians, have shown that hematopoiesis is considerably conserved throughout 
vertebrate evolution. The best understood vertebrate hematopoietic system is that of 
the laboratory mouse (Mus musculus), and recently the zebrafish (Danio rerio) has 
emerged as another excellent model organism for studying hematopoiesis (Lensch and 
Daley, 2004). Thus, I will mainly introduce hematopoiesis in the mouse and zebrafish 
in this chapter. 
 
1.1.2 Two waves of hematopoiesis: primitive and definitive 
Vertebrate hematopoiesis has two successive waves, primitive and definitive, that 
differ in anatomic location and the cell types produced. In mammals, the first or 
primitive wave of hematopoiesis, is transitory, occurs in the extraembryonic 
structure-yolk sac (YS), and produces nucleated primitive erythrocytes, some 
macrophages and rare megakaryocytes (Palis and Yoder, 2001; Xu et al., 2001; 
Medvinsky et al., 1993; Moore and Metcalf, 1970). The second or definitive wave of 
hematopoiesis is persistent, initiates from the aorta-gonad-mesonephros (AGM) 
region, then transits to the liver, thymus, spleen, and finally, moves to the bone 
marrow. Definitive hematopoiesis generates all mature blood cells (Johnson and 
Moore, 1975; Lensch and Daley, 2004; Medvinsky et al., 1993; Godin et al., 1993). 
 
1.1.2.1 Hematopoietic stem cells derive from ventral mesoderm 
HSCs are specified early in embryogenesis from ventral mesoderm. As the 
undifferentiated, self-renewing cells, mesoderm will give rise to stem cells for the 
blood, mesenchyme, kidney, muscle, and notochord (from ventral to dorsal) (Zon, 
1995). The understanding of ventral mesoderm induction comes mainly from studies 
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in Xenopus. The unfertilized Xenopus egg is radially symmetric with a dark 
pigmented animal hemisphere and a lightly colored yolky vegetal hemisphere. Sperm 
entry initiates a rotation of the cortex of the egg with respect to the internal cytoplasm. 
This cortical rotation results in the dorsal side being defined by the formation of the 
Nieuwkoop center in the vegetal region on the side opposite sperm entry (Huber and 
Zon, 1998; De Robertis and Kuroda, 2004). At blastula stage, vegetal signals, which 
are maternally derived and separated into ventral-vegetal and dorsal-vegetal signals, 
induce the equatorial cells (known as the marginal zone) to form dorsal and ventral 
mesoderm. Fibroblast growth factor (FGF) may be the ventral-vegetal signal that 
induces mesoderm with ventro-lateral character. Vg-1, activin, two members of the 
transforming growth factor-β (TGF-β) family, and Wnt11, a member of the Wg/Wnt 
proteins (Heasman, 2006), are likely to be the main dorsal-vegetal signals, through 
which the Nieuwkoop center specifies the Spemann’s organizer and the dorsal 
mesoderm (Huber and Zon, 1998; De Robertis and Kuroda, 2004). At the gastrula 
stage, bone morphogenetic factor 4 (BMP4), another TGF-β family member, is 
expressed in the ventral and lateral marginal zones as a ventral mesoderm-patterning 
factor. BMP4 RNA and cDNA injections ventralize embryos while dominant negative 
BMP4 receptor injections dorsalize embryos. In combination with mesoderm inducers, 
such as FGF and activin, BMP4 yields abundant hematopoietic mesoderm. BMP4 
activity is inhibited by at least three factors, chordin, follistatin and noggin, secreted 
from the Spemann’s organizer, the dorsal gastrula center (De Robertis and Kuroda, 
2004; Huber and Zon, 1998). The ventral-mesoderm patterning by BMP4 is mediated, 
at least in part, by members of the Mix and Vent families of homeobox transcription 
factors. Following gastrulation, a subset of ventral mesoderm is specified to become 
HSCs (Davidson and Zon, 2000). 
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In mouse, mesoderm is formed from cells migrating through the primitive streak 
between the presumptive ectoderm and the endoderm. The same layer of mesoderm 
extends both into the embryo and extraembryonically, into the YS. In mouse, around 
7.0-7.5 day postcoitum (dpc), the extraembryonic mesodermal cells in association 
with the visceral endoderm (VE) form the blood islands, where primitive 
hematopoiesis takes place. Structurally, blood islands consist of clusters of 
hematopoietic cells surrounded by endothelial cells (Lensch and Daley, 2004). 
TGF-β1 and BMP4 have been shown to be required for blood-island formation in the 
mouse embryo. In TGF-β1 and BMP4 mutant embryos, both blood and endothelial 
cell developments are compromised (Dickson et al., 1995; Winnier et al., 1995). 
 
Tissue recombination experiments performed in the mouse establish more directly 
that VE is required for induction of hematopoiesis in the gastrulation embryo 
(Belaoussoff et al., 1998). Around the onset of gastrulation, induction of primitive 
hematopoiesis from ectoderm (more specifically, nascent mesoderm cells arising from 
the primitive streak) requires the presence of VE. And this VE signaling is only 
required in a relatively narrow window of time, since blood formation is autonomous 
to mesectoderm by mid-streak stage. Surprisingly, VE signals can respecify the 
anterior epiblast (prospective neural ectoderm) to posterior cell fates, formation of 
blood and endothelial cells (Belaoussoff et al., 1998). Recently, Indian hedgehog 
(Ihh), expressed in VE of gastrulating mouse embryos and mature yolk sacs, was 
identified to be the VE secreted signal sufficient to induce formation of hematopoietic 
and endothelial cells. Strikingly, Ihh can also respecify anterior epiblast along 
hematopoietic and endothelial lineages. Bmp4, upregulated in response to Ihh signals, 
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may mediate activation of hematopoietic and vascular development. Although Ihh 
alone is sufficient to induce the development of hematopoiesis and vasculogenesis, 
analysis of mice deficient in Ihh shows that Ihh is not essential in these processes, 
suggesting that another hedgehog protein, perhaps Desert hedgehog (Dhh), or a 
distinct pathway must at least partially compensate for Ihh function (Dyer et al., 
2001). 
 
1.1.2.2 Primitive hematopoiesis 
As mentioned above, murine primitive or embryonic wave of hematopoiesis occurs at 
around 7-7.5 dpc in the YS blood islands derived from ventral mesoderm, and 
produces primitive erythrocytes, macrophages and rare megakaryocytes (Palis and 
Yoder, 2001; Xu et al., 2001; Medvinsky et al., 1993; Moore and Metcalf, 1970). 
Compared with the definitive red blood cells, the primitive erythroid cells are larger 
and remain nucleated (Lensch and Daley, 2004). These cells express 3 hemoglobin 
tetrameric complexes known as EI (ζ2ε2), EII (α2ε2), and EIII (α2βH12). ε and βH1 are 
embryonic forms of β-globin-like hemoglobin; ζ and α are embryonic and adult forms 
of α-globin-like hemoglobin, respectively (Fantoni et al., 1967). The embryonic forms 
of hemoglobin are uniquely adapted to the diffusion-limited, oxygen-poor 
microenvironment of the embryo prior to circulation (Leder et al., 1980). This early 
erythroid cells require the stimulation of burst promoting activity (BPA), a erythroid 
growth factor intrinsic produced by the YS (Labastie et al., 1984). In the contrast, 
erythropoietin (Epo), which is important for definitive erythroid cell survival and 
proliferation, is not required for this early red blood cell activity and not provided by 
the YS environment (Lin et al., 1996; Wu et al., 1995). 
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Prior to the emergence of primitive erythroblast, several genes important for 
hematopoiesis begin to express in the YS. These genes include stem cell leukemia 
hematopoietic transcription factor (Scl), the receptor tyrosine kinase Flk-1, which are 
expressed in both endothelial and hematopoietic progenitors (Shalaby et al., 1995; 
Shalaby et al., 1997; Shivdasani et al., 1995), and the transcription factors 
GATA-binding protein 1 (Gata-1) and Brachyury that are specifically expressed in the 
hematopoietic cells (Palis et al., 1999). Knockout of Flk-1 abolishes the formation of 
both vascular and hematopoietic lineages, although mesoderm formation appears 
intact (Shalaby et al., 1995; Shalaby et al., 1997). Targeted disruption of Scl results in 
absence of embryonic hematopoietic cells, while the initiation of endothelial cell and 
vascular formation are normal. However, yolk sac vessel patterning is perturbed 
(Shivdasani et al., 1995). The studies of the hematopoietic potential of homozygous 
mutant embryonic stem (ES) cells in chimeric mice demonstrate that both Flk-1 and 
Scl are also required for adult hematopoiesis (Porcher et al., 1996; Robb et al., 1996; 
Shalaby et al., 1997). Mutation of Gata-1 affects both primitive and definitive 
erythropoiesis (Fujiwara et al., 1996; Pevny et al., 1991). 
 
With development of the embryonic vasculature and initiation of cardiac contractions 
at 8.25dpc, the nucleated primitive red blood cells enter the circulation around 8.5dpc, 
persisting beyond the establishment of liver hematopoiesis (10.0dpc) and nearly 
absent at 15dpc (Ji et al., 2003).  
 
1.1.2.3 Definitive hematopoiesis 
Definitive hematopoiesis is believed to originate from the AGM region, which is 
derived from the intraembryonic lateral plate mesoderm, as early as 9dpc in mouse 
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(Medvinsky et al., 1993). At 10dpc, the AGM region possesses the long-term 
multilineage repopulating (LTR)-HSCs ability, able to rescue long-term blood 
formation in transplant recipients (Muller et al., 1994). Between 9.5 and 11dpc, the 
HSCs exit the AGM region and seed the fetal liver presumably through blood 
circulation (Garcia-Porrero et al., 1995). The liver remains an active hematopoietic 
organ until the neonatal period, where HSCs expand and differentiate to various cell 
types (Sasaki and Sonoda, 2000). The splenic rudiment is colonized by HSCs at 
12dpc, becoming fully hematopoietic at 14.5dpc. The spleen aids in the transition 
from fetal liver to bone marrow hematopoiesis, and its activity persists throughout the 
life span of mouse (Sasaki and Matsumura, 1988). HSCs derived lymphoid progenitor 
cells appear to enter the thymic rudiment continuously from 11dpc and the thymus 
remains a lymphopoietic organ throughout life, fundamental to the development of the 
T lymphocytes (Douagi et al., 2002). Bone marrow (BM) is colonized by HSCs at 
16dpc, and serves as the major organ producing blood cells in the juvenile and adult 
mouse (Delassus and Cumano, 1996). 
 
Additionally, definitive hematopoiesis activity was also found in the YS.  Firstly, 
before onset of the circulation, small-enucleated cells expressing adult globin, named 
as bust-forming unit-erythroid (BFU-E) cells are discovered in the YS at 8dpc (Palis 
et al., 1999). These BFU-E cells are then found in blood circulation by 9dpc, and later 
in the liver around 11dpc, suggesting this activity comes from the YS (Palis et al., 
1999). Secondly, multipotent progenitors capable of generating myeloid and lymphoid 
cells can be detected in the YS at 8.5-9dpc (Galloway and Zon, 2003; Yoder et al., 
1997a). And the YS-derived hematopoietic cells are able to form spleen colonies 
(colony-forming unit-spleen, CFU-S activity) after 9dpc. Finally, by 11dpc, the YS 
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harbors LTR-HSCs, which are able to reconstitute all aspects of long-term 
hematopoiesis when transplanted into a lethally irradiated host (Yoder et al., 1997b; 
Yoder and Hiatt, 1997). Therefore, the YS has the potential of definitive 
hematopoiesis.  
 
As mentioned above, Scl and Flk-1 are necessary for both primitive and definitive 
hematopoiesis, and Gata-1 is required for both primitive and definitive erythropoiesis 
(Pevny et al., 1991; Fujiwara et al., 1996). In contrast, Runx1 and c-Myb are required 
for definitive hematopoiesis but not primitive hematopoiesis (Wang et al., 1996; 
Mukouyama et al., 1999; Mucenski et al., 1991; North et al., 1999). Both Runx1 and 
c-Myb deficient mice display the same hematopoietic phenotype: no hematopoietic 
cells generated in the AGM region, fetal liver anemia but normal YS-derived 
erythropoiesis (Wang et al., 1996; Mucenski et al., 1991; North et al., 1999). This 
indicates that these two genes are involved in the definitive HSCs generation, 
maintenance, and proliferation or self-renew. Considering the migratory feature of 
definitive hematopoietic cells, some homing molecules must play a role during this 
early process. β-1-integrin has been identified to be necessary for the migration of the 
hematopoietic cells to the fetal liver as well as to thymus and bone marrow (Fassler 
and Meyer, 1995). Additionally, mutations in Jak2 (Neubauer et al., 1998), Epo/EpoR 
(Wu et al., 1995; Lin et al., 1996) and Erythroid Kruppel-like Factor (Eklf) (Perkins et 
al., 1995) genes disrupt predominately the definitive erythropoiesis. Taken together, 
the molecular regulation of hematopoiesis is complex and the differences between 
primitive and definitive hematopoiesis may be because of the two anatomically 
separated hematopoietic sites: the YS and the AGM region. 
 
 9
1.1.3 Putative hemangioblast 
Hematopoietic and endothelial cells have a close relationship. These cells 
concurrently emerge in the YS and express overlapping sets of genes, including Flk1, 
CD34, Scl, Flt1 and Gata-2, indicating that both of these two cell types are derived 
from a common precursor, hemangioblast (Cumano and Godin, 2001; Keller et al., 
1999). Targeted disruption of Flk-1 or TGF-β1, resulting in absence of both 
hematopoietic and endothelial cell lineages, provides additional evidence for the 
existence of hemangioblast (Dickson et al., 1995; Shalaby et al., 1995; Shalaby et al., 
1997). Furthermore, using the ES cell differentiation culture system, the blast 
colony-forming cells (BL-CFCs), which are isolated within embryoid bodies 
generated from differentiated ES cells, can generate both hematopoietic and 
endothelial cells upon culture with appropriate cytokines. Therefore, the BL-CFC 
represents the putative hemangioblast. Additionally the BL-CFCs are lost quickly 
during the embryoid body development, which may also be the feature of 
hemangioblast that makes it difficult to be identified (Choi et al., 1998; Kennedy et al., 
1997). In addition, in vitro culture system shows that TEK+ cells isolated from AGM 
and Flk+ cells sorted from ES cells and 9.5dpc YS also have the hemangiogenic 
potential (Hamaguchi et al., 1999; Nishikawa et al., 1998). Thus all of this evidence 
indicate the existence of hemangioblast.  
 
1.1.4 Hematopoietic stem cells 
1.1.4.1 Origin of Hematopoietic stem cells 
HSCs are defined by their two abilities: pluripotency and self-renewal. Pluripotency 
means that HSCs are able to create progeny of all blood cell lineages. Self-renewal is 
that HSCs can undergo cell divisions and generate the daughter cells identical to the 
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parent stem cells, maintaining the stem cell pool as well as the proliferative capacity 
of HSCs (Kondo et al., 2003). Currently HSCs have been purified using 
fluorescence-activated cell sorting (FACS) and characterized as the lineage marker-/lo 
(Lin-/lo), c-Kit+, Sca-1+ subset of marrow cells (Uchida et al., 1996). Single HSC of 
the Thy1.1 lo Lin-, c-Kit+, Sca-1+ subset is able to self-renew and reconstitute all 
lineages of the blood in long term when transplanted into irradiated mice (Smith et al., 
1991; Wagers et al., 2002b). 
 
As we have known, the primitive hematopoiesis derives form the YS, whereas the 
definitive wave occurs at the AGM region. What is the relationship between the 
primitive HSCs in YS and the definitive HSCs from AGM remains controversial. 
Some studies support the notion that the two waves of hematopoiesis are 
independently derived from two different HSC pools occurring in two distinct sites 
(Dieterlen-Lievre, 1975; Medvinsky and Dzierzak, 1996), whereas others indicate that 
the early HSCs which give rise to both primitive and definitive waves are originated 
from one anatomic site, and then migrate to the other (Johnson and Moore, 1975; 
Moore and Metcalf, 1970). The most convincing evidence to support the first 
argument comes from studies in birds, where chick yolk sacs were transplanted onto 
quail embryos before the onset of circulation, and the host quail cells were found to be 
the sole contributors to definitive hematopoiesis (Dieterlen-Lievre, 1975). In contrast, 
the studies aiming to demonstrate that YS cells possess at least the capacity of 
transition to definitive blood cells give a support to the second theory. Matsuoka and 
colleagues observed that by co-culture with AGM-derived stromal cells, both early 
YS and AGM, isolated before the onset of circulation, can generate definitive HSCs 
with a similar repopulating potential (Matsuoka et al., 2001). The other experiment 
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showed that enforced expression of HoxB4 combined with culture on hematopoietic 
stroma induces the YS cells to become the definitive HSCs with the long-term, 
multilineage hematopoiesis repopulation activity (Kyba et al., 2002). Both of these 
studies indicate that the precirculation YS hematopoietic tissues have the potential of 
definitive HSCs activity when given the proper induction. But the critical point is 
whether this proper induction also exists in vivo. In another experiment, YS cells 
isolated from 9 dpc embryos were found capable to provide long-term multilineage 
reconstitution in primary neonatal recipients, suggesting that YS HSCs are available 
to seed the fetal liver on 10.0 dpc when definitive hematopoiesis is initiated (Yoder et 
al., 1997b).  
 
Currently, three models describing the origin of definitive HSCs have been proposed 
(Galloway and Zon, 2003). The first theory states that all the HSCs are derived from 
the YS, and the AGM provides the appropriate microenvironment to enable the 
primitive YS cells to mature into definitive HSCs, capable of seeding the fetal liver 
and then bone marrow. The second model asserts that both the YS and the AGM 
generate HSCs independently, and these two sources of HSCs colonize the fetal liver, 
contributing to the definitive hematopoiesis together. In the third model, the AGM is 
the only source of HSCs, and the definitive activity observed in the YS comes from 
the AGM cells through circulation. 
 
1.1.4.2 Lineage differentiation of Hematopoietic stem cell 
Differentiation of HSCs to various blood cell types is believed to undergo a series of 
commitment steps to generate multipotent progenitors, lineage specific precursors and 
finally to terminal differentiated cells with a gradually restricted developmental 
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potential and the loss of self-renewal ability. Oligopotent progenitors, which have 
been identified in mouse, consist of common lymphoid progenitor (CLP) and 
common myeloid progenitor (CMP). CLPs develop to T, B lymphocytes and NK cells, 
whereas CMPs produce granulocyte-monocyte progenitor (GMP) and 
megakaryocyte-erythrocyte progenitor (MEP), which further differentiate to 
macrophage, granulocyte, and megakaryocyte, erythrocyte, respectively (Akashi et al., 
2000; Kondo et al., 1997) (Figure 1.1). 
 
What are the mechanisms governing the cell fate of HSCs? Two models have been 
proposed: stochastic and instructive. The stochastic hypothesis implies that HSCs 
randomly commit to self-renew or differentiate, whereas the instructive model infers 
that the external cues from the microenvironment, in which HSCs reside, drive the 
cell fate (Till, 1964; Socolovsky et al., 1998). Now it is believed that both extrinsic 
and intrinsic cellular regulators work together to determine the HSCs cell fate. Stem 
cells reside in their microenvironments, termed “niches”, which are believed to 
govern their self-renewal or differentiation. When undergoing asymmetric division, 
one daughter cell remains attached to the niche, receiving local signals to self renew, 
whereas the other daughter cell exits the niche and begins to differentiate (Wagers et 
al., 2002a). The extrinsic signals, provided by niches, influence HSCs through direct 
cell-cell or cell-extracellular matrix (ECM) interactions or through secretion of 
soluble mediators (Wagers et al., 2002a). In the absence of these signals, the 
hematopoietic cells will undergo apoptosis. The cytokines including stem cell factor 
(SCF), Flt3 (a tyrosine kinase receptor) ligand, and thrombopoietin (TPO) have been 
identified to affect the process of self-renewal and differentiation of HSCs (Nocka et 




























Figure 1.1 The hematopoietic hierarchy. The hematopoietic stem cells firstly give rise 
to common myeloid progenitors and common lymphoid progenitors, which further 
differentiate and eventually mature to all the blood lineages. MEP, 




























signaling pathways that determine cell fate have been shown to enhance the expansion 
of HSCs ex vivo. These include Wnts, Notch 1, Sonic hedgehog and BMP  
(Bhardwaj et al., 2001; Bhatia et al., 1999; Dyer et al., 2001; Reya et al., 2003; 
Varnum-Finney et al., 2000; Willert et al., 2003). How these environmental cues 
trigger the cell-intrinsic process to determine the self-renewal or differentiation of 
HSCs remains to be ascertained.  
 
Intrinsic regulation of HSC cell-fate decision is predominantly via transcriptional 
regulation. Loss-of-function and overexpression studies have identified several genes 
indispensable for hematopoietic specification during embryonic development. These 
include Scl, lim-only protein 2 (Lmo2), Runx1, Gata-2, c-Myb and Ikaros 
(Nichogiannopoulou et al., 1999; North et al., 1999; Tsai et al., 1994; Mucenski et al., 
1991; Shivdasani et al., 1995; Wang et al., 1996; Warren et al., 1994). In addition, 
Homeobox genes also play a role in hematopoiesis. For example, HOXA9 is important 
for the maintenance of the HSC pool and HOXB4 appears to promote HSC 
self-renewal in vivo (Buske et al., 2002; Lawrence et al., 2005; Lawrence et al., 1997; 
Thorsteinsdottir et al., 1999; Antonchuk et al., 2002; Sauvageau et al., 1995). More 
interestingly, several experiments indicate that multilineage genes are co-expressed in 
HSCs or multipotent progenitors, preceding commitment to differentiation per se. 
These genes include β globin, myeloperoxidase, PU.1, C/EBPα and GATA-3 (Hu et al., 
1997; Ivanova et al., 2002; Phillips et al., 2000). Lineage commitment requires not 
only the enhancement of the appropriate gene expression but also the repression of the 
alternative lineage gene program (Hoang, 2004). A subtle shift in these transcription 
factors dosages can be caused by some “stochastic” events such as interactions with 
stroma, different concentration of a growth factor through activating a signaling 
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pathway. And this subtle shift is sufficient to disrupt the balance between different 
lineage genes and drive lineage commitment through the complex transcription factor 
interaction networks. The networks include positive and negative feedback, 
cooperativity, antagonism, as well as autoregulation paths (Hoang, 2004). For instance, 
PU.1 is essential for the development of both myeloid and lymphoid lineages, but its 
down-regulation is necessary for erythroid differentiation (DeKoter and Singh, 2000; 
DeKoter et al., 1998; Scott et al., 1994; Scott et al., 1997). In contrast, GATA-1 is the 
key player in erythroid and megakaryocyte development, but negatively regulates the 
myeloid specification (Fujiwara et al., 1996; Nerlov et al., 2000; Pevny et al., 1991; 
Pevny et al., 1995). Both PU.1 and GATA-1 proteins can positively autoregulate their 
own expression and mutually antagonize the expression of each other (Tenen et al., 
1997; Chen et al., 1995). Furthermore, PU.1 and GATA-1 physically interact to 
reciprocally inhibit their respective function (Rekhtman et al., 1999; Zhang et al., 
1999). GATA-1 blocks the binding of PU.1 co-activator, c-Jun to PU.1 and then 
inhibits the activation of PU.1 target genes, whereas, PU.1 inhibits GATA-1 function 
by binding to the GATA-1 C-finger and inhibiting GATA-1 DNA binding (Nerlov et 
al., 2000; Zhang et al., 2000). In summary, combination of extrinsic cues and 
cell-intrinsic processes not only determines the HSCs cell fate but also govern 




As discussed above, the primitive erythropoiesis occurs at YS blood islands 
transiently, producing nucleated primitive erythrocytes, which contain the embryonic 
forms of hemoglobin (Lensch and Daley, 2004). The definitive erythropoiesis happens 
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at fetal liver, spleen and then bone marrow sequentially, which ultimately generates 
enucleated mature red blood cells with adult forms of hemoglobin (Lensch and Daley, 
2004). By 12dpc, smaller, anucleate, definitive erythrocytes appear in circulation and 
the population of primitive erythrocytes declines (Galloway and Zon, 2003). During 
the hierarchical ontogeny of definitive hematopoiesis, HSCs give rise to CLPs and 
CMPs; then CMPs generate GMPs and MEPs; MEPs further develop into 
megakaryocyte and erythrocyte progenitors (Kondo et al., 2003). Erythrocyte 
progenitors are not identifiable morphologically, but detected by in vitro colony 
assays as BFU-E (Orkin and Zon, 1997). EPO, SCF and other early acting cytokines, 
including interleukin-3 (IL-3), granulocyte macrophage-colony stimulating factor 
(GM-CSF) and TPO, are important for the synergistic expansion of BFU-E (Dai et al., 
1991; Sawada et al., 1989; Ratajczak et al., 1998). Primarily dependent on EPO, 
BFU-E continues differentiate into the colony forming unit-erythroid (CFU-E) and 
subsequent matures through several erythroblastic stages (Sawada et al., 1989). The 
proerythroblast is the first morphologically recognizable erythroid precursor, 
distinguished by its large nucleus and basophilic cytoplasm as revealed by 
Wright-Giemsa staining (Orkin and Zon, 1997). Only small quantities of hemoglobin 
are present at the proerythroblast stage. During further differentiation, the chromatin 
condenses and hemoglobin increases gradually. Terminally, in mammalian definitive 
erythropoiesis, non-nucleated mature red blood cells are generated. This process is 
also accompanied with the loss of cell division ability and arrest of cell cycle.  
 
The stepwise progression through erythropoiesis is tightly regulated by positive- and 
negative-acting transcription factors controlling genes involved in proliferation and 
differentiation. GATA-1, a zinc finger transcription factor is the key molecule in 
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erythroid development and is induced by EPO signal. GATA-binding motifs 
((T/A)GATA(A/G)) have been identified in the promoters or enhancers of all the 
studied erythroid and megakaryocytic-specific genes (Evans et al., 1988). Mice 
lacking GATA-1 die around 10.5dpc from severe anemia with erythroid maturation 
arrest at a proerythroblast-like stage (Fujiwara et al., 1996). In vitro differentiated 
GATA-1- ES cells are also developmentally arrested and succumb to apoptosis (Weiss 
et al., 1994; Weiss and Orkin, 1995). Thus, GATA-1 regulates the survival as well as 
the maturation of erythroid cells. 
 
Biochemical studies have shown that GATA-1 interacts with multiple proteins, 
including Friend of GATA-1 (FOG-1), EKLF, SCL, PU.1, Sp1, CBP/p300 as well as 
the SWI/SNF chromatin-remodeling complex, and regulates erythroid cell 
development as either an activator or a repressor (Rodriguez et al., 2005). So far, the 
best-studied co-activator of GATA-1 is FOG-1. FOG-1 is co-expressed with GATA-1 
during development and FOG-1 deficient mice display similar erythroid phenotype to 
that of GATA-1 null mice (Tsang et al., 1997; Tsang et al., 1998). FOG-1 contains 
nine zinc-fingers four of which individually mediate interactions with the N-finger of 
GATA-1 (Crispino et al., 1999). Activation of numerous GATA-1 target genes such 
as β-globin gene, requires the proper binding of GATA-1 with FOG-1, whereas 
other’s, notably FOG-1 itself and EKLF, are induced independent of FOG-1 (Anguita 
et al., 2004; Pal et al., 2004; Letting et al., 2004). In addition to FOG-1, GATA-1 
forms multimeric complex with SCL, Ldb1, E2A and LMO2 and activates 
glycophorin A and the α-globin locus through closely spaced GATA and E-box 
binding motifs (Lahlil et al., 2004). Interestingly, GATA-1 can also repress the 
expression of GATA-2, c-myc and c-kit, which are expressed abundantly in HSCs and 
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progenitor cells but decrease in the erythroid lineage (Rylski et al., 2003). The 
repression of GATA-2 and c-kit by GATA-1 also requires FOG-1, which recruits the 
nucleosome remodeling and histone deacetylase complex to repress transcription 
(Hong et al., 2005).  
 
1.1.6 Myeloid lineage development 
Neutrophils, basophils and eosinophils are white blood cells with granules, termed 
granulocytes. They share a precursor cell, GMP, with monocytes. IL-3 and GM-CSF 
are required for production of GMPs. Two distinct cytokines, macrophage 
colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor 
(G-CSF), support monocyte and granulocyte differentiation, respectively (Barreda et 
al., 2004).  
 
HSCs are primed for multilineage gene expression including PU.1 and GATA-1. 
Treatment of CD34+ cells with GM-CSF leads to PU.1 increase and GATA-1 
decrease. PU.1 positively autoregulates its own promoter and activates the gene for 
the GM-CSF receptor α, resulting in increases in proliferation, differentiation, and 
suppression of apoptosis of myeloid progenitors (Scott et al., 1994; Scott et al., 1997; 
Chen et al., 1995). At the same time, PU.1 downregulates GATA-1 promoter and 
inhibits GATA-1 function by interacting with it, leading to inhibition of erythroid 
pathway (Zhang et al., 2000). Analysis of PU.1-knockout mice shows that the earliest 
myeloid progenitors can form in the absence of PU.1, but cannot further differentiate, 
indicating that PU.1 is important for the further development, especially for monocyte 
and macrophage differentiation from the precursors (McKercher et al., 1996).  
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Through a relatively small region within its Ets domain, PU.1 interacts with several 
factors, including GATA-1, GATA-2, Runx1, C/EBP (CCAAT enhancer binding 
protein) and C-Jun, and mediates both positive and negative regulation of PU.1 
activity (Zhang et al., 1999; Petrovick et al., 1998).  As discussed earlier, GATA-1 
and GATA-2 inhibit PU.1 by the interaction, whereas, Runx1 and C/EBP factors have 
a cooperative and/or synergistic positive function through the interaction (Zhang et al., 
1999; Petrovick et al., 1998). C-Jun has been shown to be upregulated during 
monocytic, but not granulocytic, differentiation of GMP. Further studies found that 
C-Jun mediates the enhancement effect of Ras on PU.1 transactivation function as a 
specific coactivator, critical for activating the monocytic target promoters such as the 
M-CSF receptor promoter (Behre et al., 1999). 
 
PU.1, together with its coactivator C-Jun, induces the multipotential myeloid 
precursors to differentiate along the default monocytic pathway, whereas, C/EBPα 
acts to block the default pathway and induce granulocytic differentiation (Radomska 
et al., 1998). C/EBPα is specifically up regulated in early granulocytic cells, down 
regulated in monocytic cells (Radomska et al., 1998). Consistent with this expression 
feature, C/EBPα deficient mice show that granulocytes are blocked at an early stage 
of development, all other blood cell elements appear to be normal, indicating that 
C/EBPα is critical for early granulocyte development (Zhang et al., 1997). The target 
genes of C/EBPα include G-CSF receptor, the IL-6 receptor α and primary granule 
protein genes (Zhang et al., 1997). Another C/EBP protein, C/EBPε is essential for 
terminal maturation of granulocytes (Lekstrom-Himes and Xanthopoulos, 1999; 
Yamanaka et al., 1997). Targeted disruption of C/EBPε results in a fertile viable 
mouse whose granulocytes block at the terminal maturation stage (metamyelocyte). 
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The functionally abnormal granulocytes cannot kill bacterial targets, making the 
C/EBPε-knockout animals to develop infections in a nonsterile environment. In the 
C/EBPε-knockouts, the secondary granule protein mRNA is selectively deficient, 
whereas, the primary granule mRNA is comparable to that of wild type 
(Lekstrom-Himes and Xanthopoulos, 1999; Yamanaka et al., 1997). Therefore, 
granulocyte differentiation is induced initially by C/EBPα, which is essential for 
primary granule protein gene expression, and subsequently by C/EBPε, which is 
critical for secondary granule protein gene expression and terminal maturation.  
 
1.1.7 T Lymphocyte development 
1.1.7.1 T lymphopoiesis 
CLPs, derived from pluripotent HSCs, are capable to differentiate into T and B 
lymphocytes as well as NK cells. T-cell development depends on the 
microenvironment of thymus. From 11dpc, CLPs enter the thymic rudiment 
continuously and the thymus remains a lymphopoietic organ throughout life (Douagi 
et al., 2002). In the thymus, CLPs lose the potential for B cell and NK cell 
development. These early committed T cells lack expression of T-cell receptor (TCR), 
CD4 and CD8, and are termed double-negative (DN; no CD4 or CD8) thymocytes. 
DN thymocytes are further subdivided into four sequential stages of differentiation: 
DN1, CD44+CD25-; DN2, CD44+CD25+; DN3, CD44-CD25+; DN4, CD44-CD25-. 
DN T cells give rise to the major population of αβ TCR-expressing T cells and the 
minor population of γδ TCR-expressing cells. For cells that proceed along the αβ TCR 
pathway, DN3-stage cells first express the pre-TCR, which is composed of the 
non-rearranging pre-TCR α-chain and a rearranged TCR β-chain. At the cell surface, 
the pre-T-cell receptor forms a complex with the CD3 molecules that provide the 
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signaling components of T-cell receptors. The assembly of CD3: pre-T-cell receptor 
complex leads to cell proliferation, the expression of co-receptor proteins CD8 and 
CD4, and replacement of the pre-TCR α-chain with a newly rearranged TCR α-chain, 
which yields a complete αβ TCR. The resulted large population of double-positive 
(DP; CD4+CD8+) αβ-TCR-expressing thymocytes then interact with cortical epithelial 
cells that express a high density of MHC class I and class II molecules associated with 
self-peptides. Most DP thymocytes bear receptors that interact so poorly with the 
self-peptide-MHC ligands that the intracellular survival signals are not generated, 
which leads to death by neglect. A small fraction of DP thymocytes express TCRs that 
bind very well to self-antigens and the resulted too strong signals promote rapid 
apoptotic death (negative selection). Cells that express TCRs that recognize self MHC 
and generate appropriate intermediate level of signals initiate a multi-step process 
known as positive selection that ultimately results in lineage-specific differentiation 
into either CD4+ or CD8+ mature T cells (Germain, 2002).  
 
The mechanisms controlling the commitment of HSCs to the lymphoid lineages are 
poorly understood. The earliest known transcription factor that regulates the lymphoid 
specification and differentiation is Ikaros (Georgopoulos et al., 1994). Ikaros and its 
molecular partners, Helios and Aiolos, are zinc finger transcription factors, which 
have four N-terminal and two C-terminal zinc-finger domains. The N-terminal 
domains are crucial for DNA binding, whereas the C-terminal zinc fingers mediate the 
heterodimerization between Ikaros, Aiolos and Helios (Rebollo and Schmitt, 2003). 
Targeted disruption of Ikaros gene leads to severe deficiency in B, T and NK cell 
development, while erythroid, megakaryocyte, and myeloid cell development is 
normal (Georgopoulos et al., 1994). Interestingly, Ikaros appears to function both as a 
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transcriptional repressor and as an activator. Ikaros binds a large number of nuclear 
factors, including the histone deacetylase repressor complexes NURD and SIN3, and 
the nucleosome-remodelling complex SWI/SNF, indicating much of the influence of 
Ikaros is mediated through chromatin reorganization. Ikaros may activate or repress 
transcription in the classical way by binding to the promoter in cooperation with other 
factors. Alternatively, by physically recruiting genes or repression complexes into 
regions of pericentromeric-heterochromatin (PC-HC), the 
transcriptionally-inaccessible nuclear regions, Ikaros represses or activates gene 
transcription respectively (Westman et al., 2002). The downstream target genes of 
Ikaros identified so far include recombination-activating genes (RAG)-1 and RAG-2, 
terminal deoxynucleotidyl transferase (TdT), immunoglobulin heavy and light chains, 
Igα, and CD3 (Fuller and Storb, 1997; Fong et al., 2000). RAG-1, along with RAG-2, 
catalyzes the rearrangement of immunoglobulin genes in immature B cells and of T 
cell receptor genes in immature T lymphocytes, which plays an important role in B 
and T lymphocyte maturation. RAG-1 knock out mice have no mature T cell or B cell 
(Mombaerts et al., 1992). 
 
Several transcription factors and signal pathways have been identified to regulate T or 
B cell lineage determination from CLP. Notch1 signaling is believed to be necessary 
and sufficient to induce T-cell lineage specification in early lymphoid progenitors 
(Radtke et al., 2004; Radtke et al., 1999). The expression of a dominant active form of 
Notch1 in hematopoietic precursors results in the ectopic T cell development in BM at 
the expense of B cell development (Pui et al., 1999). Conversely, the inactivation of 
Notch 1 in newborn mice completely abrogates T cell differentiation and the thymus 
apparently becomes a site for B cell development (Wilson et al., 2001). The B lineage 
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commitment factor Pax5 is reported to repress Notch1 expression at the 
transcriptional level in B-cell progenitors, providing a possible mechanism to ensure 
B-cell development in the BM (Souabni et al., 2002). Additionally, E-box binding 
protein E2A dosage determines the choice between a B or T cell fate. Higher E2A 
activity is required for commitment into the B cell lineage and for proper B-cell 
differentiation (Herblot et al., 2002; Zhuang et al., 1996). And E2A also interacts with 
Hela E-box Binding protein (HEB), driving T cell development (Barndt et al., 2000; 
Sawada and Littman, 1993). Another key factor, GATA-3, expressed specifically in T 
and NK cells, has also been found to be required for T cell lineage commitment and 
differentiation (Ting et al., 1996).  
 
1.1.7.2 Thymus organogenesis 
In vertebrates, thymus plays an important role for T lymphocyte development. 
Thymus organogenesis in mammals requires the intercommunication of tissues from 
all three embryonic germlayers: ectoderm, mesoderm and endoderm (Manley, 2000). 
This process can be separated into three stages: formation of the thymic rudiment, the 
interaction between T cells and thymic epithelial cells (TECs), and fetal thymus 
development. In the first stage of thymic development, the third pharyngeal pouch 
endoderm provides the initiating signals for induction of the thymus. And the 
neuroectoderm-derived neural crest mesenchymal cells from the sixth hindbrain 
rhombomere respond to this signal and migrate to the third and fourth pharyngeal 
pouches, where they interact with endoderm and provide signals supporting growth 
and differentiation of the epithelial rudiment. During the second stage, the thymic 
rudiment is colonized by CLPs derived from HSCs. The interaction between CLPs 
and TECs leads to further patterning and differentiation of the TECs. Last, throughout 
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fetal development, TECs appear to progressively acquire competence to promote 
different stages of thymocyte maturation (Manley, 2000). 
 
Several factors have been identified to be involved in the early stages of thymus 
organogenesis. Mutation of the Hoxa3 gene, which is expressed in both the third 
pouch endoderm and neural crest mesenchyme, results in athymia as well as the 
pharyngeal region defects in mice (Manley and Capecchi, 1995). Thus Hoxa3 may be 
involved in the initial induction of thymus organogenesis with a general mechanism 
involved in the pharyngeal pouch endoderm development. Pax1 and Pax9, expressed 
throughout the pharyngeal endoderm, are specifically down regulated in the third 
pharyngeal pouch in Hoxa3 knockouts (Manley and Capecchi, 1995). Pax1 mutants 
have subtle defects in thymus development, whereas Pax9 inactivation leads to severe 
thymic deficiency (Peters et al., 1998; Su and Manley, 2000). Furthermore, genetic 
interaction between Hoxa3 and Pax1 genes has been indicated by the severity of the 
thymic defect in Hoxa3+/-Pax1-/- compound mutants (Su and Manley, 2000). 
Therefore, Hoxa3, Pax1 and potentially Pax9 may function in the same pathway to 
form the endoderm of thymic rudiment.  
 
Foxn1, also known as Whn, is essential for proper development of the thymus 
epithelium (Blackburn et al., 1996; Nehls et al., 1994). It is identified as the 
responsible gene for nude mice that are characterized by lack of fur development and 
thymus agenesis. Foxn1 expression is specific to epithelial cells, both in the skin and 
in the thymus. It is expressed already in all epithelial cells of the thymus before the 
entry of lymphoid progenitors (Nehls et al., 1996). Disruption of the Foxn1 gene in 
nude mice shows an arrest of differentiation of the thymic epithelium that prevents 
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colonization by CLPs (Blackburn et al., 1996; Nehls et al., 1994). The Foxn1 gene 
encodes for an evolutionarily highly conserved transcription factor of the winged 
helix domain family. The Foxn1 protein comprises a C-terminal transcriptional 
activation domain and a DNA-binding domain, both of which are critically required 
for target gene activation by Foxn1 (Boehm et al., 2003). However, the precise 
functions of Foxn1, i.e. its target genes, are still largely obscure. Some studies 
indicate that thymus-expressed chemokine (TECK), stromal cell-derived factor-1 
(SDF-1) may be the target genes of the Foxn1 and loss of them in thymus of nude 
mice leads to failure of attracting the CLPs into thymus (Boehm et al., 2003).  
 
1.2 Genetic study of hematopoiesis in Zebrafish 
1.2.1 Zebrafish is a powerful model to study hematopoiesis 
Although much advancement has been made to understand the blood forming 
processes, the underlying mechanisms of hematopoiesis have yet been fully revealed. 
The mouse system has its limitation. For example, mouse knockout techniques restrict 
to studying previously identified genes suspected of playing a role in hematopoiesis, 
but not favor to discovery of new genes involved in this process. Furthermore the 
small litter size makes the mouse not very well suited for forward genetic studies. 
Additionally, mouse embryos develop in uteri and it is difficult to study early 
hematopoiesis.  
 
Complementary to the mouse system, the zebrafish has been proved to be an ideal 
genetic model for hematopoiesis studies for the following reasons: Firstly, zebrafish 
has a similar hematopoietic program as other vertebrate organisms (Amatruda and 
Zon, 1999). It consists of multilineage of blood cells, including erythroid, myeloid, 
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lymphoid, and platelet-equivalent cells, and has two waves of hematopoiesis 
(Thompson et al., 1998). Furthermore, homologues of genes critical for hematopoiesis 
(gata factors, lmo2, scl, c-myb, ikaros, lck, c-fms, c-kit, globins) and vasculogenesis 
(tie1, tek, flk1, flt) in mice have been isolated in zebrafish and play roles similar to 
their mammalian orthologues (Paw and Zon, 2000). Thus, studies in zebrafish are 
relevant to other vertebrate organisms. Secondly, zebrafish embryos develop 
externally and are transparent, so it is easy to observe and manipulate the embryos 
under the microscope. Finally, its short generation time, rich fecundity, and high 
mutagenesis efficiency by ethylnitrosourea (ENU) make zebrafish well suited for 
forward genetic screens (Paw and Zon, 2000). So in our lab, we use zebrafish to study 
hematopoiesis. In the following sections, I will discuss the current progress in 
hematopoiesis and methods of research in this area of zebrafish studies. 
 
1.2.2 Primitive hematopoiesis in zebrafish 
In zebrafish, primitive hematopoiesis occurs in two distinct intraembryonic locations: 
the intermediate cell mass (ICM) and the rostral blood island (RBI). The ICM derives 
from two bilateral stripes in the posterior lateral mesoderm (PLM), equivalent to the 
mammalian yolk sac blood islands. It produces the primitive proerythroblasts and the 
endothelial cells of the trunk vasculature, whereas, the RBI in the anterior lateral 
mesoderm (ALM) generates mainly macrophages and possibly neutrophils, as well as 
vasculature endothelial cells (de Jong and Zon, 2005) (Figure 1.2).  
 
1.2.2.1 Primitive erythropoiesis 
In Zebrafish, the earliest primitive hematopoietic progenitors emerge at 1-2 somite 
stage (11hpf) as indicated by appearance of scl expression as a pair of bilateral stripes 
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in the PLM (Porcher et al., 1996; Liao et al., 1998). Other early hematopoietic and 
vascular markers including lmo2, gata2, draculin (drl), hhex, fli1a are also expressed 
by these progenitors (Davidson and Zon, 2004). Zebrafish mutants kugelig/cdx4, 
spadetail/tbx16, cloche have defects in the HSCs formation in the PLM (Davidson 
and Zon, 2004).    
 
Commitment of the HSCs into erythroid lineage begins at the 4-somite stage with 
appearance of gata1 expression in a subset of scl+ cells (Davidson et al., 2003; 
Detrich, III et al., 1995). These gata1 positive cells in the PLM extend anteriorly and 
posteriorly, migrate towards the midline and then converge at the 20-somite stage to 
form the ICM. During these processes, erythroid precursors further develop and 
proliferate. By 24-26 hpf when the blood circulation begins, the ICM comprises of at 
least 300 proerythroblasts (Long et al., 1997). These proerythroblasts express genes 
required for heme and globin synthesis (α and β embryonic globins, alas2, fch, urod), 
iron utilization (dmt1) and membrane stability (β-spectrin, protein 4.1r, band3), and 
mature into flattened elliptical erythrocytes which retained nucleus over the next 4 
days during circulating (Davidson and Zon, 2004). Transfusion experiments have 
demonstrated that these primitive erythrocytes are the only circulating red blood cells 
for the first 4 days postfertilization (dpf) and begin to decline by 6dpf, reaching 50% 
of the initial number at 10dpf (Weinstein et al., 1996). The bloodless mutant, defective 
in primitive erythropoiesis in the ICM, starts to restore the circulating red blood cells 




1.2.2.2 Primitive myelopoiesis 
Like the primitive progenitors in the ICM, those found in the RBI also express scl, 
lmo2, gata2 and fli1a at the 3-5 somite stage (11-12hpf), contributing to both blood 
and vascular development (Brown et al., 2000; Liao et al., 1998; Thompson et al., 
1998). This is followed soon after by pu.1 expression in a subset of scl+ RBI cells, 
indicating the initiation of myeloid lineage precursors in RBI (Bennett et al., 2001; 
Lieschke et al., 2002). These early pu.1+ myeloid cells, including macrophages and 
granulocytes, migrate toward the head midline during 11-15 somite stage (14-16hpf) 
and then migrate laterally across the yolk sac at around 22-24hpf. Then some of them 
enter circulation via the ducts of Cuvier, while others migrate into the head (Herbomel 
et al., 1999). pu.1 is also expressed at a low level in ICM blood precursors at 10-19 
somite stage (14-18hpf), then disappears due to increase of gata1. But the expression 
of pu.1 in the ALM continues until 28 to 30hpf (Lieschke et al., 2002). Zebrafish 
l-plastin, monocytes/macrophages marker, starts to be expressed in ALM at 18hpf and 
by 28hpf is detected in the posterior ICM (Herbomel et al., 1999). Consistent with this, 
lysozyme C, also specifically expressed in monocytes/macrophages, is observed over 
the anterior portion of the yolk at 20hpf and in the posterior portion in the ICM by 
30hpf (Liu and Wen, 2002). It is controversial whether these posterior macrophages 
are derived from posterior ICM or come from the circulating macrophages generated 
in RBI. The functional activity of these early macrophages has been observed as early 
as 26hpf in the ducts of Cuvier, where macrophages can be seen engulfing 
erythroblasts from the bloodstream. Additionally, macrophages at 30hpf can migrate 
to the site of infection with Escherichia coli and Bacillus subtilis and phagocytose the 
offending bacteria (Herbomel et al., 1999). 
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Zebrafish is found to have at least two types of granulocytes: neutrophilic 
granulocytes and eosinophilic granulocytes, the latter exhibiting characteristics of 
both mammalian eosinophils and basophils. The neutrophils can be morphologically 
detected in circulation and in loose connective tissue at 48hpf, whereas the site and 
time of origin of the eosinophilic granulocytes are not clear (Lieschke et al., 2001). 
Zebrafish myeloperoxidase (mpo), the granulocyte-specific marker, is first detected at 
18hpf in presumptive neutrophilic precursors within the caudal ICM. One to two 
hours later, mpo is also found in the cells scattered on the yolk sac. Some of the 
anterior mpo-expressing cells coexpress pu.1, suggesting their origin from RBI. 
However, the onset of expression of mpo in caudal ICM before circulation supports 
the argument that the ICM also gives rise to a population of myeloid progenitors 
(Bennett et al., 2001). Most of the mpo+ cells do not coexpress l-plastin, consistent 
with an idea that these two molecules mark distinct granulocyte and macrophage 
lineages respectively (Bennett et al., 2001). By 3dpf, the mpo+ cells distribute 
throughout the embryo and can be observed to accumulate at sites of injury (Lieschke 
et al., 2001). Currently it is not known how long the primitive macrophages and 
granulocytes persist in the embryo. 
 
1.2.3 Definitive hematopoiesis in zebrafish 
The definitive hematopoiesis in zebrafish is believed to start in the ventral wall of the 
dorsal aorta, the AGM equivalent, between 24-48hpf, based on the expression of 
runx1 and c-myb (Burns et al., 2002; Thompson et al., 1998; Kalev-Zylinska et al., 
2002). Studies in mice have shown that Runx1 and c-myb are essential for definitive, 
but not primitive hematopoiesis (North et al., 1999; Mucenski et al., 1991; 
Mukouyama et al., 1999; Wang et al., 1996). In zebrafish, expression of runx1 is 
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firstly detected at 12hpf in the ICM colocalizing with scl-expressing cells. By 24hpf, 
expression of runx1 in the posterior ICM is weakened, while a new domain of 
expression of runx1 appears in the ventral wall of the dorsal aorta, and persists until 
40hpf (Burns et al., 2002; Kalev-Zylinska et al., 2002). These runx1 positive cells in 
the ventral wall of the dorsal aorta also express c-myb, scl, lmo2 and ikaros (Davidson 
and Zon, 2004; Willett et al., 1999). Morpholino knockdown of runx1 abolishes the 
definitive hematopoiesis, as well as the vasculature formation (Kalev-Zylinska et al., 
2002). Thus, it is postulated that the c-myb and runx1 expressing cells are the 
definitive HSCs that subsequently seed kidney and thymus (Figure 1.2).  
 
By 5dpf, the definitive hematopoiesis is established in the kidney, the hematopoietic 
organ at adult zebrafish (Galloway and Zon, 2003; Willett et al., 1999). By 7dpf, 
erythroblasts, myeloblasts and neutrophilic granulocytes are easily observed in the 
kidney, whereas lymphoblasts are not found here until 19dpf (Danilova and Steiner, 
2002; Willett et al., 1999).  
 
Definitive erythropoiesis starts around 5dpf as indicated by the recovery of circulating 
red blood cells in the bloodless mutant at this time (Liao et al., 2002). Distinct from 
those in mammals, zebrafish mature definitive erythrocytes are nucleated and 
elliptical in shape. Similar to that in mammals, zebrafish hemoglobin is a tetrameric 
molecule that consists of two α-globin subunits and two β-globin subunits. These cells 
also undergo globin switching from primitive forms to adult forms (Brownlie et al., 
2003; Chan et al., 1997).  
 










Bilateral zebrafish thymi form as small outgrowths between the third and fourth 
pharyngeal pouches and firstly become populated by CLPs around 65hpf (Willett et 
al., 1999). Around 3-4dpf, expression of gata3, ikaros, the T cell receptor kinase lck, 
rag1 and rag2 are observed in the thymus (Trede et al., 2001; Willett et al., 1999; 
Willett et al., 1997). The thymi continue to develop and reach their adult size around 1 
month postfertilization, contributing to T lymphopoiesis throughout the life (Lam et 
al., 2002; Willett et al., 1997). The origin of the CLPs that first colonize the thymi is 
not known. They are unlikely from the HSCs in kidney considering that the kidney 
hematopoiesis occurs several days later (Willett et al., 1999). It is postulated that a 
subset of ikaros-expressing cells in the ventral wall of the dorsal aorta at 48hpf may 
seed the thymi first (Willett et al., 2001; Willett et al., 1999). 
 
1.2.4 Genetic methods to study hematopoiesis in zebrafish 
1.2.4.1 Mutagenesis Screening 
The first large-scale genetic screens in a vertebrate organism were carried out using 
zebrafish in Boston and Tuebingen (Driever and Fishman, 1996; Haffter et al., 1996). 
In these screens, ENU was used to mutagenize the DNA of the premeiotic germ cells 
in adult male fish. Then the mutagenized males (founder) were crossed with wild type 
female to produce F1 progenies, which contain heterozygotes for mutations within the 
zebrafish genome, at a rate of about 100-200 mutations per fish. The F1 fish were 
mated to wild type fish. The resulting F2 fish families were intercrossed and the 
mutant phenotypes were scored in the F3 generation (Figure 1.3). Over 2,000 mutants 
with abnormal embryonic development were isolated by visual inspection in the F3 
generation (Driever and Fishman, 1996; Haffter et al., 1996). These mutants may 





Figure 1.3 Outline of forward genetic screen in zebrafish (Haffter et al., 1996).  
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development (Weinstein et al., 1996; Ransom et al., 1996). Once the mutant is 
isolated, positional cloning is needed to perform to identify the responsible gene 
causing the phenotype. Some of the mutated genes have been cloned including those 
involved in hematopoiesis. For example, weissherbst mutant gene encodes 
Ferroportin 1, a novel iron exporter (Donovan et al., 2000; Fraenkel et al., 2005); 
yquem mutant gene encodes uroporphyrinogen decarboxylase (Wang et al., 1998). In 
the following ENU mutagenesis screens, whole-mount in situ hybridization (WISH) 
and fluorescent reporters were usually used to examine the expression of specific gene 
transcripts for mutants screening (de Jong and Zon, 2005).  
 
In addition to chemical-induced mutations, insertional mutagenesis using a retroviral 
vector is also applied to cause genomic mutagenesis in zebrafish. This method allows 
rapid isolation of the disrupted genes by inverse PCR. However, the efficiency of 
insertional mutagenesis is low, only about 10% of the rate by ENU mutagenesis 
(Amsterdam et al., 1999; Amsterdam et al., 2004; Golling et al., 2002).  
 
1.2.4.1.1 Zebrafish Genomics 
The zebrafish genome is about 1700Mb, consisting of 25 chromosomes. The Sanger 
Institute started sequencing the genome of the zebrafish from February 2001 
(http://www.sanger.ac.uk/Projects/D_rerio/). The strategy being used is clone mapping 
and sequencing from BAC and PAC libraries, in combination with a whole genome 
shotgun (WGS) assembly. The clones are selected for sequencing based on their 
locations in the physical map, then manually annotated and accessible in Vega 
(http://vega.sanger.ac.uk/Danio_rerio/index.html). Sequences released from Vega 
currently cover around 890Mb (Jun 2006) of the zebrafish genome, of which 280Mb 
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has been manually annotated. The assembly is generated based on the integration of 
the finished clone sequences and WGS sequences which are filled in the gaps between 
the clone contigs. The assembly is automatically annotated and can be browsed on the 
Ensembl site (http://www.ensembl.org/Danio_rerio/index.html). Currently the Sanger 
Institute has released the sixth assembly of the zebrafish genome (Zv6) in Ensembl, 
which includes 21,503 genes, 130 pseudogenes and 3,421 non-coding genes. The 
zebrafish genome project greatly simplifies the process of mapping the mutant genes.   
 
1.2.4.1.2 Principles of Positional Cloning 
In general, positional cloning consists of three steps (Detrich et al. 1999). The first 
step involves the identification of a DNA segment (marker) that is near the mutant 
locus by linkage analysis. The most commonly used approach is called Bulk 
Segregation Analysis (BSA) shown in fgure 1.4.  
 
In the second step of positional cloning, the closest marker is used to isolate clones 
from genomic libraries. If the marker and the mutant locus are closely linked, the first 
clones isolated may contain the gene. Otherwise, the process is repeated to carry out a 
genomic walk until linkage analysis demonstrates that the mutant locus is 
encompassed in a contiguous stretch of genomic DNA (contig). Based on the database 
of Zebrafish Genome Fingerprinting Project established by Sanger Institute 
(http://www.sanger.ac.uk/Projects/D_rerio/WebFPC/zebrafish/small.shtml), which 
provides over 2,500 FPC contigs including the clone sequences, it is easy now to 
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Figure 1.4 Bulk segregation analysis to isolate linked SSLP.
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The third step is identification of the gene within the contig region. This may be 
accomplished in a number of ways, ranging from transgenic rescue of the mutation to 
sequence analysis of the genomic region. 
 
1.2.4.2 Morpholinos 
Antisense morpholino oligos (MOs), first developed for clinical therapeutic 
applications, were introduced into developmental biology early in 2000 and have been 
used in a range of model organisms, including zebrafish, frog, chick, and mouse to 
knockdown the mRNA of specific genes of interest (Nasevicius and Ekker, 2000; 
Heasman, 2002). As DNA analogs, they are not susceptible to enzymatic degradation 
and are stable in the cell. MOs work to block the translation initiation or interfere with 
normal splicing of the specific mRNA by targeting the translation initiation site or 
splicing sites. The advantages of MOs are high specificity and simple delivery method 
such as microinjection in zebrafish. However, they have limitations in that MOs only 
persist for 3-6 days and their injection can produce dose-dependent toxicity (Heasman, 
2002). But, with cautious use and clear controls, MOs has proved to be the most 
generally used and useful reverse genetic method to study hematopoiesis in zebrafish.  
 
1.2.4.3 Transgenic Reporters 
Microinjection of DNA construct into 1-cell stage zebrafish embryos is successfully 
used to generate transgenic zebrafish carrying transgenic reporter such as GFP and 
DsRed under the control of the specific gene promoter. These transgenic fish express 
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the fluorescent proteins in the specific regions and the flurescent positive cells are 
easily visible under the microscope in the transparent embryos (de Jong and Zon, 
2005). Stable transgenic line can be generated with 1-5% efficiency of the germline 
transmission (de Jong and Zon, 2005). The fluorescent transgenic fish can be used in 
mutant screening, cellular defect analysis in mutants, cell fate mapping and 
hematopoietic cell transplantation experiments (Langenau et al., 2004; Traver et al., 
2003).  
 
1.2.4.4 Targeting Induced Local Lesions In Genomes (TILLING) 
Although forward genetic studies are extremely valuable for hematopoiesis research 
in zebrafish, cloning of the responsible genes is still laborious. Reverse genetic 
techniques undoubtedly provide an alternative way to reveal gene functions. 
Morpholino knockdown is the most widely used reverse genetic method in zebrafish, 
but it has limitation that has been discussed above. Targeted gene knockout routinely 
done in mice, which requires homologous recombination in pluripotent ES cells, has 
not been established in zebrafish. Recently, target-selected mutagenesis, that is 
random mutagenesis followed by screening for mutations in specific target genes, has 
been used to complement reverse genetic analysis in zebrafish. This method, also 
called TILLING (targeting induced local lesions in genomes), has been successfully 
used in Caenorhabditis elegans, Drosophila, plants, mouse, rat and zebrafish 
(Wienholds et al., 2003; McCallum et al., 2000; Zan et al., 2003; Jansen et al., 1997; 
Beier, 2000; Bentley et al., 2000). In zebrafish, just like the forward genetic screens, 
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this strategy uses ENU to mutagenize the male fish, which are mated to wild type 
females to generate F1 populations. DNA from sacrificed F1 males or tail clip DNA 
from live F1 fish are screened for mutations in a specific gene of interest. The 
screening can be performed by direct sequencing of PCR products spanning the 
sequences of interest. Alternatively, an enzyme, CEL-I, which cleaves heteroduplex 
and is faster and cheaper, has also been proved successful (Wienholds et al., 2003). 
The mutant line is then recovered from cryopreserved sperm by in vitro fertilization 
or from the live F1 fish by mating. By this method, 15 different mutations in the rag-1 
gene have been identified (Wienholds et al., 2002; Wienholds et al., 2003).  
 
1.2.5 Important zebrafish hematopoietic mutants  
Over 50 blood mutants, consisting of 26 complementation groups, have been 
identified in large-scale zebrafish genetic screens (Weinstein et al., 1996; Ransom et 
al., 1996). Additionally, other hematopoietic mutants have been isolated as 
spontaneous mutations. These mutants, which were initially scored by observation of 
decreased blood circulation and then characterized by WISH analysis of the 
hematopoietic markers’ expression, can be further subgrouped into the following 3 
categories (Ransom et al., 1996).  
  
1.2.5.1 HSC mutants 
The HSC mutants, including cloche (clo), spadetail (spt) and kugelig (kgg), display 
defects in the development or maintenance of HSCs. The clo mutant has a severe 
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deficiency in endothelial and all lineages of blood cells, indicating clo is specific to 
hemangioblast formation (Stainier et al., 1995). The expressions of scl, gata2, lmo2, 
gata1, hhex, runx1 and runx3 are all downregulated in the clo mutant. And 
overexpression of scl or hhex, but not bmp4, can rescue the clo defects, suggesting clo 
may act after bmp4 pathway but upstream of scl and hhex (Liao et al., 2002; Liao et 
al., 1998). Transient expression of runx1 partially rescues clo, indicating its role is 
also downstream of clo (Kalev-Zylinska et al., 2002). However, none of them is a 
candidate for clo gene based on the mapping data. 
 
spt mutant embryos display a defect in mesoderm cell migration, resulting in aberrant 
somite patterning and accumulation of mesoderm cells in the tail, which specifically 
disrupts the HSC formation in the ICM as indicated by reduced expression of 
hematopoietic markers scl, gata1, gata2 and runx1. In contrast, coexpression of scl 
and flk at the 10-somite stage suggests that the angioblast formation is not disturbed in 
spt. ALM myelopoiesis and pronephronic duct formation are also normal in spt 
mutants (Amacher et al., 2002). Overexpression of scl in spt mutant successfully 
rescues erythroid development, suggesting that the spt works upstream of scl in HSC 
formation (Dooley et al., 2005). The spt mutant gene has been cloned and shown to be 
the tbx16 gene, encoding a T-box transcription factor that regulates proper cell 
migration during gastrulation (Griffin et al., 1998).  
 
The gene responsible for the kgg mutant, cdx4, is a member of the caudal-related 
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homeobox transcription factor family involved in Antero-Posterior patterning of the 
embryonic body axis by regulating hox genes (Davidson et al., 2003). kgg mutant has 
a severe reduction in the population of ICM-HSCs without disruption of the adjacent 
pronephronic duct precursors, indicating that the reduction of HSCs is due to a 
specific dysfunction of hox genes during HSC development rather than general 
posterior patterning defects. Consistent with this, overexpression of hoxb7 or hoxa9a, 
but not scl, restores the erythroid production without correcting the morphological 
defects in kgg mutant. It is postulated that the cdx4-hox pathway acts upstream of scl, 
and perhaps other essential scl cofactors, to specify ICM-HSC fate (Davidson et al., 
2003).  
 
1.2.5.2 Erythroid progenitor mutants 
Several mutants including bloodless (bls), moonshine (mon) and vlad tepes (vlt) are 
defective in the development of the erythroid progenitor cells. bls has no circulating 
red blood cells until 5dpf when the definitive hematopoiesis initiates (Liao et al., 
2002). First isolated as a spontaneous mutation, the bls mutation is inherited in a 
dominant manner with incomplete penetrance, where the bloodless phenotype various 
from complete absence of circulating blood cells to severe anemia. bls mutants show 
that decreased number of primitive hematopoietic progenitors are formed from the 
PLM, but fail to differentiate and undergo apoptosis (Liao et al., 2002). Additionally 
bls mutants exhibit delayed initiation of lymphopoiesis, but normal primitive 
macrophage development. Overexpression of scl, but not bmp4 and gata1, partially 
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rescues the gata1-expressing cells in the anterior ICM, suggesting that bls may 
regulate primitive hematopoietic cell differentiation or survival, potentially by 
regulating the expression of scl. Furthermore, cell transplantation experiments 
indicate that the bls gene is required in a non-cell autonomous manner for primitive 
hematopoiesis (Liao et al., 2002). But the bls gene has not been identified. 
 
mon mutants display a severe anemia due to specific disruptions of both primitive and 
definitive erythropoiesis (Ransom et al., 2004). The hematopoietic progenitors are 
correctly specified early during the development of mon mutant embryos, but block in 
maturation at the proerythroblast stage and undergo apoptosis. In contrast, mon 
mutants have normal myeloid and lymphoid development. Positional cloning has 
revealed that mon encodes the zebrafish ortholog of mammalian transcriptional 
intermediary factor 1γ (TIF1γ), a transcription factor critical for the differentiation of 
erythroid precursors in a cell-autonomous manner (Ransom et al., 2004).  
 
gata1 is identified to be the responsible gene for vlt mutant. vlt mutant exhibits an 
almost complete lack of circulating blood cells at the onset of circulation (Lyons et al., 
2002). However, intact expression of scl, lmo-2 and cbfb before 24hpf demonstrates 
the presence of normal hematopoietic progenitors. Myeloid and lymphoid lineage 
development is also normal in vlt mutant indicated by the intact expression of pu.1, 
l-plastin and c/ebp1, and ikaros and rag-1, respectively (Lyons et al., 2002). 
Therefore, consistent with the studies in mice, gata-1 is essential for the 
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differentiation of the hematopoietic progenitors down the erythroid lineage. 
 
1.2.5.3 Late stage erythrocyte mutants 
This group of mutants initiates hematopoiesis normally with normal expression of 
gata1, typically pigmented blood, and staining with o-dianisidine. They begin to 
develop anemia around 2-4 dpf. This group of mutants is further divided into 3 
subclasses: cytoskeletal protein mutants, hypochromic mutants and photosensitive 
mutants (Weinstein et al., 1996; Ransom et al., 1996).  
 
Cytoskeletal protein mutants include merlot (mot), chablis (cha), riesling (ris) and 
retsina (ret).  Mot and cha encode erythrocyte protein 4.1, a structural membrane 
protein expressed in erythrocytes that anchors the spectrin-actin cytoskeleton to the 
cell membrane by binding to spectrin (Shafizadeh et al., 2002). ris encodes the 
erythroid β-spectrin protein (Liao et al., 2000). These three mutants all have normal 
onset of primitive hematopoiesis, but develop anemia by 4dpf due to the hemolysis of 
the abnormal red blood cells with membrane defects. Similar to mot, cha and ris, ret 
mutant also become anemic around 4dpf. But the circulating erythrocytes in ret 
display a defect in cytokinesis. band 3, which plays a critical role in chromosomal 
segmentation during anaphase, is revealed to be the gene affected in ret mutants (Paw, 
2001; Paw et al., 2003).  
 
Hypochromic mutants may have defects in any aspect of hemoglobin biosynthesis, 
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resulting in decreased level of hemoglobin in erythrocytes that show microcytic and 
hypochromia phenotype. This subgroup includes sauternes (sau) which encodes 
δ-aminolevulinate (ALAS2), an enzyme important in the heme biosynthetic pathway 
(Brownlie et al., 1998), weissherbst (weh) and chardonnay (cdy) that encode the iron 
transporter ferroportin 1 and divalent metal transporter 1 respectively (Donovan et al., 
2000; Donovan et al., 2002), and chianti (cia) that encodes the transferrin receptor 1 
critical for iron acquisition by erythrocytes (Wingert et al., 2004).  
 
Photosensitive mutants display defective erythrocytes characterized by 
autofluorescence and lysis when exposed to ambient light. These mutants include 
dracula (drc), desmodius (dsm), freixinet (frx), and yquem (yqe). The drc mutant gene 
encodes ferrochelatase and provides a model for erythropoietic protoporphyria 
(Childs et al., 2000), whereas the porphyric phenotype of yqe is due to a mutation in 
the gene encoding uroporphyrinogen decarboxylase (UROD), homozygous 
deficiencies in which, cause hepatoerythropoietic porphyria (HEP) in humans (Wang 
et al., 1998). 
 
All together, the zebrafish hematopoietic mutants not only enrich the knowledge of 
the conserved hematopoietic process, but also provide valuable models for human 
blood diseases.  
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1.3 Aims of the study 
We use genetic methods to study hematopoiesis in zebrafish. Firstly, scored by WISH 
of rag1 (Willett et al., 1997), we carried out a forward genetic screen to isolate the 
zebrafish mutants defective in hematopoiesis, especially T lymphocyte development. 
Secondly, among the isolated mutants, wz260 proved to be a new allele of ugly 
duckling (udu) (Hammerschmidt et al., 1996), was selected for detailed 
characterization and positional cloning. Furthermore, functional study of udu gene in 
hematopoiesis was performed.  
 46
Chapter Ⅱ Materials and Methods 
 
2.1 Zebrafish maintenance and embryo culture 
Zebrafish was maintained under the standard condition by the fish facility of IMCB. 
Zebrafish AB strain was used for mutagenesis, whereas WIK strain served as the 
mapping strain for positional cloning. udutu24 mutant was kindly provided by Dr. Jiang 
Yun-Jin. And Tg(-5.0scl:EGFP)sq1 transgenic fish was generated by Jin Hao in our lab. 
 
To obtain synchronized embryonic stages of zebrafish embryos, a pair of male and 
female fish was mated in the crossing tank separated by a transparent divider in the 
afternoon. The divider was pulled out next morning and the fertilized eggs were 
collected 15 min after the female fish started to spawn and raised in 0.03% sea salt 
egg water at 28.5°C. The stages of the embryos were determined according to 
Kimmel’s description (Kimmel et al., 1995). 
 
2.2 Whole-mount in situ hybridization (WISH) and o-dianisidine staining 
2.2.1 Digoxigenin (DIG)-labeled RNA probe synthesis 
Plasmid DNAs were linearized by the appropriate restriction enzyme (Table 2.1) and 
then purified using the PCR purification kit (QIAgen). 1μg linearized plasmid DNA, 
1μl RNA polymerase (SP6 or T7 or T3 from Stratagene), 1μl RNase inhibitor (Roche), 
2μl 10X DIG RNA labeling mix (Roche), 4μl 5X reaction buffer (Stratagene), and 
nuclease free water was used for a 20μl-reaction of in vitro transcription. After 
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incubation in a 37°C water bath for 2 hr, 1μl RNase-free DNase I (Roche) was added 
to the reaction for further incubation at 37°C for 20 min. The reaction was stopped by 
1µl 0.5M EDTA (pH 8) and the RNA products were precipitated with 2.5µl 4M LiCl 
and 75µl 100% ethanol at -80°C for 30 min followed by centrifugation at 4°C for 
30min at 12,000 rpm. After washed with 70% cold ethanol, the RNA pellet was 
air-dried and resuspended in 20µl sterile DEPC water. 0.5μl of the RNA probe was 
loaded onto a 1% agarose gel to determine its quality and quantity. Finally, the probe 
was dissolved in WISH hybridization buffer (50% formamide, 5XSSC, 0.92mM citric 
acid, 0.1% Tween20, 50μg/ml heparin and 500μg/ml tRNA) at a final concentration of 
0.5μg per ml and stored at -20°C.  
 
2.2.2 WISH procedure for rag1 screening 
4dpf or 5dpf fish embryos were fixed in 4% paraformaldehyde dissolved in PBS (PFA) 
for 2 hr at room temperature (RT). All the following steps were carried out at RT 
unless specified. The fixed embryos were washed 2x5 min in PBST (PBS with 0.1% 
Tween 20), 1x5 min in 100% methanol, and then stored in fresh 100% methanol at 
-20°C for at least 20 min. For rehydration, the embryos were successively incubated 
in 50% and 30% methanol in PBST for 5 min each followed by 2x5 min washes in 
PBST. The embryos were further permeabilized by proteinase K (10μg/ml) 
(Finnzymes, Finland) digestion for 20 min. After a brief wash in PBST, the embryos 
were fixed in 4% PFA for 20 min followed by 3x10 min washes in PBST. 
 48
Subsequently the embryos were pre-hybridized in WISH hybridization buffer (Hb) for 
at least 2 hr at 60°C. Then the pre-Hb was removed and the embryos were hybridized 
with DIG-labeled rag1 RNA probe (0.5μg/ml in WISH Hb) overnight (O/N) at 60°C. 
The RNA probe was removed and stored at -20°C for re-use. The embryos were 
successively washed in 2XSSCT at 60°C, 0.2XSSCT at 60°C, and PBST at RT for 10 
min each. Then the embryos were blocked in 10% bovine calf serum (BCS)/PBST at 
RT for 1 hr followed by incubation with anti DIG-AP antibody (Roche) at 1:2000 
dilution in 10% BCS/PBST for 2 hr at RT. After washed 2x10 min in PBST, 2x10 min 
in buffer 9.5T (100mM Tris, 5mM MgCl2, 0.1% Tween20, pH adjusted to 9.5), the 
embryos were stained with NBT/BCIP color substrate solution (one NBT/BCIP tablet 
(Sigma) in 10 ml sterile water with 0.1% Tween20) in dark at RT. The rag 1 signal 
could be detected after 1-2 hr of staining. 
 
2.2.3 High-resolution WISH protocol 
Except rag1, WISH was performed as follow. All of the steps were carried out at RT 
unless specified. Fish embryos were dechorionated by pronase (0.5mg in 1ml egg 
water) treatment or with forceps manually. The embryos were washed briefly in PBST 
to remove the chorions before fixed in 4% PFA at 4°C O/N. The fixed embryos were 
washed 2x5 min in PBST, 1x5 min in 100% methanol, and then stored in fresh 100% 
methanol at -20°C for at least 20 min. These embryos were then re-hydrated with a 
series of methanol/PBST solutions (3:1, 1:1, 1:3), 5 min each, and subsequently 2x5 
min wash in PBST. The embryos were permeabilized by proteinase K digestion 
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(10μg/ml) for an appropriate time (Table 2.2). After a brief wash in PBST, the 
embryos were refixed in 4% PFA for 20 min followed by 5x5 min washes in PBST. 
The embryos were equilibrated in WISH pre-Hb for 5 min at 65°C, and then changed 
into fresh WISH pre-Hb and pre-hybridized for 2-5 hr at 65°C. Then the pre-Hb was 
replaced by the Hb with specific RNA probe (0.5μg/ml in Hb), which had been 
denatured at 68°C for 8 min followed by immediately cooling on ice, and the 
hybridization was performed O/N at 65°C. On the next morning, the Hb with the 
RNA probe was removed and stored at -20°C for recycling use. The embryos were 
then washed as following: 2x30 min in 2X50%formamide/2XSSCT at 65°C, 3x20 
min in 2XSSCT at 65°C, 2x30 min in 0.2XSSCT at 65°C, and 2x 5min in PBST at RT. 
After the washes, the embryos were blocked by 2% lamb serum in PBST for at least 1 
hr at RT, and followed by incubation with anti-DIG-AP antibody solution (1:5000 
dilution in the blocking buffer) O/N at 4°C. Subsequently the embryos were washed 
with PBST 6x20 min, and then buffer 9.5T 2x10 min. The embryos were stained with 
NBT/BCIP substrate solution in dark from 1/2 hr to O/N at 4°C depending on the 
probe used. The color reaction was stopped by washing the embryos twice with PBST 
for 10 min each, followed by fixing with 4% PFA for 1 hr. After 1 hr washes with 
PBST, the embryos were equilibrated in 70% glycerol at 4°C O/N for taking images. 
 
2.2.4 o-Dianisidine staining of hemoglobin 
2dpf live embryos were dechorionated by pronase treatment or with forceps manually,  
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Table 2.1 List of Constructs for antisense RNA Probes 
 






rag-1 PBluescript KS+ BamHI T7 1426-2944 
hoxa3a pGEM-Teasy SacI T7 Full length 
foxn1 pGEM-Teasy StyI SP6 131-828 
scl pGEM-Teasy PstI T7 4-1125 
lmo2 pGEM-Teasy SalI T7 872-1643 
gata-1 - XbaI T7 - 
band3 pGEM-Teasy BamHI SP6 1174-3378 
βe1-globin PBluescript SK+ XbaI T7 30-584 
pu.1 pGEM-Teasy SacII SP6 1-1005 
mpo pGEM-Teasy ApaI SP6 44-2325 
l-plastin PBluescript KS+ ApaI T3 404-800 
lysozyme C PBluescript KS+ xhoI T7 - 
gata2 pDrive xbaI T7 931-2394 
udu pcDNA3.1(-) Asp718 T7 30-6708 
p53 pBluescript SK+ ClaI T3 Full length 
gadd45αl pGEM-Teasy ApaI SP6 83-903 










Table 2.2 Duration of Proteinase K Permeabilization for Zebrafish WISH 
 






followed by a brief wash in PBST to remove the chorions. The embryos were then 
incubated with o-dianisidine staining buffer (o-dianisidine (0.6mg/ml), 0.01M sodium 
acetate (pH 4.5), 0.65%H2O2, and 40% (v/v) ethanol) in dark for 15 min(Detrich, III 
et al., 1995). The signals were then observed under the light microscope. For taking 
photos, the stained embryos were fixed by PFA and equilibrated in 70% glycerol.  
 
2.3 Genetic Screen 
2.3.1 ENU mutagenesis 
The ENU mutagenesis was performed according to standard protocols with minor 
modifications (Mullins et al., 1994; Solnica-Krezel et al., 1994). Before mutagenesis, 
AB strain male fish were crossed with females to select the male fish that generated 
fertilized eggs. 6 to10 of the selected males were placed in an 800ml plastic cylinder 
with fine mesh bottom, and then dunked in 300ml of ENU working solution (3mM 
ENU in 10mM sodium phosphate buffer) at 22.5°C. After one hour’s treatment, the 
fish were transferred to the cylinder with fresh fish water and left for 6 hr, then 
transferred into a 5-liter container with 28°C fish water O/N. The treatment was 
repeated 3 times within 1 to 3 weeks. The ENU working solution was inactivated by 
incubating with equal amount of 2X inactivation solution (20% sodium thiosulfate, 
1% NaOH) O/N before discarding. 
 
2.3.2 Generation of F1 fish and F2 families 
On the third day after the last mutagenesis treatment, the ENU treated male fish were 
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mated with wild type females. Initially, these male fish were unable to produce viable 
embryos due to severe defects in early embryogenesis. After the second or third cross, 
the mutagenized males (F0) produced relative normal F1 embryos. Each F0 male was 
used to generate about 100 to 150 F1 progeny. The surviving adult F1 fish were mated 
with each other to produce the F2 families.  
 
2.3.3 rag1 screen 
The matured siblings in F2 families were intercrossed for F3 mutant screening. Ideally, 
each F2 family should have about 10 successful crosses. Approximately 400 crosses 
were set up a week. Embryos from successful crosses were collected and the F2 
parents were maintained in individual tank with appropriate tracking number. Next 
morning the dead embryos were removed and the egg water was replaced with PTU 
water (0.003% 1-phenyl-2-thiourea in egg water) to prevent pigmentation. At 4 dpf, 
about 40 surviving embryos from each cross were subjected to WISH using rag1 as a 
probe in specially designed boxes (section 2.2.2). When one quarter of the F3 
embryos lost the rag1 signal, the respective F2 parents (heterozygous) were scored as 
potential mutants and subjected to confirmation by repeating the WISH in their F3 
embryos. 
 
2.3.4 Outcrossing to generate F3, F4, and F5 progeny 
The confirmed F2 heterozygous mutants were out-crossed with AB strain wild type to 
generate the F3 progeny to adulthood, and the mutant fish were identified by rag1 
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staining. The same process was repeated at least twice to clean the genetic 
background.  
 
2.4 Positional cloning of wz260 
2.4.1 Generation of mapping families and collection of the embryos 
The AB background F4 or F5 heterozygous mutants were map-crossed with WIK wild 
type to generate the mapping families. The heterozygous hybrid mutants (as many as 
possible) were identified by rag1 WISH staining. For each mapping family, AB F4 or 
F5 heterozygous mutant and WIK wild type were referred as AB grandparent and 
WIK grandparent respectively, whereas the identified heterozygous hybrid mutants 
were designated as parents. Each pair of parents were maintained in individual tank 
and mated weekly. The resulting embryos were segregated into mutant and sibling 
groups based on the rag1 expression and stored in methanol at -20°C.  
 
2.4.2 DNA preparation 
Once the mapping family was successfully established and around 10 pairs of parents 
were identified, the AB and WIK grandparents were sacrificed and their genomic 
DNA were extracted by QIAgen Genomic-tip 100/G kit according to the 
manufacturer’s instruction. To prepare the single embryo genomic DNA, embryos 
were placed into the wells of 96-well plate individually, incubating in 50μl 1X TE 
buffer (pH8.0) with 0.5mg/ml proteinase K at 55°C O/N. After incubation at 98°C for 
10min, 1μl of embryo DNA sample was used as template for each PCR reaction. 
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2.4.3 Bulk segregation analysis (BSA) 
BSA was used to determine the linkage between the mutation and molecular markers 
of simple sequence length polymorphisms (SSLP) that distribute throughout the 
genome (http://134.174.23.167/zonrhmapper/positionCloningGuidenew/index.htm). 
Genomic DNA from AB/WIK grandparents, 2 mutant pools (mixture of 24 single 
embryos each pool) and 2 sibling pools (mixture of 24 single embryos each pool) was 
subjected to PCR analysis with 300 pairs of SSLP markers covering the entire 
zebrafish genome (12 per chromosome, Table 2.3) as primers. PCR products were run 
on 3.5% MS agarose gels at two hundred volts for two hours to separate bands of 
different alleles. Linkage was assumed when a WIK band presented in the sibling 
pools but was absent in the mutant pools (Figure 1.4). In this case, z10036 and z1215 
on chromosome 16 appeared to be linked with wz260 mutant (Figure 4.6). 
 
2.4.4 Linkage analysis with single mutant embryos 
The potential linked markers isolated from BSA were tested on individual mutant 
embryo and the linkage was confirmed when most of the mutant embryos showed AB 
band only with a few recombinant mutant embryos containing both AB band and 
WIK band (Figure 4.7). The recombinants are important for determination of the 
positions between the linked SSLP markers and the mutation. If no recombinant 
embryos are shared by 2 linked SSLP markers, like z10036 and z1215, the mutation is 
localized between these 2 markers, one as the North, the other as the South. Otherwise, 
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Table 2.3 300 pairs of SSLP markers used for BSA 
 
A. 
Plate-1 1 2 3 4 5 6 7 8 9 10 11 12  
A >z4593 >z9394 z3705 >z1705 >z1351 >Z9704 z5508 >Z6802 >Z22347 >z1781 z6974 z13296 LG1 
B >z4278 >z851 >Z7634 >z4662 z13620 >z1406 >z6617 z7358 >z1703 >Z20550 z22747 z13475 LG2 
C >z872 >Z7506 >Z8208 >z15457 >z9964 >Z11227 >z3725 >z20058 >Z7486 >z1191 >z6019 z1185 LG3 
D >z3275 >z984 >Z10164 >Z7490 >Z21636 z20450 >z5112 >z1366 z20533 z9920 z3439(L3) z9257 (L3) LG4 
E >z15414 >Z11496 >Z6727 z6614 >z1390 >z3804 >Z14143 >z4299 >z1677 >z1202 z1454 z8921 LG5 
F z15448 >z13275 >z880 >z6624 z10914 >z5294 >Z13614 z9230 >z4297 >z1680 z1701 gof2 LG6 
G >z3273 >Z10785 >z1206 >z4706 >z1182 z1059 >Z8156 z1239 >Z13880 >Z13936 >z5563 >z1313 LG7 





Plate-2 1 2 3 4 5 6 7 8 9 10 11 12  
A >Z20860 >z1777 >z562 >Z6268 >z4673 >z5080 >z1805 >z20031 >Z10789 >z4577 >z1270 z7564 LG9 
B >z9199 >Z6410 >Z8146 z3835 >z1145 z1191 z13219 >z9701 >z3260 z14193 z7262 z6427 LG10
C >z1590 >z3527 >Z13666 >z4190 >z1393 >6909 >z13411 >z3362 >Z10919 z8032 z10727 z13395 LG11
D >z1778 >z1225 >Z21911 >z1473 >z4188 >z4830 z1400 >z1358 z7576 z22103 z6920 z1312 LG12
E >z1531 >z5643 >z6104 >Z13611 >z5395 >z1627 >Z7102 >z6657 >z1826 >z6007 z9951 z17223 LG13
F z9366 >z5436 >z1536 >z5435 >z4203 >Z22107 >z1226 >z6666 >z3984 >z1801 z11837 z22144(L20) LG14
G >Z10289 >Z6312 >Z6712 >Z21982 >z4396 >Z11320 >Z13230 z7216 >Z7381 >z6024 >z5223 z21165 LG15





Plate-3 1 2 3 4 5 6 7 8 9 10 11 12  
A z9692 >z4268 >z1490 >Z22083 >Z22674 >z9847 z21703 >z4053 >z3491 >z1928 z3165 z6010 LG17 
B >z1136 >z1144 >Z13329 >Z8488 >Z10008 z8343 >z9154 >z5321 z11944 z7654 z11685 z20046(L20) LG18 
C >z4009 >z160 >Z7450 >z3782 >z3816 >Z11403 >Z6661 >Z7926 >z1803 z5183 z7686 z4825 LG19 
D >z4329 >Z8554 >z3954 >Z22041 >Z7158 >z3964 >Z11841 >Z10056 >Z9334 >Z9708 >Z6804 z7171 LG20 
E >z3476 >z1274 z10508 >z4492 >Z10960 z6089 >z4425 >z1497 >z4074 z7925 z7405 z13719 LG21 
F >z1148 >Z10673 z11752 >z230 >Z10321 >Z21243 z9516 >Z9817 >z4682 z3093 z13223 z3286 LG22 
G >z5683 >Z8945 >z4003 >z15422 >z4421 >z3157 >z1773 >z176 z20039 z5141 z20133 z3211(L20) LG23 




Plate-4 1 2 3 4 5 6 7 8 9 10 11 12  
A >z1378 >z13232 >z3490 >z3528 >z5669 >z1462 >z9290 z11092 z8224 z1213 z8780 z1431 LG25
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the mutation is localized on the same side of the markers. The marker with fewer 
recombinants is closer to the mutation. The genetic distance between a SSLP marker 
and a mutation can be calculated according to the following formula: 
 
Genetic distance (centimorgan(cM))=recombinant number/ total meiosis events X 100 
= recombinant number/ (total embryo number X 2) X 100 
 
Based on the Zebrafish Genetic Maps such as MGH and T51 
(http://zfin.org/cgi-bin/mapper_select.cgi), more SSLP markers between z10036 and 
z1215 were screened to narrow down the wz260 interval (Table 2.4). Two closer SSLP 
markers z17246 and zk30O16-SSLP-S16 were then used to perform fine mapping by 
analyzing 5,864 meiosis events (Figure 4.9).  
 
2.4.5 Searching for the contigs and clones containing the mutant gene 
The closest North and South markers were used to blast the Ensembl 
(http://www.ensembl.org/Danio_rerio/index.html) or Vega database 
(http://vega.sanger.ac.uk/Danio_rerio/index.html), to define the North contig and 
South contig (www.sanger.ac.uk/Projects/D_rerio/WebFPC/zebrafish/small.shtml). If 
the North contig and South contig were not the same one, it would be necessary to 
link them together by their sharing markers or clones so that the genetic map 
embracing the mutant gene was linked with the physical map (Figure 4.10). 
Additional SSLP and Single nucleotide polymorphism (SNP) markers (Table 2.4) 
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were designed based on the BAC or BAC end sequences in the contig to further 
narrow down the mutant locus. wz260 was mapped to a region covering by three 
overlapping BACs, zC196P10, zK7E18 and zC113G11 (Figure 4.10).  
 
2.4.6 Identification of the mutant gene by sequencing analysis 
Among the three BACs, zC196P10 was most likely to contain wz260 mutant gene 
because it contained the nearest north marker SSLP-N6 with only 1 recombinant, 
corresponding to 0.02cM. Therefore I sequenced the RT-PCR products of the 4 
Ensemble genes in BAC zC196P10 to search the point mutation site by comparing 
wz260-/- and wild type. The DNA sequencing analysis found that wz260-/- mutant 
zebrafish harbored a point mutation (T to A) in the Ensemble Gene 
ENSDARG00000005867. As complementary test revealed that wz260 was a new 
allele of ugly duckling (udu) (Hammerschmidt et al., 1996), we designated it as 
udusq1zl. The other allele, udutu24 also had a point mutation (T to A) in a different site 
of Ensemble Gene ENSDARG00000005867 (Figure 4.11 and 4.12). 
 
2.5 Amplification of udu cDNA and the related plasmid construction 
2.5.1 Total RNA extraction from embryos 
Total RNA was extracted from 1dpf udusq1zl homozygous mutant and wild type 
embryos, respectively, using TRIzol (Gibco-BRL, USA), treated with DNase I and 
purified using RNeasy Mini kit (QIAgen).  
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2.5.2 5’ and 3’ Rapid Amplification of cDNA Ends (RACE) 
5’ and 3’ RACE were performed using the BD SMARTTM RACE cDNA 
Amplification Kit (Clontech, USA) according to the protocol provided by the 
manufacturer. RACE primers for udu gene were listed in Table 2.5. The RACE 
products were purified by gel-purification kit (QIAgen) and cloned into 
pGEM®T-Easy Vector (Promega) for sequencing. Full-length sequence of udu was 
obtained by alignment of the end sequences and the middle fragments acquired from 
RT-PCR. 
 
2.5.3 Cloning of udu cDNA constructs containing the wild type allele and the 
udusq1zl allele (pcDNA3.1- udu-wt, pcDNA3.1- udu-T2976A) 
Total RNAs extracted from 1dpf udusq1zl homozygous mutant and wild type embryos 
were reversely transcribed using SuperScript™ III RNase H Reverse Transcriptase 
(Invitrogen) respectively. The synthesized cDNAs were used as templates to do PCR 
to amplify 2 fragments of udu cDNA (the primers were listed in Table 2.6). The first 
fragment (from 30bp to 2248bp) was subcloned into pcDNA3.1 vector (+) (Invitrogen) 
with Asp718 and BamHI. Then the second fragment (from 2248bp to 6708bp) was 
inserted into the pcDNA3.1 containing the first udu fragment construct with BamHI 
and XhoI. By this method, both the wild type and udusq1zl alleles of udu cDNA 
including all the coding region and most 5’ and 3’ UTR region were cloned into 
pcDNA3.1 vector (+) (Figure 2.1A). 
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2.5.4 Cloning of Flag-tagged and HA-tagged udu cDNA constructs 
(pcDNA3.1-N-Flag-udu-wt and pcDNA3.1-C-HA-udu-wt) and SANT-L domain 
deficient mutant construct (pcDNA3.1-udu-ΔSANT-L) 
The Asp718 recognizing sequence joint with Flag tag sequence immediately followed 
by the initial part of udu coding sequence was designed as primers to amplify the N 
terminal Flag tagged udu fragments (Table 2.6). The XhoI recognizing sequence 
connective with C terminal HA tagged udu primers were also used to amplify the C 
terminal HA tagged udu fragments (Table 2.6). Then using the appropriate restriction 
enzymes, the N/C tagged udu fragments were subcloned into pcDNA3.1-udu-wt, 
replacing the corresponding untagged region (Table 2.6), to generate 
pcDNA3.1-N-Flag-udu-wt and pcDNA3.1-C-HA-udu-wt.  
 
To make pcDNA3.1-udu-ΔSANT-L construct, SANT-L domain deficient C terminal 
fragment was also amplified using the specially designed primers and subcloned into 
pcDNA3.1-udu-wt, replacing the intact C terminal as the strategy in Figure 2.1B 
(Table 2.6 and Figure 2.1B). 
 
2.6 udu cRNAs rescue experiments 
2.6.1 Synthesis of udu cRNAs 
Using smaI linearized pcDNA3.1- udu-wt, pcDNA3.1- udu-T2976A and 
pcDNA3.1-udu-ΔSANT-L as templates, the capped RNAs were synthesized and  
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Table 2.5 Primers for 5’and 3’RACE of udu gene 
 
Name Sequence 
udu-3’-GSP 5’- CCTCTCAGTCCTGCTGGCATTGAAG -3’ 
udu-5’-GSP 5’- GCAATGGACGCTTAGACCGAGTTCG -3’ 
udu-3’-NGSP 5’- GCCACTCTTCTGAAGGGTCACACAC -3’ 




Table 2.6 Primers for cloning of udu cDNA constructs 
 






































































polyadenylated using Ambion’s mMessage mMachine High yield capped RNA 
Transcription kit and Ambion’s Poly(A) Tailing Kit, respectively, according to the 
manufacturer’s protocols (Ambion, USA). The concentration and the quality of the 
RNAs were determined by electrophoresis. 
 
2.6.2 microinjection 
For rescue experiment, about 1μg/μl cRNA was diluted 3 times with phenol red (0.1% 
in DPBS, Sigma) and 2nl was injected into each one-cell stage embryo derived from 
crosses of the adult udusq1zl heterozygous fish, by using gas microinjector (PLI-100, 
HARVARD APPARATUS). 
 
2.6.3 Evaluation of the rescue efficiency and genotyping analysis 
WISH of band3 at 22hpf stage, o-dianisidine staining of hemoglobin at 2dpf stage 
were used to evaluate the rescue efficiency. After scoring the phenotypes, the 
embryos’ genomic DNA was extracted individually (section 2.4.2) and genotyped by 
sequencing the PCR products with the primers (5’- 
AAACACGCTACCCACAGTTCC-3’/5’-TTGTCTGATGTCTGTTGCTGC-3’). The 
rescue efficiency was calculated as division of the rescued mutant number by the total 
mutant number. 
 
2.7 Morpholino knockdown 



































































































Figure 2.1 Cloning strategy of udu constructs. (A) To generate pcDNA3.1- udu-wt and pcDNA3.1- udu-T2976A, 2 overlapping fragments of 
udu cDNA that contain the BamHI cutting site were amplified from the cDNAs of 1dpf wild type or udusq1zl homozygous mutant embryos (the 
primers were listed in Table 2.6). The first fragment, joint with an Asp718 cutting sequence at beginning, was subcloned into pcDNA3.1 vector 
(+) with Asp718 and BamHI. The second fragment, with a XhoI cutting sequence in the end, was then subcloned into the pcDNA3.1-udu-first 
construct with the enzymes BamHI and XhoI. By this method, both the wild type and udusq1zl alleles of udu cDNA including all the coding 
region and most of the 5’ and 3’ UTR regions were cloned into pcDNA3.1 vector (+). (B) To make pcDNA3.1-udu-ΔSANT-L construct, 
SANT-L domain deficient C terminal fragment was amplified in two parts, subcloned into pBluescriptSK vector and then into 





TTTT-3’) and MO-udu-2 (5’-AAAAGGCTTGCTGACCGTCGTTGTC-3’), were 
designed to specifically block the RNA splicing of the udu gene, whereas the p53 MO 
(5’-GCGCCATTGCTTTGCAAGAATTG-3’) (Langheinrich et al., 2002) (Gene Tools, 
USA) was used to target the translational initiation site of the p53 gene. The Standard 
Control MO provided by Gene Tools was used as control. ~0.5-1 pmol per embryo of 
each MO was injected into the one-cell stage embryos. 
 
2.8 Acridine orange staining 
Acridine orange (AO, acridinium chloride hemi- [zinc chloride], Sigma) was used to 
detect cell death. Embryos were dechorionated and placed in 5µg/ml of AO in egg 
water. After 30 minutes of staining, embryos were washed with egg water and viewed 
using the green filter with a fluorescence microscope.  
 
2.9 FACS, cytology, and cell cycle analysis 
The 24hpf udu-/- mutant and sibling embryos (300-400/each pool) obtained from 
crosses of adult udu+/-/Tg(-5.0scl:EGFP)sq1 and udu+/- fish were separated based on the 
morphological phenotype and disaggregated in cold 0.9X PBS with 5% FBS. The cell 
suspensions were passed through a 70 µm-pore size filter and spun at 1000 rpm for 5 
min. The pellets were re-suspended in 1ml Cell Dissociation Buffer-Free Hanks 
(Gibco, USA) and incubated at 37 °C for 20 min. After addition of 1ml washing 
buffer (Hanks buffered saline solution containing 20% calf serum, 5mM CaCl2 and 
DNAse (50µg/ml)), the cell suspensions were spun at 1000rpm for 5 min and 
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re-suspended in PBS. After passing through a 40 µm-pore size filter, 106 cells/ml 
samples were applied for FACS analysis (Beckton Dickinson).  
 
For cytology analysis, about 1-2 x 105 sorted GFP+ cells were cytocentrifuged at 
500rpm for 5 min onto glass slides and subjected to May-Grunwald and Giemsa 
staining. Images were captured by Olympus BX51 microscope equipped with 
Olympus DP70 digital camera.   
 
For cell cycle analysis, cell suspensions (1 x 106 cells) were spun at 1000rpm for 5 
min, re-suspended in 1ml warmed (37 °C) DMEM (Gibco, USA) supplemented with 
2% Fetal Calf Serum, 10mM HEPES buffer (Gibco, USA), and 5µg/ml Hoechst 
33342 (Sigma, USA), and incubated at 37 °C for 1hr. The cells were then put on ice 
immediately, spun down at 1000rpm for 5 min at 4 °C, re-suspended in ice-cold 
HBSS (Hanks Balanced Salt Solution from Gibco) with 2% Fetal Calf Serum and 
10mM HEPES buffer (Gibco, USA), and finally subjected to cell cycle analysis by 
FACS. 
 
2.10 Cell transplantation 
Donor embryos derived from mating between adult udu+/- fish were injected at the 
one-cell stage with rhodamine-dextran (Invitrogen). At around 3hpf, the injected 
donor embryos were dechorionated with forceps in an agarose- (2% agarose in 0.3X 
Danieau buffer) coated Petri-dish covered with 1X Danieau buffer and 15-30 donor 
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cells from each embryo were transplanted into dechorionated host embryos of the 
same stage. The manipulated donor embryos were saved for genotyping analysis. 
Contribution of the rhodamine-dextran-labeled donor cells to the circulating blood 
cells in the host embryos was scored at around 30hpf under fluorescent microscope. 
 
2.11 Northern blot analysis of udu transcripts 
2.11.1 RNA Preparation  
Total RNA was prepared from different stages of zebrafish (1-8 cell stage, 6-8hpf, 
12hpf, 24hpf, 3dpf, adult) using TRIzol (Gibco-BRL, USA). RNA concentration was 
double checked by UV-spectrometry and agarose gel. Then mRNA was isolated from 
the total RNA using QIAgen’s oligotex mRNA kit.  
 
2.11.2 Dig-labeled RNA Probe Preparation 
Dig-labeled udu-3’ (5995-6716bp of the cDNA) RNA probe was prepared and 
purified as described in section 2.2.1(Table 2.1). Probe concentration was checked by 
UV-spectrometry and agarose gel. Probe aliquots were stored in -80°C. 
 
2.11.3 Northern blot 
4.5µl mRNA sample (1µg) was mixed with RNA loading buffer (2.0µl 10X MOPS, 
10.0µl de-ionized formamide, 3.5µl 37% Formaldehyde, 2µl 0.4% bromophenyl blue) 
and denatured at 65°C for 15 min followed by immediately transferring on ice. Then 
the samples were loaded on a 0.7% agarose gel (0.7g agarose in 84.6ml RNase free 
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water, 10ml 10X MOPS, 5.4ml 37%Formaldehyde for 100ml gel) and run at 3-4V/cm 
with 1X MOPS running buffer for 6 hr. After running, the RNA gel was rinsed 4 
times in de-ionized water and then soaked in water for 5 min. At the same time, a 
Nylon membrane (Hybond N+, Amersham Bioscience) was wetted and immersed in 
distilled water. Then both the gel and membrane were soaked in 20X SSC transfer 
buffer for 5 min. Subsequently, the membrane transfer system was set up to transfer 
RNA O/N. On the second day, the transferred membrane was cross-linked under the 
UV light and stained with Methylene blue solution followed by wash with water. 
Based on the marker position, the membrane was cut into two parts. The upper one 
was used for udu RNA probe, whereas the bottom one was used for elf1α RNA probe. 
The membranes were pre-hybridized with hybridization buffer (Roche) at 68°C for 1 
hour in the rotating incubator followed by adding the probe into hybridization buffer 
(20ng/ml) and further incubating at 68°C O/N. On the third day, the membranes were 
washed vigorously as following: 2X15min in 2XSSC/0.1%SDS at RT, 2X15min in 
2XSSC/0.1%SDS at 68°C, 2X15min in 0.2XSSC/0.1%SDS at 68°C. After washed, 
the membranes were equilibrated in washing buffer (Roche) for 5min, incubated in 
blocking buffer (Roche) for 30min, and then in Anti-Digoxigenin-AP antibody 
solution (1:20,000 diluted in blocking buffer, Roche) for 30min. Finally the 
membranes were vigorously washed 2X15min in washing buffer. To detect the 
signals, the membranes were equilibrated first in detection buffer for 5min and then 




2.12 Generation of rabbit anti-udu antibodies  
2.12.1 GST-fusion protein expression and purification 
Two DNA fragments corresponding to amino acids 4 to 91 (N-terminal) and 1818 to 
1941 (C-terminal) of udu were PCR amplified with primers udu-N-F/R 
(5'-CGGGATCCAAACGCAAGTCTTCTTCTCCA-3'/5'-GGAATTCTCATGACCGC
AAAGGGGATGAA-3') and udu-C-F/R (5'-CGGGATCCAAACATCGAAGGCAT 
AAGAGA-3'/5'-GGAATTCTCACTCTTCATCTCGGCTGTGCTT-3') respectively 
using pcDNA3.1- udu-wt as the template. The DNA fragments were digested with 
restriction enzymes BamHI and EcoRI and ligated into the same site of pGEX-6p-1 
vector (Amersham) to generate pGEX-udu-N/C-Antigen. The constructs were verified 
by DNA sequencing and then transfected into E. coli strain BL21. BL21 harboring the 
pGEX-udu-N/C-Antigen was grown in 2 L of LB medium at 37 °C and induced with 
0.1 mM IPTG at 30 °C for 3 h upon reaching log phase. The cells were harvested by 
centrifugation, resuspended and incubated in lysis buffer (20 mM Tris-HCl, pH 7.6, 
500 mM NaCl, 0.1 mM PMSF, 2 mM benzamidine, 2 mM DTT) for 30min, and lysed 
by sonication. Clarified cell lysate was applied to a glutathione Sepharose 4B column 
(Amersham). GST-fusion protein was eluted by glutathione and half of them were 
subjected to PreScission protease (Amersham) digestion at 4°C O/N to cleave the 
GST tag. After desalting, the GST-udu-N/C-Antigen and untagged udu-N/C-Antigen 
were eluted with PBS and protein concentrations were determined with Coomassie 
staining. The concentrations were adjusted to 2mg/ml and the protein aliquots were 
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stored at –80°C. 
 
2.12.2 Immunization of rabbits with GST-Udu-N/C-Antigen 
For the priming immunization, 1ml 2mg/ml GST-udu-N/C-Antigen was mixed with 
1ml Complete Freunds adjuvant (CFA; sigma) by two 3ml-syringes and a plastic 
3-way stopcock on ice. Each GST fusion protein was used to inject 2 rabbits, with 
1mg per rabbit. Then at two-week intervals, booster injections were performed with 
the same antigen (0.3-0.5mg) mixed with Incomplete Freunds adjuvant (IFA; Sigma). 
50ml blood was collected from each rabbit from the 4th booster onwards. The blood 
sample was allowed to stand 4hr at RT and then O/N at 4°C until a clot formed. After 
removal of the clot and debris by centrifuging 10min at 4000rpm, 4°C, serum was 
collected and stored in aliquots at –80°C. 
 
2.12.3 Antibody affinity purification 
100μg of untagged udu-N/C-Antigen was run on SDS-PAGE gel and then transferred 
to PVDF membrane. The PVDF membrane was stained with 0.1% (w/v) Ponceau S in 
5% (v/v) acetic acid (Sigma) for a few seconds so that the protein could be visualized. 
Then the PVDF membrane corresponding to the untagged udu-N/C-Antigen protein 
was excised and destained with 0.1M sodium hydroxide for 10 seconds followed by 
several rinse with deionized water. The membrane was placed in a 15ml Falcon tube, 
ensuring that the side of the membrane containing the protein is facing up. After 
blocked with 5% (w/v) skim milk powder (Diploma) in PBS for more than 1 hr, the 
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membrane was treated successively with 0.2M glycine (pH 2.5) 3min, PBS 3X1min, 
50mM Tris (pH 8.5) 1min, 100mM ethanolamine (Sigma) 3min and PBS 3X1min. 
These successive treatments were repeated for 2 more times. The membrane was then 
blocked with 5% milk in PBS for 1hr and incubated with 0.5ml of corresponding 
rabbit serum at 4°C O/N. After rinsed 3 times and further washed 3X1hr with PBS at 
4°C, the antibody was eluted by incubating the membrane with 600μl 0.2 M glycine, 
pH 2.5 for 3 min and the 600μl of glycine containing the eluted antibody was 
collected into a 1.5ml tube containing 150μl 1 M Tris, pH 8.0, and 30μl BSA 
(10mg/mL) (NEB), mixed well and stored at 4°C. The membrane could be 
regenerated by repeating the successive treatments (skip the glycine treatment) and 
reused for more than 10 times to purify the same antibody.  
 
2.13 Western blot analysis of Udu protein expression in transfected cells 
2.13.1 Extraction of proteins from cultured cells transfected with udu constructs 
293T cells were grown in 6-well plate and transfected with pcDNA3.1-udu-wt, 
pcDNA3.1-N-Flag-udu-wt and pcDNA3.1-C-HA-udu-wt respectively, using 
SuperFect Transfection Reagent (QIAgen) according to the manufacturer’s protocol. 
After 24hr of post-transfection, cells were washed twice with ice-cold PBS, and then 
harvested with 1ml ice-cold PBS by scraping with cell scraper followed by 
centrifugation at 4°C for 5min at 5,000rpm. The cell pellet was resuspended in 50μl 
whole cell lysis buffer (20mM Hepes, pH 7.9, 280mM KCl, 1mM EDTA, 0.1mM 
Na3VO3, 10% (v/v) Glycerol, 0.5% (v/v) NP40 (IGEPAL), 20mM NaF, 1mM DTT) 
 75
with Protease Inhibitor Cocktail (Roche) and incubated on ice for 10min to lyse the 
cells. After spun down at 4°C for 10min at 14,000rpm, the supernatant was saved as 
protein extraction at -80°C. 
 
2.13.2 Western blot 
5µl (about 30µg) protein extract was mixed with 2X SDS gel sample buffer (6% SDS, 
0.25M Tris, pH 6.8, 10% glycerol, bromophenyl blue and 20mM DTT), boiling for 5 
min, and then loaded on a 10% SDS polyacrylamide gel. For the western blot that 
tests the udu antibody using the untagged udu-N/C-Antigen, 20% SDS 
polyacrylamide gel was used. After 3 hr running at 30mA, the electrophoresed 
proteins were transferred onto methanol pretreated PVDF membrane. The membrane 
was blocked in 5% milk in PBS at 4°C O/N, then incubated with primary antibody 
(anti-flag/HA monoclonal antibody or anti-udu-C/N-Antigen rabbit serum) in 
blocking buffer for 2hr at RT. After washed in PBST 3X10min, the membrane was 
incubated with an appropriate secondary antibody (HRP conjugated) diluted in 
blocking buffer for 1 hr. The membrane was then washed in PBST 3X10min and the 
signals were detected with Amersham ECL kit.  
 
2.14 Immunohistochemistry staining 
COS-7 cells were grown on 22 x 22mm cover slips in 35-mm wells and transfected 
with pcDNA3.1-udu-wt using SuperFect Transfection Reagent (QIAgen) according to 
the manufacturer’s protocol. After 24hr of post-transfection, cells were washed with 
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PBS-CM (PBS with 1mM CaCl2 and 1mM MgCl2) and fixed with 3% 
paraformaldhyde (Fluka) in PBS-CM at 4 °C for 30 min. The fixed cells were washed 
with PBS-CM (2 times), 0.26% NH4Cl in PBS-CM (2 times), PBS-CM (2 times), and 
permeabilized with 0.1% saponin (Sigma) in PBS-CM at room temperature for 15 
min. The permeabilized cells were then incubated with rabbit anti-Udu-C-Antigen 
antibody (against aa 1818-1941) in FDB (PBS-CM with 5% normal goat serum, 2% 
fetal bovine serum, and 2% BSA) at 4 °C overnight. After rinsed with 0.1% saponin 
in PBS-CM (3 times), the cells were incubated with Alexa Fluor 488 donkey 
anti-rabbit IgG antibody (Molecular Probes, USA), washed with 0.1% 
saponin/PBS-CM (5 times), mounted with Vectashield mounting medium for 
fluorescence with propidium iodine (PI) (Vector, USA) and visualized on a Zeiss 
LSM 510 confocal system.  
 
2.15 Affymetrix Array 
Total RNA was extracted from the 1dpf udusq1zl homozygous mutant and sibling 
embryos, respectively, using TRIzol (Gibco-BRL, USA), treated with DNase I and 
purified using RNeasy Mini kit (QIAgen). Hybridization was performed according to 
the manufacturer’s instruction (Affymetrix). Data were analyzed using Microarray 
Suite 5.0 software (Affymetrix). 
 
2.16 Real time PCR and Semi-quantitative RT-PCR 
Total RNA was extracted as described above and reverse transcribed using 
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SuperScript™ III RNase H Reverse Transcriptase (Invitrogen). The amount of reverse 
transcribed cDNAs was normalized with the Realtime LightCycler (Roche) using 
elongation factor 1α (elf1α) as a reference. Semi-quantitative RT-PCR was performed 
for either 25 or 30 cycles at 94°C for 30 sec; 58°C for 10 sec; 72°C for 30 sec. Primer 
sequences are listed as follows: p53 (5’-GCTTTTAGATTTAGTACAACCATTG 
-3’/5’-GCAAATGCGTGTAAACAGTAATAAG-3’), caspase8 (5’-GGAATGATCTG 
GAAGCCTGG-3’/5’-TAGCGTGGTTCTGGCATCTG-3’), fos (5’-CCAAAACAGA 




GG-3’), elf1α (5’-CTTCTCAGGCTGACTGTGC-3’/5’-CCGCTAGCATTACCCTCC 
-3’). 
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Chapter Ⅲ Genetic Screen for T lymphocyte deficient mutants 
 
3.1 Results 
3.1.1 Genetic screen for rag1-deficient mutants 
After three rounds of ENU treatments (described in section 2.3.1), only 8 out of 40 
male wild-type AB fish survived, one of which was sterile, possibly due to the high 
ENU concentration. The remaining 7 founder fish were used to generate about 700 F1 
progeny by crossing with wild-type AB females, with the limit of 150 F1 fish from 
each founder (Table 3.1). The efficiency of mutagenesis was then determined by the 
frequency of induced mutations at the pigmentation locus, albino, by crossing the 
founder fish with albino homozygotes. It was found to be about 2X10-3, within the 
normal mutagenesis rates of 0.9-3.3X10-3 (van Eeden et al., 1999). The F1 fish 
derived from different founders were inter-crossed to generate 330 F2 families for 
genetic screen. 
 
rag1 was used as a marker to score the mutants defective in T lymphocyte 
development or thymus organogenesis. As shown in figure 3.1, expression of rag1 in 
thymus was clearly detected by WISH in the 4dpf wild-type fish (Figure 3.1). WISH 
of rag1 was carried out with 4-5dpf F3 embryos from random sibling crossing within 
individual F2 family. When one quarter of the F3 embryos were negative for rag1 
expression, the corresponding F2 parents were scored as potential mutant carriers  











Figure 3.2 Detection of rag1 expression in wild type and mutant embryos. WISH of 
rag1 (arrows) in 5dpf wild type (top) and mutant (bottom) larval.  
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Based on Mendelian segregation principle, half of the fish in each F2 family are 
heterozygous for a particular recessive mutation. The probability that both male and 
female are heterozygous can be calculated based on the formula 1 – 0.75n where the n 
represents the number of successful crosses. We therefore set the criteria that 4 
successful crosses should be the minimum number screened for each F2 family, which 
gave a 70% possibility of identifying the existed mutants. A total of 1551 successful 
crosses from 270 F2 families were screened and the average successful cross number 
achieved for each F2 family was 5.74, reaching 81% of the average probability to 
identify one mutation in our screen (Table 3.1). The other 60 F2 families were sex 
biased and could not produce enough successful crosses. Our primary screen resulted 
in isolation of 140 mutants from 110 families. These 140 F2 mutants were out-crossed 
with AB wild type to generate F3 families. During the F3 generation, 24 families were 
abandoned due to problems such as sterility, sex bias or absence of the mutant 
phenotype in the next generation. The remaining 86 mutant families were confirmed 
to be rag1 expression deficient and were subjected to preliminary characterization 
(Table 3.1).  
 
3.1.2 Data management 
To organize the mutants efficiently, a fish-screen/mutant management database was 
established by using File Maker Pro 5.0 (Filemaker Inc.). As illustrated in Figure 3.3, 
the database consisted of three aspects of each mutant: I) basic information, which 
included the origin of founder, the family number, the number of screens and the time  
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Table 3.1 Summary of rag1 genetic screen 
 
 Number 
Founder Fish 7 
F1 Fish ~700 
F2 Families 330 
Screened F2 Families 270 
Successful Crosses 1551 
Successful Crosses per Family 5.74 
Primary Identified Mutants 422 
Identified Mutants Family 180 
Rescreened Confirmed Mutants 140 
Rescreened Confirmed Mutant Families 110 
Identified F3 Mutant Families 86 
Mutants retained and characterized 13 
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of out-cross; II) morphological phenotype under microscope; III) results of 
preliminary characterization. All the parameters were searchable, which made it easy 
to trace each pair of mutants during the screen. 
 
3.1.3 Preliminary characterization of the rag1-deficient mutants 
To investigate whether other hematopoietic lineage cells were defective in the 86 
mutants we isolated, blood circulation was examined at the 3dpf and 5dpf embryos 
from crosses of the heterozygous F3 mutants. One mutant, wz260, lacked blood 
circulation. The decreased blood cell number was confirmed by o-dianisidine staining 
(Figure 3.4). This mutant was selected for further characterization and positional 
cloning, which would be discussed in detail in the next chapter.  
 
WISH of hoxa3 and foxn1/whnb was also performed at the 2dpf and 4dpf mutant 
embryos, respectively (Figure 3.5), to examine thymus organogenesis in these 86 
rag-1 expression-deficient mutants. None of the mutants lost the expression of hoxa3 
or foxn1/whnb, indicating that the thymus rudiment was generated normally in all of 
the mutants. However, in 6 of the mutants (wz118, wz121, wz147, wz214, wz244 and 
wz370), the expression domains of foxn1 corresponding to the thymic rudiments 
appeared to be smaller and more condensed (figure 3.6). At this moment, we were 
unable to determine whether loss of rag1 expression in these 6 mutants was due to the 
thymus rudiment abnormality or lymphoid lineage deficiency. However, considering 
that other rag1-deficient mutants showed normal foxn1 expression, I speculated that 
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Figure 3.3 Database management of rag1 screen. A fish screen/mutant management 
database was established by using File maker Pro 5.0. Panel A shows an example of a 
full data input screen for a mutant. Panel B shows the summarized screen-shot of the 









Figure 3.4 o-dianisidine staining of 2dpf wild type and mutant wz260 (udu) embryos. 
The o-dianisidine stains hemoglobin in the erythroid cells and develops brown 
coloration. (A and B) In wild type embryos, the stained erythroid cells were 
distributed in the heart (H), common cardinal vein (CCV) (A), and caudal vein (CV) 








Figure 3.5 Expression of hoxa3 and foxn1 in zebrafish. WISH of hoxa3 (arrows) in 












Figure 3.6 foxn1 condensed expression domain in some mutant embryos. WISH of 












the condensed foxn1 expressions represented abnormal thymus development that 
might cause failure of recruitment of the CLPs. 
 
Finally, morphology phenotype was also used to exclude mutants with general defects. 
At last, in addition to wz260, 12 morphologically relative normal mutants (wz180, 
wz193, wz213, wz174, wz179, wz161, wz116, wz262, wz244, wz194, wz147 and wz370) 
were selected for maintenance and further study (figure 3.7).  
 
3.2 Discussion 
We carried out a forward genetic screen to isolate T lymphocyte deficient mutants 
based on WISH of rag1. With 2X10-3 mutagenesis efficiencies, 540 genomes were 
screened and 86 mutants were recovered from the F3 generation. The large number of 
the mutants isolated from our small-scale screen is possible because mutations in any 
genes affecting T cell development or thymus organogenesis could lead to loss of 
rag-1 expression in thymus.  
 
In principle, rag1 expression-deficient mutants could be grouped into five different 
categories with deficiency in: I) Hemangioblast; II) HSC or multipotent progenitors; 
III) CLPs; IV) T cell lineage; V) Thymus organogenesis.  
 
Based on results of preliminary characterization, none of the 86 rag1-deficient 

























Figure 3.7 Twelve rag1-deficient mutants with relatively normal morphology. Each panel consists of 4dpf wild type (with thymic rag1 staining 
indicated by arrows) and rag1 deficient mutant fish. 
 
wz180 wz193 wz213 wz174 
wz179 wz161 wz116 wz262 
wz244 wz194 wz147 wz370 
 89
raised the possibility that it might belong to Category II mutants, defective in HSC or 
multipotent progenitors. Other 85 mutants could not be excluded from this group 
based solely on the preliminary characterization. This was because most of our 
mutants die within 10dpf when the definitive red blood cells start to be dominant in 
circulation. Thus it was impossible to observe definitive blood circulation. 
Examination of runx1 and c-myb (Burns et al., 2002; Thompson et al., 1998; 
Kalev-Zylinska et al., 2002) may provide clues to define mutants of this group. 
Category III mutants are defective in T and B lymphocyte development with intact 
erythroid and myeloid lineages. In zebrafish, B lymphocytes are first detected in 
kidney by rag1 expression at 21dpf (Willett et al., 1999). The early lethal phenotypes 
of our rag1-deficient mutants make it impossible to examine B lymphocyte defects in 
this category. Finally, both Category IV (T cell lineage) and V (Thymus organogenesis) 
mutants lose only T lymphocyte but not the other blood cells. However, the causes of 
the T cell defect in these two categories are different. Category IV mutants have 
cell-autonomous defects in T cell development such as cell survival, differentiation, 
and migration, whereas Category V mutants are defective in thymus organogenesis, 
resulting in loss of T cells. foxn1, which is highly enriched in the thymus epithelial 
cells, is a well-known molecular marker important for thymus organogenesis, and 
serves as a thymus-specific marker that may distinguish these two types of mutants 
(Blackburn et al., 1996; Nehls et al., 1994). However, none of the 86 rag1-deficient 
mutants lost the foxn1 expression, indicating that generation of the thymus rudiment 
occurs in these mutants. But we still could not exclude the possibility that the thymus 
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rudiment has other defects taking place before CLPs colonization, such as inability to 
provide the appropriate signals to attract or interact with CLPs. The condensed 
expression pattern of foxn1 in some mutants may represent the defective thymus 
before the CLPs entry, or the thymus that failed to expand further due to the absence 
of CLPs. 
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Chapter Ⅳ Characterization of udu mutant embryo, positional cloning and 
functional study of udu gene 
 
4.1 Results 
4.1.1 Characterization of udu mutant 
4.1.1.1 Morphological phenotype of wz260 and complementary test between 
wz260 and ugly duckling (udutu24) 
From the rag1-deficient mutants we isolated, I selected wz260 for further study 
including detailed characterization and positional cloning. wz260 mutant began to 
show notable morphological abnormality at around 20hpf, such as short body axis, 
bent-down tail, irregular somites, small head, small eyes and no circulation with a 
cardiac edema. Later on, the general retarded phenotype became more severe and the 
fish died around 10dpf (Figure 4.1). These morphological phenotypes were similar to 
those of the zebrafish mutant ugly duckling (udutu24) isolated in the 1996 Tuebingen 
large scale screen (Hammerschmidt et al., 1996). I thus speculated that wz260 mutant 
might be a new allele of udutu24. Complementation test was performed by mating the 
wz260 heterozygous female with udutu24 heterozygous male and vice versa. One 
quarter of the resulting embryos displayed the similar morphological phenotypes with 
wz260 or udutu24 mutant embryos and also lost rag1 expression in thymus (Figure 4.1). 
These observations confirmed that wz260 was indeed a new allele of udutu24 and 






























Figure 4.1 Morphological phenotype of udu (wz260) mutant. Live fish photos of wild 
type (A, C, E and G) and udu mutant fish (B, D, F and H) at 1dpf (A and B), 2dpf (C 
and D), 3dpf (E and F) and 4dpf (G and H). WISH of rag1 (arrow) in 5dpf wild type 













4.1.1.2 Primitive hematopoietic hypoplasia in udu-/- mutant 
Observation under the microscope indicated that red blood cells significantly 
decreased in the udu-/- mutant embryos. O-dianisidine staining of hemoglobin was 
then carried out. It showed that the stained erythrocytes were indeed markedly 
reduced in the 2dpf udu-/- mutant embryos (Figure 3.4). To explore the hematopoietic 
defects in depth, I examined the expression of two critical early hematopoietic 
markers lmo2 and scl (Liao et al., 1998; Gering et al., 1998). Whole-mount in situ 
hybridization (WISH) showed that neither lmo2 (data not shown) nor scl exhibited 
apparent expression differences between the udu-/- mutant and wild type embryos 
before 10-somite stage (Figure 4.2A and B), indicating that the udu gene is 
dispensable for the specification of hematopoietic progenitors. However, by the 
18-somite stage, the level of scl and lmo2 expression was reduced in the ICM region 
in udu-/- mutant. Considering that at this stage the ICM region consists mainly of 
erythroblasts, I speculated that the erythropoiesis was affected in udu-/- mutant. This 
was confirmed by the reduction of gata1 expression from the 18-somite stage 
onwards (Figure 4.2C and D). Especially, by 22hpf, the expression of band3, an 
erythrocyte-specific membrane protein critical for erythrocyte maturation (Paw et al., 
2003), was dramatically reduced in the udu-/- mutant embryos (Figure 4.2E and F). 
And this remarkable decrease of band3 expression at 22hpf could not be fully 
explained by the reduction of red blood cell number because expression of βe1-globin 
remained relative normal or only slightly reduced in these 22hpf udu-/- mutant 
embryos (Figure 4.2G and H). Thus aberration in erythrocyte differentiation is very 
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likely the main reason for the decrease of band3 expression in udu mutant, eventually 
leading to red blood cell hypoplasia as indicated by βe3-globin expression from 30hpf 
onwards (Figure 4.2 I-L). 
 
Similar to erythropoiesis, initiation of myelopoiesis was normal as indicated by 
beginning of pu.1 expression before the 10-somite stage (Figure 4.3 A and B). But 
further differentiation of primitive myeloid cells in udu mutant was impaired as it was 
shown by the decreased expression of pu.1, mpo and lyc by 24hpf in the ALM (Figure 
4.3 C-H) where primitive myelopoiesis occurs. Notably, ectopic elevated expression 
of pu.1 and mpo in the ICM region was detected in the udu-/- mutant embryos between 
24hpf and 30hpf (Figure 4.3 C-F). However, no ectopic elevated l-plastin (data not 
shown) or lyc expression was seen in the ICM region of these mutant embryos (Figure 
4.3 G and H), suggesting that the ectopic pu.1 and mpo expression in the ICM region 
was possibly caused by the increased number of the immature precursors rather than 
alteration of cell fate. This was further supported by the cytology analysis, which 
revealed that there was no obvious increase of myeloid lineage cells in the mutant 
embryos (data not shown).  
 
4.1.1.3 Abnormal proliferation and differentiation of hematopoietic cells in udu-/- 
To further illustrate the cellular defect of the hematopoietic hypoplasia in udu mutant, 
we performed acridine orange staining on different stages of the udu mutant and wild 

















Figure 4.2 Primitive erythropoiesis is impaired in the udu-/- mutant. (A-L) WISH of 
scl (A, B), gata1 (C, D), band3 (E, F), βe1-globin (G, H), and βe3-globin (I-L) in the 
wild type (A, C, E, G, I and K) and the udu-/- mutant embryos (B, D, F, H, J and L). 

















Figure 4.3 Myelopoiesis is defective in the udu-/- mutant. (A-H) WISH of pu.1 (A, B, 
C and D), mpo (E and F) and ly c (G and H) in the 10-somite (10s) (A and B) and 
24hpf (C-H) wild type (A, C, E and G) and udu-/- mutant embryos (B, D, F and H). All 
embryos are in lateral views with anterior to the left.  
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nervous system (CNS), no significant increase in apoptosis was observed in the ICM 
(Figure 4.4), suggesting that aberration in cell cycle rather than apoptosis may 
possibly contribute to the eventual absence of hematopoietic cells in udu mutant. To 
further clarify this issue, I out-crossed the udu heterozygous mutant fish with the 
Tg(-5.0scl:EGFP)sq1 (referred to as Tg(5'5kbscl:EGFP) in the original paper) 
transgenic line (Jin et al., 2006), in which the expression of the enhanced green 
fluorescent protein (EGFP) reporter gene is under control of scl promoter. The 
resulting udu+/-/Tg(-5.0scl:EGFP)sq1 was then mated with udu+/- fish. Finally, the GFP 
positive cells of the 24hpf udu-/-/Tg(-5.0scl:EGFP)sq1 and sibling embryos were 
collected by the fluorescent activated cell sorting (FACS) (Figure 4.5A and D) and 
subjected to cell cycle analysis. DNA content examination using Hoechst 33342 
staining revealed that, while wild type displayed 45.06%, 43.93% and 11.01% of cells 
in G1/G0, S and G2/M phases, respectively (Figure 4.5B), the udu-/- mutant cells 
exhibited abnormal accumulation in G2/M (43.16%) and reduction in G1/G0 (32.13%) 
and S (24.71%) phases (Figure 4.5E). Besides, cytology analysis showed that the wild 
type GFP+ cells consisted of mainly erythroid cells in various levels of differentiation 
(more differentiated cells showed a round central nucleus, chromatin condensation 
and were smaller in size) and some myeloid cells (characterized by their irregular 
nucleus) (Figure 4.5C). In contrast, the udu-/- mutant GFP+ cells were much larger, 
lacked chromatin condensation (Figure 4.5F), and similar to those found in the 16hpf 
wild type embryos (data not shown). It appeared that loss of udu gene leads to the 






Figure 4.4 Extensive cell deaths in the CNS but not in the ICM in the udu-/- mutant. 








Figure 4.5 The udu-/- erythroid cells are defective in proliferation and differentiation. 
(A and D) FACS profile of the cell suspensions from the 24hpf wild type (A) or udu-/- 
mutant (D) embryos. The y axis indicates the intensity of the EGFP expression and 
the x axis represents the cell size. (B and E) The EGFP-positive hematopoietic cells in 
A and D (gated in the rectangle) are collected, respectively, and subjected to DNA 
content analysis by the Hochest33342 staining. The y-axis indicates the cell number 
whereas the x-axis represents the DNA content. The percentages of each phase in cell 
cycle are given. (C and F) May-Grunwald and Giemsa staining analysis 
(magnification x1000) of the sorted EGFP-positive cells in A and D. Black and red 













are actually defective in proliferation and differentiation. 
 
4.1.2 Identification of the udu mutant gene 
4.1.2.1 Positional cloning of udu gene 
To unravel the molecular basis that underlies the phenotype of udu-/- mutant, I next 
went on to clone the udu gene by positional cloning. By bulk segregation analysis 
(BSA), I found that the udu mutation was linked to SSLP (simple sequence length 
polymorphism) marker z10036 and z1215 on linkage group 16 (Figure 4.6). And the 
linkage was confirmed by 172 single embryo linkage analyses (Figure 4.7). Among 
the 172 embryos, there were 14 and 33 recombinants for marker z10036 and marker 
z1215 respectively. These recombinants of the two markers had no overlap, indicating 
that the udu gene was localized between z10036 and z1215. The z10036 direction was 
defined as North and the z1215 direction as South. The genetic distance between 
z10036 and udu gene was 4.1cM (14/(172X2)), whereas the genetic distance between 
z1215 and udu gene was 9.6cM (33/(172X2). 
 
Based on the genetic map provided by ZFIN (The Zebrafish Information Network), 
additional SSLP markers between z10036 and z1215 were screened for polymorphism 
first and then used to narrow down the udu interval (Figure 4.8). One polymorphic 
SSLP marker z17246 shared 2 recombinants with z10036 and was a closer north 
marker. To find a closer south marker, SSLP markers were designed based on the 
sequence of BAC zK30O16 that contained a BAC end marker zK30O16.sp6 mapped 
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between z10036 and z1215 (Figure 4.8). One marker SSLP-S16 on BAC zK30O16 
was found to have 2 recombinants that were shared with z1215, indicating that it was 
a closer south marker. Then the fine mapping was carried out using z17246 and 
SSLP-S16. 2,932 mutant embryos were analyzed, 29 recombinants were found for 
SSLP-S16 and 20 recombinants for z17246 (Figure 4.9). Therefore, the genetic 
distance between udu gene and z17246 or SSLP-S16 was estimated to be 0.34cM and 
0.49cM, respectively. The distance was close enough to carry out genome walking to 
link the genetic map with the physical map.  
 
Based on Ensembl (http://www.ensembl.org/Danio_rerio/index.html) and Vega 
database (http://vega.sanger.ac.uk/Danio_rerio/index.html), as well as Zebrafish 
Genome Fingerprinting Project database provided by Sanger Center 
(www.sanger.ac.uk/Projects/D_rerio/WebFPC/zebrafish/small.shtml), blast search 
using z17246 and SSLP-16 found out the North Contig #9751 and the South Contig 
#10178 respectively. Due to the incomplete sequences and some mistakes in the 
shotgun assembly, these two contigs were mapped to two distinct regions at a long 
distance on Ensembl. It was not possible considering the real genetic distance. 
Therefore, I tried to link these two contigs together by blast searching using all the 
BAC end sequences within the two contigs. I found 7 BAC clones (zK7E18, 
zK181B14, zK185J5, zK254G19, zK31I15, zK288H24 and zK230G12) whose one 
end overlapped with North Contig #9751 and the other end overlapped with South 






























Figure 4.6 BSA identified that the udu mutation was linked to SSLP marker z10036 





























































































Figure 4.7 Single embryo linkage analyses of marker z10036 (A) and z1215 (B). In both of the panels, the first and last lanes are size standard 
markers. The lanes labeled with “S” and “wt” indicate the siblings and wild type embryos, respectively. The lanes labeled with “R” indicate the 
udu-/- embryos in which recombination occurred between the udu gene and marker z10036 (A) or z1215 (B). The unlabeled lanes indicate the 
udu-/- embryos without recombination. 
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Figure 4.8 The genetic map T51 and MGH provided by ZFIN. Only the udu intervals 
are shown in the panel. The firstly identified linked markers by BSA (z10036 and 
z1215) as well as the markers used for fine mapping (z17246 and zK30O16.sp6) are 
















Figure 4.9 Fine mapping using z17246 and SSLP-S16. (A and B) Single mutant 
embryo linkage analysis with z17246 (A) and SSLP-S16 (B). The lanes labeled with 
“AB” and “Wik” represent the AB and Wik grandparents’ allele respectively. The 
lanes labeled with “R” indicate the recombinant udu-/- embryos’ allele. The unlabeled 
























To further narrow down the udu region, more markers were designed and screened for 
polymorphism based on the BAC clone sequences of the two contigs. Among the 
numerous markers I designed, only 2 SSLP and 5 Single Nucleotide Polymorphism 
(SNP) markers showed polymorphism between AB and WIK, and could be used for 
mapping (Table 2.4). The nearest north marker SSLP-N6 on BAC zC196P10 showed 
only 1 recombinant, corresponding to 0.02cM, whereas the nearest south marker 
SSLP-S18 located on BAC zC113G11 showed 27 recombinants. Thus, the udu gene 
was mapped within a 3-BAC overlapping region, zC196P10, zK7E18 and zC113G11 
(Figure 4.11). To test if one of the 4 predicted genes in BAC zC196P10 was udu gene, 
I sequenced the RT-PCR products of these 4 genes to identify the mutation by 
comparing udu-/- and wild type sequences. DNA sequencing analysis showed that a 
point mutation (T to A) of udusq1zl existed in Ensembl Predicted Gene 
ENSDARG00000005867, which appeared to be a novel gene. The other allele, udutu24 
also had a point mutation (T to A) in a different site of Ensembl Gene 
ENSDARG00000005867 (Figure 4.12). By using 5’ and 3’ RACE, I determined that 
the full-length cDNA sequence of ENSDARG00000005867 was 6,787 base pairs, 
comprising 31 exons, and 30.64 kb of genomic sequence (Figure 4.11 and 4.13). The 
open reading frame started from nucleotide 91 (on exon2) and ended at nucleotide 
6258 (on exon31), encoding a 2,055 amino acid (aa) protein. The point mutation in 
udutu24 and udusq1zl occurred at T1461 (exon12) and T2976 (exon21), respectively, 













Figure 4.10 Alignment of North Contig #9751 and South Contig #10178. Each contig consists of a series of BAC clones aligned together. The 
seven green BAC clones, in which one end overlaps with North Contig #9751, and the other end overlaps with South Contig #10178, bridge the 
North and South Contigs. The SSLP and SNP markers as well as the corresponding recombinant numbers out of 2,932 embryos are labeled in 







































Figure 4.11 Positional cloning and gene structure of udu gene. (A) The udu gene is 
mapped to LG16 within the region covered by three BACs, zC196P10, zK7E18 and 
zC113G11. The number in red represents the number of the recombinants over 5,864 
meiosis events for each SSLP marker. Sequence analysis confirms that the udu 
mutation is situated in the BAC zC196P10. (B) The udu gene consists of 31 exons 
(solid box) and encodes a protein of 2055 aa. Both udutu24 and udusq1zl harbor a 



















Figure 4.12 The nonsense mutation in Ensemble Gene ENSDARG00000005867 (udu 
gene) in udutu24 and udusq1zl mutants. (A) Sequence comparison of Ensemble Gene 
ENSDARG00000005867 RT-PCR products from wild type and udutu24 heterozygous 
mutant around the point mutation site. (B) Sequence comparison of Ensemble Gene 
ENSDARG00000005867 RT-PCR products from wild type and udusq1zl homozygous 

































































































Figure 4.13 udu cDNA sequence. 
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4.1.2.2 Confirmation of identity of the udu gene by cRNA rescue and morpholino 
knockdown  
To investigate if the udu mutant phenotype was indeed caused by mutation in the 
Ensembl gene ENSDARG00000005867, in vitro synthesized wild type 
ENSDARG00000005867 cRNA was injected into one-cell stage udu-/- mutant 
embryos. Examination of the band3 expression by WISH and red blood cell number 
by O-dianisidine staining showed that primitive erythropoiesis was restored in 59 
(92%) out of the 64 injected udu-/- mutant embryos (Figure 4.14 and Table 4.1). In 
contrast, the mutant udu-T2976A cRNA which carries the point mutation in udusq1zl 
mutant failed to do so (Figure 4.14 and Table 4.1). I then carried out a second 
experiment, in which the Ensemble gene ENSDARG00000005867 expression was 
knocked down by the antisense morpholino oligonucleotides (MO) approach. Two 
udu MOs, MO-udu-1 and MO-udu-2, which specifically target the splice junction of 
the Ensembl gene ENSDARG00000005867, were synthesized and injected into the 
one-cell stage wild type embryos. WISH of band3 and βe1-globin showed that the 
embryos injected with either MO-udu-1 or MO-udu-2 mimicked the udu-/- mutant 
phenotype whereas the control MO had no effect (Figure 4.14). Taken together, these 
data demonstrate that the udu mutant phenotype is caused by loss-of-function of the 
ENSDARG00000005867 gene (herein referred as the udu gene).  
 
4.1.3 Functional study of udu gene 
4.1.3.1 Expression pattern of udu 
WISH showed that the udu transcript was detected as early as the one-cell stage in 




Figure 4.14 Confirmation of the udu gene by cRNA rescue and morpholino 
knockdown. (A-D) WISH of band3 in the 22hpf wild type embryo (A), udu-/- embryo 
(B), udu-/- embryo injected with in vitro synthesized udu-wt RNA (C), and udu-/- 
embryo injected with in vitro synthesized udu-T2976A RNA (D). (E-H) o-dianisidine 
staining of 2dpf wild type embryo (E), udu-/- embryo (F), udu-/- embryo injected with 
in vitro synthesized udu-wt RNA (G), and udu-/- embryo injected with in vitro 
synthesized udu-T2976A RNA (H). (I-N) band3 (I, J and K) and βe1-globin (L, M 
and N) expressions by WISH in the 22hpf control morphants (I and L), MO-udu-1 
morphants (J and M) and MO-udu-2 morphants (K and N). In all the panels, embryos 





Table 4.1. Rescue results 
 













22/22 0/20 - 23/24 0/21 
% Rescued  92% 0% 0% 94% 0% 
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expression during blastula stages and the expression was reduced at the onset of 
gastrulation (~6hpf). Around the time that segmentation started, the udu transcript, 
presumably the zygotic mRNA, began to re-appear in a ubiquitous manner, and was 
subsequently enriched in the CNS as well as the ICM from the 18-somite stage 
onwards. At 24hpf, udu mRNA was also detected in the anterior parts of kidney ducts. 
 
Northern blot analysis showed that udu mRNA is expressed at all stages examined 
(1-8 cell stage, 6-8hpf, 12hpf, 24hpf, 3dpf, adult). udu mRNA was observed as a 
single transcript of approximately 7kb size, which corresponds to the size obtained by 
RACE (Figure 4.16).  
 
To study the Udu protein expression, I generated anti-Udu-N and C-terminus rabbit 
serum. Western blotting analysis showed that the affinity purified antibodies were 
capable of recognizing untagged Udu-N-Antigen (residue 4-91aa) and Udu-C-Antigen 
(residue 1818-1941aa) respectively (Figure 4.17). 
 
These anti-Udu polyclonal antibodies were also used to examine the udu protein 
expression in zebrafish by western blot as well as whole-mount 
immunohistochemistry staining. Unfortunately, the Udu antibodies did not work well 
with the whole fish embryos after many times of trying and protocols modification. 
This could be due to the low Udu protein expression in zebrafish and the relatively 
high background caused by ubiquitous expression. Therefore, I had to switch to detect 
the ectopically expressed Udu protein in 293T cells transfected with 
pcDNA3.1-udu-wt, pcDNA3.1-N-Flag-udu-wt and pcDNA3.1-C-HA-udu-wt 





Figure 4.15 The temporal and spatial expressions of the udu gene during early 
zebrafish development. (A-I) Lateral views of WISH of udu in the one-cell (A), 
2.5hpf (B), 4hpf (C), 6hpf (D), 10hpf (E), 12hpf (F), 14hpf (G), 18hpf (H), and 24hpf 
(I) embryos. White and black arrows indicate the ICM and the anterior region of 
kidney duct, respectively. Embryos in A to D are orientated with animal pole on top 




















Figure 4.16 Northern blot analysis of udu mRNA expression at different stages of 
zebrafish (1-8 cell stage, 6-8hpf, 12hpf, 24hpf, 3dpf, adult). udu mRNA is observed as 
a single transcript approximately 7kb (upper panel). elf1α mRNA is detected as a 
loading control (lower panel). 
 




antibodies could specifically detect the Flag or HA tagged Udu with a molecular 
weight ~250KD (Figure 4.18). Anti-Udu-C-Antigen antibodies not only detected the 
similar sized band of Udu, but also several smaller bands that may represent either 
degraded Udu protein or different isoforms of Udu (Figure 4.18). Further analysis is 
required to clarify this issue. The immunohistochemistry staining results of the 
transfected cells would be addressed in section 4.1.3.3. 
 
4.1.3.2 Cell-autonomous erythroid defect in the udu-/- mutant 
From the temporal and spatial expressions of the udu, it is quite possible that Udu 
plays a cell-autonomous role during the primitive red blood cell development. To test 
this speculation, I performed cell transplantation experiment. Around 15-30 donor 
cells from the 3hpf udu-/- mutant or sibling embryos pre-injected with 
rhodamine-dextran were transplanted into the same stage wild type host embryos. 
Contribution of the donor cells to the circulating blood cells in the host embryos was 
scored at around 30hpf by counting the number of the rhodamine-dextran labeled cells 
in the circulation under fluorescent microscope. As summarized in Table 4.2, when 
sibling donor cells were transplanted, about 42% (50/119) of the recipients had the 
rhodamine-dextran labeled donor cells in circulation, of which 20% (10/50) contained 
10 to 30 circulating donor cells and 22% (11/50) had more than 30 circulating donor 
cells. In contrast, when the udu-/- mutant cells were transplanted, only 26.7% (16/60) 
of the host embryos had the donor cells contributing to the blood circulation. More 
importantly, none of these embryos contained more than 10 circulating 
rhodamine-dextran labeled cells. Although non cell-autonomous effect is not excluded, 
the transplantation result strongly indicates that the udu gene can act 

















Figure 4.17 Western blot examination of purified anti-Udu-N and C-Antigen 
polyclonal antibodies by recognizing the untagged Udu-N-Antigen and 
Udu-C-Antigen. Lane 1 is the size standard marker; lane 2, 5 and 8 run GST protein; 
lane 3, 6 and 9 run untagged Udu-N-Antigen; lane 4, 7 and 10 run untagged 
Udu-C-Antigen. Lane 2-7 were detected by affinity purified anti-Udu-N-Antigen 





















Figure 4.18 Western blot analysis of the ectopic expressed Udu protein in 293T cells. 
(A) anti-Udu-C-Antigen antibody (lane2-5) and anti-Udu-N-Antigen antibody 
(lane6-9) to detect Udu proteins in 293T cells transfected with pcDNA3.1(lane2,6), 
pcDNA3.1-udu-wt(lane3,7), pcDNA3.1-udu-T2976A(lane4,8) and pcDNA3.1-udu- 
ΔSANT-L(lane5,9). (B) anti-flag monoclonal antibody to detect Udu proteins in 293T 
cells transfected with pcDNA3.1(lane2), pcDNA3.1-N-Flag-udu-wt(lane3). (C) 
anti-HA monoclonal antibody to detect Udu proteins in 293T cells transfected with 
pcDNA3.1(lane2), pcDNA3.1-udu-wt(lane3), pcDNA3.1-udu-T2976A(lane4) and 
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Table 4.2 Summary of cell transplantation analysis 
 





































4.1.3.3 The udu gene encodes a putative transcriptional modulator 
Blast search of public databases revealed that the Udu protein had the highest 
homology to human and mouse GON4L (Kuryshev et al., 2006) (Figure 4.19). 
Sequence alignment showed that there were several highly conserved regions (Figure 
4.19 and 4.20A). The first three conserved regions (CR-1, CR-2 and CR-3) shared no 
obvious similarity to any of the known domains. The fourth and fifth (from aa 1538 to 
1740), either of which were predicted to consist of four α-helixes, were similar to the 
PAH repeats found in SIN3 proteins, and thus were designated as PAH-like (PAH-L) 1 
and 2 domain (Figure 4.20A). Finally, the solution structure (IUG2_A) of the last 
conserved region (SANT-L) of the mouse Udu homologue GON4L 
(www.ebi.ac.uk/thornton-srv/databases/cgi-bin/pdbsum/GetPage.pl?pdbcode=1ug2) 
revealed that this conserved region resembled the SANT domain found in several 
chromatin-remodeling molecules (Figure 4.20A and B), suggesting that the Udu 
protein may be involved in transcription regulation. 
 
To test this possibility, I carried out rescue experiments with the truncated 
udu-ΔSANT-L RNA, in which the three α-helixes (from aa 1963 to 2031) of the 
SANT-L domain of the Udu protein was deleted (Table 2.6 and Figure 2.1B). As 
shown in Figure 4.20, the red blood cell development was restored in the mutant 
embryos injected with the udu-wt RNA (Figure 4.20E). However, the truncated 
udu-ΔSANT-L RNA failed to do so (Figure 4.20F), demonstrating that the SANT-L 
domain is critical for the function of the Udu protein. I also transfected the udu cDNA 
(pcDNA3.1-udu-wt) into COS7 cells to examine the sub-cellular localization of the 
Udu protein. Immunohistochemistry staining showed that the Udu protein was 
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predominantly localized in the nucleus (Figure 4.20G-I). Taken together, these results 
strongly indicate that the Udu protein may function as a regulator of transcription.  
 
4.1.3.4 The udu-/- erythroid defect is mediated by a p53-dependent pathway 
To identify potential target genes perturbed in udu mutant, I performed microarray 
analysis. Result from two sets of independent experiments showed that expressions of 
87 and 57 genes were down- and up-regulated, respectively, with 2-fold and above 
differences in the udu-/- mutant embryos (Table 4.3 and 4.4). Interestingly, several 
up-regulated genes, including p53, fos, mdm2, gadd45αl, caspase 8, and tdag51, are 
known to be involved in cell cycle control and apoptosis (Table 4.4).  Their 
up-regulation in the udu-/- mutant embryos was further confirmed by 
Semi-quantitative RT-PCR (Figure 4.21). Considering the G2/M cell cycle arrest of 
the udu-/- erythroid cells, I focused on p53 and its downstream target gadd45αl. WISH 
showed that in the 24hpf udu-/- mutant embryos the expression levels of p53 (Figure 
4.22A and B) and gadd45αl (Figure 4.22I and J), especially p53, were significantly 
elevated in the CNS and the ICM, where the endogenous udu expression is normally 
enriched at this stage, suggesting that the G2/M cell cycle arrest of the udu-/- erythroid 
cells is possibly caused by abnormal activation of the p53 pathway. To test this 
possibility, I knocked down the p53 protein in the udu-/- mutant embryos by the p53 
MO. The erythrocyte-deficient phenotype was rescued in the udu-/- mutant embryos 
injected with the p53 MO but not control MO (Figure 4.22C-H). As anticipated, 
elevated gadd45αl expression was no longer detected in these p53 morphant mutants 
(Figure 4.22I-K). These data strongly suggest that loss-of-function mutation in the 














Figure 4.19 Sequence alignment of the zebrafish Udu, human and mouse GON4L 
proteins. Identical amino acids are labeled in red whereas homologous residues, 
which are scored if they are within a single group of neutral (A, C, G, P, S, T), 
hydrophobic (I, L, M, V), acidic (D, E, N, Q), basic (H, K, R), or aromatic (F, W, Y), 




Figure 4.20 The Udu protein is a putative transcriptional modulator. (A) The Udu 
protein contains six conserved regions: CR-1, CR-2, CR-3, PAH-L1, PAH-L2 and 
SANT-L. (B) Protein sequence alignment of the SANT-L domain between zebrafish 
Udu (top, fish-Udu-1947-2039aa) and mouse Udu homologue GON4L (1UG2_A). 
(C-F) Lateral views of o-dianisidine staining of the 2dpf wild type (C), udu-/- mutant 
embryos (D), the udu-/- mutant embryo injected with udu-wt RNA (E), and the udu-/- 
mutant embryo injected with udu-ΔSANT-L RNA (F). (G) Propidium Iodide (PI) 
staining of the pcDNA3.1-udu-wt transfected COS7 cells. (H). Immunohistochemistry 
staining of the pcDNA3.1-udu-wt transfected COS7 cells with the 
anti-Udu-C-Antigen polyclonal antibody. (I) Superimposed image of G and H. Arrows 
in C and E indicate o-dianisidine stained red blood cells. Scale bars in G-I represent 
10μm. 
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Table 4.3 Summary of down-regulated genes in udu-/- mutant 
 
Affymetix gene ID Gene name Signal log 
ratio in 1st 
experiment 
Signal log 
ratio in 2nd 
experiment 
Dr.20971.1.S2_at solute carrier family 4, anion 
exchanger, member 1 
-6.6 -4.1 
Dr.3027.1.S1_at erythrocyte membrane protein band 
4.1 (elliptocytosis 1, RH-linked) 
-4.2 -2.1 
Dr.16496.1.A1_at --- -3.3 -1.1 
Dr.10343.1.S1_at ATPase, Na+/K+ transporting, 
alpha 1a.2 polypeptide 
-2.7 -2.9 
Dr.450.1.S1_at carbonic anhydrase -2.4 -3.1 
Dr.21393.1.A1_at --- -2.2 -1.9 
Dr.12602.1.S1_at lysozyme -2.1 -2.5 
Dr.24764.1.S1_at --- -2.1 -1.5 
Dr.12386.2.S1_a_at mesogenin 1 -1.9 -1.4 
Dr.20010.14.S1_at --- -1.8 -2.2 
Dr.25422.1.S1_s_at hemoglobin alpha embryonic-1 -1.8 -2.1 
Dr.371.1.S1_at zgc:85892 -1.8 -2 
Dr.1450.1.S1_s_at hemoglobin alpha embryonic-3 -1.8 -2 
Dr.5372.1.S1_x_at hairy-related 4 -1.8 -1.8 
DrAffx.1.52.S1_at ataxin 2-binding protein 1-like -1.8 -1.7 
Dr.5404.1.S1_at calymmin -1.7 -2 
DrAffx.1.85.S1_s_at hemoglobin beta embryonic-1 -1.7 -1.9 
Dr.19402.1.A1_at --- -1.7 -1.7 
Dr.355.1.S1_at GATA-binding protein 1 -1.7 -1.5 
Dr.25683.10.S1_at --- -1.6 -2.1 
Dr.14667.1.S1_at crystallin, beta B1 -1.6 -2.1 
Dr.2166.1.S1_at uroporphyrinogen decarboxylase -1.6 -1.9 
Dr.25729.1.S1_at zgc:92724 /// zgc:86750 -1.6 -1.9 
Dr.20143.1.S1_at hairy-related 3 -1.6 -1.6 
Dr.25060.3.A1_at --- -1.6 -1.6 
Dr.5434.1.S4_at proteolipid protein 1a -1.6 -1.5 
Dr.4827.1.A1_at leukocyte cell derived chemotaxin 
1 
-1.6 -1.4 
Dr.12569.1.S1_at Kruppel-like factor d -1.5 -1.9 
Dr.8180.1.S1_at aminolevulinate, delta-, synthetase 
2 
-1.5 -1.9 
Dr.24891.1.S1_at --- -1.5 -1.6 
Dr.14668.1.S1_at GTP cyclohydrolase 1 -1.5 -1.6 
Dr.8232.1.S1_at hairy/enhancer-of-split related with 
YRPW motif 2 
-1.5 -1.2 
Dr.318.1.A1_at achaete-scute complex-like 1b 
(Drosophila) 
-1.4 -1.7 
Dr.4160.1.A1_at --- -1.4 -1.6 
Dr.1837.1.A1_at --- -1.4 -1.6 
Dr.555.1.S1_at neurogenin 1 -1.4 -1.6 
Dr.10718.1.S1_at neurogenic differentiation 4 -1.4 -1.6 
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Affymetix gene ID Gene name Signal log 
ratio in 1st 
experiment 
Signal log 
ratio in 2nd 
experiment 
Dr.7857.1.A1_at --- -1.4 -1.2 
Dr.3211.1.A1_at --- -1.3 -1.9 
Dr.4171.1.A1_at phenylalanine hydroxylase -1.3 -1.6 
Dr.8072.1.S1_at developing brain homeobox 1b -1.3 -1.6 
Dr.441.1.S1_at sb:cb343 -1.3 -1.5 
Dr.21808.1.A1_at --- -1.3 -1.4 
Dr.22360.1.A1_at zgc:85890 -1.3 -1.3 
Dr.11651.1.S1_at MCM5 minichromosome 
maintenance deficient 5 (S. 
cerevisiae) 
-1.3 -1.3 
Dr.1050.1.S1_at --- -1.3 -1.3 
DrAffx.1.60.S1_at pancreas specific transcription 
factor, 1a 
-1.3 -1.3 
DrAffx.2.19.S1_at embryonic globin beta e3 -1.3 -1.1 
Dr.15802.2.S1_a_at --- -1.2 -2 
Dr.5278.1.A1_at Receptor PTP-like protein IA-2 -1.2 -1.7 
Dr.3920.1.S1_at oligodendrocyte lineage 
transcription factor 2 
-1.2 -1.7 
Dr.20958.1.S1_at --- -1.2 -1.7 
Dr.180.1.A1_at cytochrome P450, family 26, 
subfamily b, polypeptide 1 
-1.2 -1.6 
Dr.10652.1.S1_at spectrin, beta, erythrocytic -1.2 -1.4 
Dr.4833.6.S1_at --- -1.2 -1.4 
Dr.19463.1.S1_at --- -1.2 -1.3 
Dr.10336.1.S1_at dopachrome tautomerase -1.2 -1.2 
Dr.2291.1.S1_at MCM2 minichromosome 
maintenance deficient 2, mitotin (S. 
cerevisiae) 
-1.2 -1.2 
Dr.25187.1.S1_a_at hairy-related 8a -1.2 -1.2 




Dr.9225.1.A1_at --- -1.2 -1 
Dr.518.1.A1_at --- -1.1 -1.7 
Dr.3407.1.A1_at Transcribed locus, weakly similar 
to NP_034066.1 procollagen, type 
IX, alpha 3 [Mus musculus] 
-1.1 -1.5 
Dr.10492.1.S1_at deltaA -1.1 -1.4 
Dr.18233.1.A1_at metallothionein 2 -1.1 -1.2 
Dr.19643.1.A1_at --- -1.1 -1.2 
Dr.21068.1.S1_s_at POU domain gene 1 /// POU 
domain gene 23 
-1.1 -1.2 
Dr.4299.1.S1_at --- -1.1 -1.2 
Dr.23386.1.A1_at --- -1.1 -1.1 
Dr.1691.6.A1_at --- -1.1 -1.1 
Dr.18025.1.A1_at --- -1.1 -1 
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Affymetix gene ID Gene name Signal log 
ratio in 1st 
experiment 
Signal log 
ratio in 2nd 
experiment 
DrAffx.2.105.S1_at --- -1.1 -1 
Dr.18151.1.S1_at --- -1 -2.2 
Dr.5112.1.S3_at --- -1 -1.6 
Dr.13772.1.A1_at --- -1 -1.3 
Dr.3967.1.A1_at --- -1 -1.3 
Dr.221.1.S1_at POU domain gene 47 -1 -1.3 
Dr.6932.3.S1_at --- -1 -1.2 
Dr.5091.1.S1_at MCM4 minichromosome 
maintenance deficient 4, mitotin (S. 
cerevisiae) 
-1 -1.2 
Dr.3153.1.A1_at --- -1 -1.1 
Dr.26331.1.A1_at --- -1 -1.1 
Dr.18075.1.S1_at --- -1 -1 
Dr.12717.1.S1_at zgc:55612 -1 -1 
Dr.5345.1.S1_at F-box protein 5 -1 -1 





Table 4.4 Summary of up-regulated genes in udu-/- mutant 
 
Affymetix gene ID Gene name Signal log 
ratio in 1st 
experiment 
Signal log 
ratio in 2nd 
experiment
Dr.12986.1.A1_a_at v-fos FBJ murine osteosarcoma 
viral oncogene homolog 
3.1 2.7 
Dr.17659.1.S1_at --- 2.6 3.1 
Dr.11242.1.A1_at pleckstrin homology-like domain, 
family A, member 3 
2.5 3.7 
Dr.15033.1.S1_at --- 2.4 2.7 
Dr.5925.1.A1_at --- 2.2 2 
Dr.23587.1.A1_at growth arrest and 
DNA-damage-inducible, alpha like
2 2.8 
Dr.7532.1.A1_at --- 2 1.4 
Dr.4083.1.A1_at Transcribed locus 2 1.1 
Dr.10914.1.A1_at Wu:fc49d01 1.9 2 
Dr.25767.1.S1_at Transcribed locus 1.9 1.6 
Dr.10334.1.S1_at caspase 8 1.8 2.4 
Dr.13121.1.A1_x_at --- 1.8 1.1 
Dr.2953.1.S1_at zgc:55750 1.7 2.3 
Dr.14434.1.S1_a_at piwi-like 1 (Drosophila) 1.7 2 
Dr.12491.1.A1_at --- 1.6 2 
Dr.15596.1.A1_at --- 1.6 1.4 
Dr.13161.1.S1_at Gadd45b1 1.5 2 
Dr.26003.1.A1_at Transcribed locus 1.5 2 
Dr.11708.1.S1_at zgc:55580 1.5 1 
Dr.12833.1.A1_at zgc:64213 1.4 2.3 
Dr.18644.1.A1_at --- 1.4 1.7 
Dr.15822.1.S1_at zgc:64174 1.4 1.5 
Dr.12724.1.A1_at --- 1.4 1.3 
Dr.23385.1.A1_at Transcribed locus, weakly similar 
to NP_508841.1 actin (act-4) 
[Caenorhabditis elegans] 
1.3 2.2 
Dr.17587.1.A1_at Transcribed locus, weakly similar 
to NP_766602.1 hypothetical 
protein A330042H22 [Mus 
musculus] 
1.3 2.1 
Dr.7110.1.S1_at zgc:77614 1.3 2.1 
Dr.8209.1.S2_at forkhead box O5 1.3 1.6 
Dr.15781.1.S1_at vaccinia related kinase 2 1.3 1.6 
Dr.14673.2.S1_at zgc:92830 1.3 1.5 
Dr.681.1.A1_at zgc:65909 1.3 1.4 
Dr.8946.1.A1_x_at Transcribed locus 1.3 1.2 
Dr.7787.1.S1_at --- 1.2 1.7 
Dr.16174.1.A1_at Transcribed locus, moderately 
similar to NP_034768.2 basic 
transcription element binding 
protein 1 [Mus musculus] 
1.2 3.4 
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Affymetix gene ID Gene name Signal log 
ratio in 1st 
experiment 
Signal log 
ratio in 2nd 
experiment
Dr.2052.1.S1_at tumor protein p53 1.2 1.5 
Dr.6820.1.A1_at GTP binding protein 1, like 1.2 1.4 
Dr.6496.2.A1_at --- 1.2 1.3 
Dr.3197.1.A1_a_at Transcribed locus 1.2 1 
Dr.25767.1.S1_x_at Transcribed locus 1.1 2.2 
Dr.11479.1.A1_at --- 1.1 1.7 
Dr.6709.1.S1_at --- 1.1 1.6 
Dr.8000.1.S1_at zgc:101700 1.1 1.5 
Dr.2067.1.A1_at --- 1.1 1.3 
Dr.25536.1.A1_at --- 1.1 1.2 
Dr.5129.1.S1_at zgc:56722 1.1 1.2 
Dr.24233.1.S1_at Fibronectin 1-like 1.1 1.2 
Dr.3197.3.A1_x_at Transcribed locus 1.1 1.2 
Dr.25376.1.A1_at --- 1.1 1 
Dr.4048.1.S1_at --- 1.1 1 
Dr.6242.1.A1_at --- 1 1.5 
Dr.16273.1.S1_at Transcribed locus 1 1.2 
Dr.3197.1.A1_x_at Transcribed locus 1 1.1 
Dr.542.1.S1_at murine double minute 2 homolog 1 1.1 
Dr.12425.1.S1_at zgc:92533 1 1.1 
Dr.8145.1.S1_at insulin-like growth factor 2 
precursor 
1 1.1 

























Figure 4.21 Verification of elevated p53 and its target gene expressions in the udu-/- 
mutant embryos by semi-quantitative RT-PCR. Left and right lanes represent the 






Figure 4.22 The hematopoietic phenotype of the udu-/- mutant is mediated by a 
p53-dependent pathway. (A and B) WISH shows that p53 expression is elevated in the 
24hpf udu-/- mutant embryo (B) compared to the wild type (A). (C-E) WISH of band3 
in the 22hpf wild type embryo (C) and udu-/- mutant morphants injected with control 
MO (D) or p53 MO (E). (F-H) O-dianisidine staining of the 2dpf wild type embryo (F) 
and udu-/- mutant morphants injected with control MO (G) or p53 MO (H). (I-K) 
WISH of gadd45αl in the 24hpf wild type embryo (I) and the udu-/- mutant morphants 
injected with control MO (J) or p53 MO (K). Arrows in F and H indicate o-dianisidine 




4.2.1 Analysis of the hematopoietic phenotype of udu mutant 
The zebrafish mutant ugly duckling (udutu24) was first isolated from the 1996 
Tuebingen large scale screen as a mutant affecting morphogenesis during gastrulation 
and tail formation (Hammerschmidt et al., 1996). In this project, I reported the 
isolation and detailed study of a new udu allele, udusq1zl, as a mutant with defect in 
hematopoiesis. Cell cycle, cytology, and transplantation analyses showed that the 
primitive erythroid cells in the udusq1zl homozygous mutants were severely impaired 
in proliferation and differentiation in a cell-autonomous fashion. In addition to the 
primitive erythropoiesis, primitive myelopoiesis and definitive lymphopoiesis also 
had defects in udu-/- mutant, indicated by decreased lysozyme C expression and 
absence of rag1 expression respectively. But the myelopoiesis and lymphopoiesis 
abnormality in udu-/- mutant was not studied extensively in this thesis. Thus it was not 
clear whether the defects in the myelopoiesis and lymphopoiesis of the udu-/- mutant 
shared similar features or similar mechanisms with primitive erythropoiesis. udu RNA 
microinjection, as well as p53 MO, could successfully correct the mutant 
erythropoiesis phenotype to a satisfactory degree, but failed to restore the 
myelopoiesis and lymphopoiesis (data not shown). One possibility was the limitation 
of the rescue assay: slight increment of lysozyme C positive cell number was difficult 
to judge, whereas, the rag1 expression at 4dpf could not be rescued due to the short 
life span of the udu RNA and the p53 MO. The other possibility was that the 
mechanism to cause myelopoietic and lymphopoietic defects was more complex than 
that to cause erythropoietic abnormality so that myelopoiesis and lymphopoiesis were 
harder to be restored. For example, cell migration that was required during 
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myelopoiesis and lymphopoiesis, could be impaired in udu-/- mutant since 
morphogenesis was also affected in udu-/- mutant during gastrulation and tail 
formation. Finally, definitive erythropoiesis was not established in udu-/- mutant, but 
whether the initiation of the definitive hematopoiesis occurred and at which stage 
definitive hematopoiesis defects occurred remains not clear at this moment. 
 
The comparable levels of expression of lmo2 and scl in udu-/- mutant and wild type 
before 10-somite stage indicate that the udu gene is dispensable for initiation of 
formation of primitive hematopoietic stem cell and early erythroid progenitor 
specification. However, presence of high level of maternal udu RNA raised a 
possibility that the lack of early hematopoietic phenotype in udu mutant is due to the 
function of the maternal udu RNA. Since both udu allele are homozygous lethal and 
die around 7-10dpf, it excludes the possibility to analyse the mutant progeny directly. 
The primordial germ cells replacement approach described by Ciruna et al. can be 
used to clarify this issue (Ciruna et al., 2002).  
 
4.2.2 Cell-autonomous role of udu gene in erythropoiesis 
The transplantation experiment was only performed in one direction: transplanting 
udu-/- mutant or sibling donor cells into wild type host embryos. The results showed 
that donor cells from udu-/- mutant could contribute to host circulating blood cells but 
with fewer number and lower ratio compared with wild type donor cells, indicating 
that the udu-/- mutant donor cells could specify into erythrocytes but failed to further 
proliferate. Therefore, I concluded that the udu gene could act cell-autonomously to 
affect development of the primitive red blood cell. However, I did not carry out 
experiment to test non cell-autonomous effect because the udu-/- mutant embryos have 
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no blood circulation but still have some erythrocytes expressing the hematopoietic 
markers, thereby preventing us from determining whether the wild type donor cells 
could contribute to normal erythrocytes in udu-/- mutant host. So I could not exclude 
that the udu gene may also act non cell-autonomously in the regulation of primitive 
erythropoiesis. 
 
4.2.3 The putative molecular mechanism involving Udu protein 
In this part of my project, I cloned the udu gene, which encodes a novel nuclear 
protein that contains several evolutionary conserved regions, including two PAH-L 
repeats and a SANT-L or Myb-like DNA binding domain. The PAH domain, 
originally defined in the yeast SIN3 protein (Wang et al., 1990), is distantly related to 
the helix-loop-helix motif and has been shown to mediate protein-protein interactions 
(Spronk et al., 2000). The yeast SIN3 protein and its related mammalian homologues 
Sin3A and Sin3B interact, through the PAH domain, with numerous sequence-specific 
transcription factors and recruit the histone deacetylases (HDAC) to suppress 
downstream target gene transcription (Silverstein and Ekwall, 2005). The SANT and 
Myb-DNA binding (Myb-DB) domains have a similar overall structure but confer 
distinct functions (Boyer et al., 2004). The Myb-DB domain usually contains two to 
three tandem repeats and recognizes specific DNA sequence, whereas the SANT 
domain consists of one to two repeats and appears to play an important role in 
chromatin remodeling (Boyer et al., 2004). Considering the fact that the Udu protein 
contains only one repeat of this domain that appears to lack obvious patch of positive 
electrostatic surface, a notable feature of Myb-DB domain (Ogata et al., 1994), by 
structural modeling analysis (data not shown), we believe that this conserved region 
may resemble a SANT domain. Given the fact that the Udu protein has both PAH-L 
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and SANT-L domains, it is reasonable to speculate that Udu may function as a 
chromatin-remodeling molecule involved in transcription regulation of many target 
genes. However, further experiments are needed to confirm my hypothesis. 
 
4.2.4 The possible relationship between Udu and p53 
In this project, I found that there was robust elevation of the tumor suppressor p53 
expression as well as several p53 downstream targets in the udu-/- mutant embryos. 
Knockdown of the p53 protein expression by p53 MO could correct the mutant 
phenotype to a similar degree as the udu RNA complementation did. Thus, I 
concluded that the Udu protein plays a crucial role in regulating the proliferation and 
differentiation of erythroid cells through a p53-dependent pathway. 
 
p53 is well recognized as one of the most important tumor suppressors in preventing 
cancer by modulating downstream target gene expression in response to various cell 
stresses, such as DNA damage and oncogene activation, resulting in cell cycle arrest 
or death of abnormal cells (Michael and Oren, 2002; Vogelstein et al., 2000). 
Although p53-deficient animals are viable and display no obvious developmental 
abnormality (Jin et al., 2000; Ollmann et al., 2000; Schumacher et al., 2005; 
Donehower et al., 1992), over-expression of p53 during embryogenesis causes various 
developmental defects in mouse, fly and worm (Jin et al., 2000; Ollmann et al., 2000; 
Pan and Griep, 1994; Schumacher et al., 2005). In addition, the developmental defects 
caused by loss-of-function mutations in zebrafish DNA polymerase delta1 and def 
have been shown to be associated with increased p53 activity (Plaster et al., 2006; 
Chen et al., 2005). More recent studies in p53-null and Mdm2, a negative regulator of 
p53 (Michael and Oren, 2002), conditional knockout mice have shown that p53 
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suppresses osteoblast differentiation and bone formation (Lengner et al., 2006; Wang 
et al., 2006). All these observations imply that p53 plays an important role in 
maintaining normal cell growth and differentiation during animal development. Our 
finding that the erythrocyte cell cycle and CNS apoptotic defects (data not shown) in 
the udu-/- mutant are mediated through a p53-dependent fashion has provided another 
example to demonstrate that the p53 activity must be tightly controlled during 
embryogenesis in order to maintain normal cell growth and differentiation. Given the 
fact that Gadd45 is a well-known p53 downstream target gene involved in apoptosis 
and cell cycle regulation in mammals (Mak and Kultz, 2004; Michael and Oren, 2002; 
Vogelstein et al., 2000), we speculate that the G2/M cell cycle arrest of the udu-/- red 
blood cells is likely mediated by the p53-gadd45 pathway. At this moment it is not 
clear, however, how loss-of-function mutation in the udu gene leads to up-regulation 
of p53 activity. One possible explanation is that the Udu protein may function as a 
general transcription regulator and its loss-of-function causes a global change in gene 
expression, which somehow leads to activation of p53 pathway and up-regulation of 
p53 expression. However, the fact that in the 24hpf wild type zebrafish embryos both 
udu and p53 expressions are enriched in the CNS and the ICM, where rapid cell 
proliferation is taking place, raises the possibility that the Udu protein may act as a 
suppressor that directly regulates transcription or the protein activity of p53. 
Nonetheless, identifying the interaction partners or the direct target genes of Udu in 
the near future will help understand the relationship between Udu and p53. 
 
In addition, it is worthy to mention that as a result of segmental duplication on human 
chromosome 1q22, a new gene next to the human GON4L is generated (Kuryshev et 
al., 2006). Surprisingly, this segmental duplication does not exist in rat, mouse, 
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chicken and zebrafish, suggesting that this duplication may be associated with more 
recent evolutionary events specific for the anthropoid primates (Kuryshev et al., 2006). 
This new gene, the Yin Yang (YY) 1-associated protein (YY1AP), encodes a protein 
highly similar (99% identity) to the region from aa residues 590 to 1337 of GON4L. 
YY1 is a multifunctional transcription factor involved in activation, repression and 
initiation of gene transcription (Shi et al., 1997; Thomas and Seto, 1999). Recent 
studies have shown that YY1 negatively regulates the p53 protein activity by 
disrupting the p53-p300 complex and enhancing the p53-Mdm2 interaction (Gronroos 
et al., 2004; Sui et al., 2004). YY1AP was isolated in a yeast two-hybrid screening as 
a YY1 interacting protein and was shown to be a co-activator of YY1 (Wang et al., 
2004). Given the high degree of identity in their protein sequences between YY1AP 
and GON4L, it is conceivable to speculate that the Udu protein may play a role in 
down-regulation of the p53 activity through YY1. 
 
4.2.5 The Udu homologue GON4L may be associated with tumor development 
It has been known for sometime that human chromosome 1q22, where GON4L gene 
is localized, is amplified in several human cancer types, including ovarian and breast 
cancer (Cheng et al., 2004), sarcomas (Knuutila, 2004), and hepatocellular carcinoma 
(Wong et al., 1999; Marchio et al., 1997). A more detailed study has further confirmed 
that three loci covered by YAC955E11, YAC876B11 and YAC945D5 within 1q21-q22 
have the highest amplified copy number in five out of the ten hepatocellular 
carcinoma cases examined (Wong et al., 2003). Intriguingly, the genomic fragment 
covered by the YAC876B11 contains a marker D1S2140 that is 30kb apart from the 
GON4L gene, suggesting that perhaps amplification of the GON4L gene is associated 
with tumor development that warrants future study. 
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4.2.6 Essential role of Udu in proliferation and differentiation of erythroid 
lineage 
In this thesis I report the isolation and detailed study of a newly identified zebrafish 
udu mutant allele, udusq1zl. Loss-of-function mutation in the udu gene disrupts 
primitive erythroid cell proliferation and differentiation in a cell-autonomous manner, 
resulting in red blood cell hypoplasia. Positional cloning reveals that the udu gene 
encodes a novel nuclear factor that contains two PAH-L repeats and a SANT-L domain. 
Moreover, the expression of the tumor suppressor p53 and several p53 downstream 
targets is elevated in the udusq1zl mutant embryos. Knockdown of the p53 protein by 
p53 MO could correct the mutant phenotype to the same extent as udu RNA injections 
in mutant embryos. Thus, these results indicate that the Udu protein is very likely to 
function as a transcription regulator essential for the proliferation and differentiation 
of erythroid lineage, probably through a p53-dependent pathway. However, it is not 
clear what is the molecular mechanism of Udu function in erythroid lineage 
proliferation and differentiation, two exclusive but interdependent processes 
coordinated elaborately during cell development. At this moment, I have not 
identified the relationship between Udu and the known factors involved in primitive 
erythropoiesis. Injection of scl or gata1 RNA into udu homozygous mutant embryos 
failed to rescue erythropoiesis (data not shown), suggesting that the function of Udu 
in erythroid lineage development is not mediated by Scl or Gata1. Although the Udu 
pathway is not identified yet, udu mutant definitively provides a valuable model to 




Akashi,K., Traver,D., Miyamoto,T., and Weissman,I.L. (2000). A clonogenic common myeloid 
progenitor that gives rise to all myeloid lineages. Nature 404, 193-197. 
Amacher,S.L., Draper,B.W., Summers,B.R., and Kimmel,C.B. (2002). The zebrafish T-box genes no 
tail and spadetail are required for development of trunk and tail mesoderm and medial floor plate 
8. Development 129, 3311-3323. 
Amatruda,J.F. and Zon,L.I. (1999). Dissecting hematopoiesis and disease using the zebrafish. Dev Biol 
216, 1-15. 
Amsterdam,A., Burgess,S., Golling,G., Chen,W., Sun,Z., Townsend,K., Farrington,S., Haldi,M., and 
Hopkins,N. (1999). A large-scale insertional mutagenesis screen in zebrafish. Genes Dev 13, 
2713-2724. 
Amsterdam,A., Nissen,R.M., Sun,Z., Swindell,E.C., Farrington,S., and Hopkins,N. (2004). 
Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A 101, 
12792-12797. 
Anguita,E., Hughes,J., Heyworth,C., Blobel,G.A., Wood,W.G., and Higgs,D.R. (2004). Globin gene 
activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. 
EMBO J 23, 2841-2852. 
Antonchuk,J., Sauvageau,G., and Humphries,R.K. (2002). HOXB4-induced expansion of adult 
hematopoietic stem cells ex vivo. Cell 109, 39-45. 
Barndt,R.J., Dai,M., and Zhuang,Y. (2000). Functions of E2A-HEB heterodimers in T-cell development 
revealed by a dominant negative mutation of HEB. Mol. Cell Biol. 20, 6677-6685. 
Barreda,D.R., Hanington,P.C., and Belosevic,M. (2004). Regulation of myeloid development and 
function by colony stimulating factors. Dev. Comp Immunol. 28, 509-554. 
Behre,G., Whitmarsh,A.J., Coghlan,M.P., Hoang,T., Carpenter,C.L., Zhang,D.E., Davis,R.J., and 
Tenen,D.G. (1999). c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J. Biol. 
Chem. 274, 4939-4946. 
Beier,D.R. (2000). Sequence-based analysis of mutagenized mice. Mamm. Genome 11, 594-597. 
Belaoussoff,M., Farrington,S.M., and Baron,M.H. (1998). Hematopoietic induction and respecification 
of A-P identity by visceral endoderm signaling in the mouse embryo. Development 125, 5009-5018. 
Bennett,C.M., Kanki,J.P., Rhodes,J., Liu,T.X., Paw,B.H., Kieran,M.W., Langenau,D.M., 
Delahaye-Brown,A., Zon,L.I., Fleming,M.D., and Look,A.T. (2001). Myelopoiesis in the zebrafish, 
Danio rerio. Blood 98, 643-651. 
Bentley,A., MacLennan,B., Calvo,J., and Dearolf,C.R. (2000). Targeted recovery of mutations in 
Drosophila. Genetics 156, 1169-1173. 
Bhardwaj,G., Murdoch,B., Wu,D., Baker,D.P., Williams,K.P., Chadwick,K., Ling,L.E., Karanu,F.N., 
and Bhatia,M. (2001). Sonic hedgehog induces the proliferation of primitive human hematopoietic cells 
via BMP regulation. Nat. Immunol. 2, 172-180. 
Bhatia,M., Bonnet,D., Wu,D., Murdoch,B., Wrana,J., Gallacher,L., and Dick,J.E. (1999). Bone 
morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J. Exp. 
Med. 189, 1139-1148. 
Blackburn,C.C., Augustine,C.L., Li,R., Harvey,R.P., Malin,M.A., Boyd,R.L., Miller,J.F., and 
 138
Morahan,G. (1996). The nu gene acts cell-autonomously and is required for differentiation of thymic 
epithelial progenitors. Proc. Natl. Acad. Sci. U. S. A 93, 5742-5746. 
Boehm,T., Bleul,C.C., and Schorpp,M. (2003). Genetic dissection of thymus development in mouse 
and zebrafish. Immunol Rev 195, 15-27. 
Boyer,L.A., Latek,R.R., and Peterson,C.L. (2004). The SANT domain: a unique histone-tail-binding 
module? Nat Rev Mol Cell Biol 5, 158-163. 
Brown,L.A., Rodaway,A.R., Schilling,T.F., Jowett,T., Ingham,P.W., Patient,R.K., and Sharrocks,A.D. 
(2000). Insights into early vasculogenesis revealed by expression of the ETS-domain transcription 
factor Fli-1 in wild-type and mutant zebrafish embryos. Mech Dev 90, 237-252. 
Brownlie,A., Donovan,A., Pratt,S.J., Paw,B.H., Oates,A.C., Brugnara,C., Witkowska,H.E., Sassa,S., 
and Zon,L.I. (1998). Positional cloning of the zebrafish sauternes gene: a model for congenital 
sideroblastic anaemia. Nat Genet 20, 244-250. 
Brownlie,A., Hersey,C., Oates,A.C., Paw,B.H., Falick,A.M., Witkowska,H.E., Flint,J., Higgs,D., 
Jessen,J., Bahary,N., Zhu,H., Lin,S., and Zon,L. (2003). Characterization of embryonic globin genes of 
the zebrafish. Dev Biol 255, 48-61. 
Burns,C.E., DeBlasio,T., Zhou,Y., Zhang,J., Zon,L., and Nimer,S.D. (2002). Isolation and 
characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators. 
Exp Hematol. 30, 1381-1389. 
Buske,C., Feuring-Buske,M., Abramovich,C., Spiekermann,K., Eaves,C.J., Coulombel,L., 
Sauvageau,G., Hogge,D.E., and Humphries,R.K. (2002). Deregulated expression of HOXB4 enhances 
the primitive growth activity of human hematopoietic cells. Blood 100, 862-868. 
Carver-Moore,K., Broxmeyer,H.E., Luoh,S.M., Cooper,S., Peng,J., Burstein,S.A., Moore,M.W., and de 
Sauvage,F.J. (1996). Low levels of erythroid and myeloid progenitors in thrombopoietin-and 
c-mpl-deficient mice. Blood 88, 803-808. 
Chan,F.Y., Robinson,J., Brownlie,A., Shivdasani,R.A., Donovan,A., Brugnara,C., Kim,J., Lau,B.C., 
Witkowska,H.E., and Zon,L.I. (1997). Characterization of adult alpha- and beta-globin genes in the 
zebrafish. Blood 89, 688-700. 
Chen,H., Ray-Gallet,D., Zhang,P., Hetherington,C.J., Gonzalez,D.A., Zhang,D.E., Moreau-Gachelin,F., 
and Tenen,D.G. (1995). PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 11, 
1549-1560. 
Chen,J., Ruan,H., Ng,S.M., Gao,C., Soo,H.M., Wu,W., Zhang,Z., Wen,Z., Lane,D.P., and Peng,J. 
(2005). Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion 
growth of digestive organs in zebrafish. Genes Dev 19, 2900-2911. 
Cheng,K.W., Lahad,J.P., Kuo,W.L., Lapuk,A., Yamada,K., Auersperg,N., Liu,J., Smith-McCune,K., 
Lu,K.H., Fishman,D., Gray,J.W., and Mills,G.B. (2004). The RAB25 small GTPase determines 
aggressiveness of ovarian and breast cancers. Nat Med 10, 1251-1256. 
Childs,S., Weinstein,B.M., Mohideen,M.A., Donohue,S., Bonkovsky,H., and Fishman,M.C. (2000). 
Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic 
protoporphyria. Curr Biol 10, 1001-1004. 
Choi,K., Kennedy,M., Kazarov,A., Papadimitriou,J.C., and Keller,G. (1998). A common precursor for 
hematopoietic and endothelial cells. Development 125, 725-732. 
Ciruna,B., Weidinger,G., Knaut,H., Thisse,B., Thisse,C., Raz,E., and Schier,A.F. (2002). Production of 
maternal-zygotic mutant zebrafish by germ-line replacement. Proc Natl Acad Sci U S A 99, 
14919-14924. 
 139
Crispino,J.D., Lodish,M.B., MacKay,J.P., and Orkin,S.H. (1999). Use of altered specificity mutants to 
probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex. Mol Cell 3, 
219-228. 
Cumano,A. and Godin,I. (2001). Pluripotent hematopoietic stem cell development during 
embryogenesis. Curr Opin Immunol 13, 166-171. 
Dai,C.H., Krantz,S.B., and Zsebo,K.M. (1991). Human burst-forming units-erythroid need direct 
interaction with stem cell factor for further development. Blood 78, 2493-2497. 
Danilova,N. and Steiner,L.A. (2002). B cells develop in the zebrafish pancreas. Proc Natl Acad Sci U S 
A 99, 13711-13716. 
Davidson,A.J., Ernst,P., Wang,Y., Dekens,M.P., Kingsley,P.D., Palis,J., Korsmeyer,S.J., Daley,G.Q., and 
Zon,L.I. (2003). cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox 
genes. Nature 425, 300-306. 
Davidson,A.J. and Zon,L.I. (2000). Turning mesoderm into blood: the formation of hematopoietic stem 
cells during embryogenesis. Curr. Top. Dev. Biol. 50, 45-60. 
Davidson,A.J. and Zon,L.I. (2004). The 'definitive' (and 'primitive') guide to zebrafish hematopoiesis. 
Oncogene 23, 7233-7246. 
de Jong,J.L. and Zon,L.I. (2005). Use of the zebrafish system to study primitive and definitive 
hematopoiesis. Annu Rev Genet 39, 481-501. 
De Robertis,E.M. and Kuroda,H. (2004). Dorsal-ventral patterning and neural induction in Xenopus 
embryos. Annu. Rev. Cell Dev. Biol. 20, 285-308. 
DeKoter,R.P. and Singh,H. (2000). Regulation of B lymphocyte and macrophage development by 
graded expression of PU.1. Science 288, 1439-1441. 
DeKoter,R.P., Walsh,J.C., and Singh,H. (1998). PU.1 regulates both cytokine-dependent proliferation 
and differentiation of granulocyte/macrophage progenitors. EMBO J. 17, 4456-4468. 
Delassus,S. and Cumano,A. (1996). Circulation of hematopoietic progenitors in the mouse embryo. 
Immunity. 4, 97-106. 
Detrich,H.W., III, Kieran,M.W., Chan,F.Y., Barone,L.M., Yee,K., Rundstadler,J.A., Pratt,S., Ransom,D., 
and Zon,L.I. (1995). Intraembryonic hematopoietic cell migration during vertebrate development. Proc. 
Natl. Acad. Sci. U. S. A 92, 10713-10717. 
Dickson,M.C., Martin,J.S., Cousins,F.M., Kulkarni,A.B., Karlsson,S., and Akhurst,R.J. (1995). 
Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. 
Development 121, 1845-1854. 
Dieterlen-Lievre,F. (1975). On the origin of haemopoietic stem cells in the avian embryo: an 
experimental approach. J Embryol. Exp Morphol. 33, 607-619. 
Donehower,L.A., Harvey,M., Slagle,B.L., McArthur,M.J., Montgomery,C.A., Jr., Butel,J.S., and 
Bradley,A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous 
tumours. Nature 356, 215-221. 
Donovan,A., Brownlie,A., Dorschner,M.O., Zhou,Y., Pratt,S.J., Paw,B.H., Phillips,R.B., Thisse,C., 
Thisse,B., and Zon,L.I. (2002). The zebrafish mutant gene chardonnay (cdy) encodes divalent metal 
transporter 1 (DMT1). Blood 100, 4655-4659. 
Donovan,A., Brownlie,A., Zhou,Y., Shepard,J., Pratt,S.J., Moynihan,J., Paw,B.H., Drejer,A., Barut,B., 
Zapata,A., Law,T.C., Brugnara,C., Lux,S.E., Pinkus,G.S., Pinkus,J.L., Kingsley,P.D., Palis,J., 
 140
Fleming,M.D., Andrews,N.C., and Zon,L.I. (2000). Positional cloning of zebrafish ferroportin1 
identifies a conserved vertebrate iron exporter. Nature 403, 776-781. 
Dooley,K.A., Davidson,A.J., and Zon,L.I. (2005). Zebrafish scl functions independently in 
hematopoietic and endothelial development. Dev Biol 277, 522-536. 
Douagi,I., Vieira,P., and Cumano,A. (2002). Lymphocyte commitment during embryonic development, 
in the mouse. Semin. Immunol 14, 361-369. 
Driever,W. and Fishman,M.C. (1996). The zebrafish: heritable disorders in transparent embryos. J Clin 
Invest 97, 1788-1794. 
Dyer,M.A., Farrington,S.M., Mohn,D., Munday,J.R., and Baron,M.H. (2001). Indian hedgehog 
activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in 
the mouse embryo. Development 128, 1717-1730. 
Evans,T., Reitman,M., and Felsenfeld,G. (1988). An erythrocyte-specific DNA-binding factor 
recognizes a regulatory sequence common to all chicken globin genes. Proc. Natl. Acad. Sci. U. S. A 85, 
5976-5980. 
Fantoni,A., Bank,A., and Marks,P.A. (1967). Globin composition and synthesis of hemoglobins in 
developing fetal mice erythroid cells. Science 157, 1327-1329. 
Fassler,R. and Meyer,M. (1995). Consequences of lack of beta 1 integrin gene expression in mice. 
Genes Dev. 9, 1896-1908. 
Fong,I.C., Zarrin,A.A., Wu,G.E., and Berinstein,N.L. (2000). Functional analysis of the human RAG 2 
promoter. Mol. Immunol. 37, 391-402. 
Fraenkel,P.G., Traver,D., Donovan,A., Zahrieh,D., and Zon,L.I. (2005). Ferroportin1 is required for 
normal iron cycling in zebrafish. J Clin Invest 115, 1532-1541. 
Fujiwara,Y., Browne,C.P., Cunniff,K., Goff,S.C., and Orkin,S.H. (1996). Arrested development of 
embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad 
Sci U S A 93, 12355-12358. 
Fuller,K. and Storb,U. (1997). Identification and characterization of the murine Rag1 promoter. Mol. 
Immunol. 34, 939-954. 
Galloway,J.L. and Zon,L.I. (2003). Ontogeny of hematopoiesis: examining the emergence of 
hematopoietic cells in the vertebrate embryo. Curr Top. Dev Biol 53, 139-158. 
Garcia-Porrero,J.A., Godin,I.E., and Dieterlen-Lievre,F. (1995). Potential intraembryonic hemogenic 
sites at pre-liver stages in the mouse. Anat. Embryol. (Berl) 192, 425-435. 
Georgopoulos,K., Bigby,M., Wang,J.H., Molnar,A., Wu,P., Winandy,S., and Sharpe,A. (1994). The 
Ikaros gene is required for the development of all lymphoid lineages. Cell 79, 143-156. 
Gering,M., Rodaway,A.R., Gottgens,B., Patient,R.K., and Green,A.R. (1998). The SCL gene specifies 
haemangioblast development from early mesoderm. EMBO J 17, 4029-4045. 
Germain,R.N. (2002). T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2, 
309-322. 
Godin,I.E., Garcia-Porrero,J.A., Coutinho,A., Dieterlen-Lievre,F., and Marcos,M.A. (1993). Para-aortic 
splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature 364, 67-70. 
Golling,G., Amsterdam,A., Sun,Z., Antonelli,M., Maldonado,E., Chen,W., Burgess,S., Haldi,M., 
Artzt,K., Farrington,S., Lin,S.Y., Nissen,R.M., and Hopkins,N. (2002). Insertional mutagenesis in 
 141
zebrafish rapidly identifies genes essential for early vertebrate development. Nat Genet 31, 135-140. 
Griffin,K.J., Amacher,S.L., Kimmel,C.B., and Kimelman,D. (1998). Molecular identification of 
spadetail: regulation of zebrafish trunk and tail mesoderm formation by T-box genes 
19. Development 125, 3379-3388. 
Gronroos,E., Terentiev,A.A., Punga,T., and Ericsson,J. (2004). YY1 inhibits the activation of the p53 
tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci U S A 101, 12165-12170. 
Haffter,P., Granato,M., Brand,M., Mullins,M.C., Hammerschmidt,M., Kane,D.A., Odenthal,J., van 
Eeden,F.J., Jiang,Y.J., Heisenberg,C.P., Kelsh,R.N., Furutani-Seiki,M., Vogelsang,E., Beuchle,D., 
Schach,U., Fabian,C., and Nusslein-Volhard,C. (1996). The identification of genes with unique and 
essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36. 
Hamaguchi,I., Huang,X.L., Takakura,N., Tada,J., Yamaguchi,Y., Kodama,H., and Suda,T. (1999). In 
vitro hematopoietic and endothelial cell development from cells expressing TEK receptor in murine 
aorta-gonad-mesonephros region. Blood 93, 1549-1556. 
Hammerschmidt,M., Pelegri,F., Mullins,M.C., Kane,D.A., Brand,M., van Eeden,F.J., Furutani-Seiki,M., 
Granato,M., Haffter,P., Heisenberg,C.P., Jiang,Y.J., Kelsh,R.N., Odenthal,J., Warga,R.M., and 
Nusslein-Volhard,C. (1996). Mutations affecting morphogenesis during gastrulation and tail formation 
in the zebrafish, Danio rerio. Development 123, 143-151. 
Heasman,J. (2002). Morpholino oligos: making sense of antisense? Dev Biol 243, 209-214. 
Heasman,J. (2006). Maternal determinants of embryonic cell fate. Semin. Cell Dev. Biol. 17, 93-98. 
Herblot,S., Aplan,P.D., and Hoang,T. (2002). Gradient of E2A activity in B-cell development. Mol Cell 
Biol 22, 886-900. 
Herbomel,P., Thisse,B., and Thisse,C. (1999). Ontogeny and behaviour of early macrophages in the 
zebrafish embryo. Development 126, 3735-3745. 
Hoang,T. (2004). The origin of hematopoietic cell type diversity. Oncogene 23, 7188-7198. 
Hong,W., Nakazawa,M., Chen,Y.Y., Kori,R., Vakoc,C.R., Rakowski,C., and Blobel,G.A. (2005). 
FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1. EMBO 
J. 24, 2367-2378. 
Hsia,N. and Zon,L.I. (2005). Transcriptional regulation of hematopoietic stem cell development in 
zebrafish. Exp Hematol. 33, 1007-1014. 
Hu,M., Krause,D., Greaves,M., Sharkis,S., Dexter,M., Heyworth,C., and Enver,T. (1997). Multilineage 
gene expression precedes commitment in the hemopoietic system. Genes Dev. 11, 774-785. 
Huber,T.L. and Zon,L.I. (1998). Transcriptional regulation of blood formation during Xenopus 
development. Semin. Immunol. 10, 103-109. 
Ivanova,N.B., Dimos,J.T., Schaniel,C., Hackney,J.A., Moore,K.A., and Lemischka,I.R. (2002). A stem 
cell molecular signature. Science 298, 601-604. 
Jansen,G., Hazendonk,E., Thijssen,K.L., and Plasterk,R.H. (1997). Reverse genetics by chemical 
mutagenesis in Caenorhabditis elegans. Nat. Genet. 17, 119-121. 
Ji,R.P., Phoon,C.K., Aristizabal,O., McGrath,K.E., Palis,J., and Turnbull,D.H. (2003). Onset of cardiac 
function during early mouse embryogenesis coincides with entry of primitive erythroblasts into the 
embryo proper. Circ. Res. 92, 133-135. 
Jin,H., Xu,J., Qian,F., Du,L., Tan,C.Y., Lin,Z., Peng,J., and Wen,Z. (2006). The 5' zebrafish scl 
 142
promoter targets transcription to the brain, spinal cord, and hematopoietic and endothelial progenitors. 
Dev Dyn. 235, 60-67. 
Jin,S., Martinek,S., Joo,W.S., Wortman,J.R., Mirkovic,N., Sali,A., Yandell,M.D., Pavletich,N.P., 
Young,M.W., and Levine,A.J. (2000). Identification and characterization of a p53 homologue in 
Drosophila melanogaster. Proc Natl Acad Sci U S A 97, 7301-7306. 
Johnson,G.R. and Moore,M.A. (1975). Role of stem cell migration in initiation of mouse foetal liver 
haemopoiesis. Nature 258, 726-728. 
Kalev-Zylinska,M.L., Horsfield,J.A., Flores,M.V., Postlethwait,J.H., Vitas,M.R., Baas,A.M., 
Crosier,P.S., and Crosier,K.E. (2002). Runx1 is required for zebrafish blood and vessel development 
and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of 
leukemogenesis. Development 129, 2015-2030. 
Keller,G., Lacaud,G., and Robertson,S. (1999). Development of the hematopoietic system in the mouse. 
Exp Hematol. 27, 777-787. 
Kennedy,M., Firpo,M., Choi,K., Wall,C., Robertson,S., Kabrun,N., and Keller,G. (1997). A common 
precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386, 488-493. 
Kimmel,C.B., Ballard,W.W., Kimmel,S.R., Ullmann,B., and Schilling,T.F. (1995). Stages of embryonic 
development of the zebrafish 
35. Dev Dyn. 203, 253-310. 
Knuutila,S. (2004). Cytogenetics and molecular pathology in cancer diagnostics. Ann Med 36, 
162-171. 
Kondo,M., Wagers,A.J., Manz,M.G., Prohaska,S.S., Scherer,D.C., Beilhack,G.F., Shizuru,J.A., and 
Weissman,I.L. (2003). Biology of hematopoietic stem cells and progenitors: implications for clinical 
application. Annu Rev Immunol 21, 759-806. 
Kondo,M., Weissman,I.L., and Akashi,K. (1997). Identification of clonogenic common lymphoid 
progenitors in mouse bone marrow. Cell 91, 661-672. 
Kuryshev,V.Y., Vorobyov,E., Zink,D., Schmitz,J., Rozhdestvensky,T.S., Munstermann,E., Ernst,U., 
Wellenreuther,R., Moosmayer,P., Bechtel,S., Schupp,I., Horst,J., Korn,B., Poustka,A., and Wiemann,S. 
(2006). An anthropoid-specific segmental duplication on human chromosome 1q22. Genomics. 
Kyba,M., Perlingeiro,R.C., and Daley,G.Q. (2002). HoxB4 confers definitive lymphoid-myeloid 
engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109, 29-37. 
Labastie,M.C., Thiery,J.P., and Le Douarin,N.M. (1984). Mouse yolk sac and intraembryonic tissues 
produce factors able to elicit differentiation of erythroid burst-forming units and colony-forming units, 
respectively. Proc. Natl. Acad. Sci. U. S. A 81, 1453-1456. 
Lahlil,R., Lecuyer,E., Herblot,S., and Hoang,T. (2004). SCL assembles a multifactorial complex that 
determines glycophorin A expression. Mol. Cell Biol. 24, 1439-1452. 
Lam,S.H., Chua,H.L., Gong,Z., Wen,Z., Lam,T.J., and Sin,Y.M. (2002). Morphologic transformation of 
the thymus in developing zebrafish. Dev Dyn. 225, 87-94. 
Langenau,D.M., Ferrando,A.A., Traver,D., Kutok,J.L., Hezel,J.P., Kanki,J.P., Zon,L.I., Look,A.T., and 
Trede,N.S. (2004). In vivo tracking of T cell development, ablation, and engraftment in transgenic 
zebrafish. Proc Natl Acad Sci U S A 101, 7369-7374. 
Langheinrich,U., Hennen,E., Stott,G., and Vacun,G. (2002). Zebrafish as a model organism for the 
identification and characterization of drugs and genes affecting p53 signaling. Curr Biol 12, 2023-2028. 
 143
Lawrence,H.J., Christensen,J., Fong,S., Hu,Y.L., Weissman,I., Sauvageau,G., Humphries,R.K., and 
Largman,C. (2005). Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and 
repopulating ability of hematopoietic stem cells. Blood 106, 3988-3994. 
Lawrence,H.J., Helgason,C.D., Sauvageau,G., Fong,S., Izon,D.J., Humphries,R.K., and Largman,C. 
(1997). Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, 
erythroid, and lymphoid hematopoiesis. Blood 89, 1922-1930. 
Leder,P., Hansen,J.N., Konkel,D., Leder,A., Nishioka,Y., and Talkington,C. (1980). Mouse globin 
system: a functional and evolutionary analysis. Science 209, 1336-1342. 
Lekstrom-Himes,J. and Xanthopoulos,K.G. (1999). CCAAT/enhancer binding protein epsilon is critical 
for effective neutrophil-mediated response to inflammatory challenge. Blood 93, 3096-3105. 
Lengner,C.J., Steinman,H.A., Gagnon,J., Smith,T.W., Henderson,J.E., Kream,B.E., Stein,G.S., 
Lian,J.B., and Jones,S.N. (2006). Osteoblast differentiation and skeletal development are regulated by 
Mdm2-p53 signaling. J Cell Biol 172, 909-921. 
Lensch,M.W. and Daley,G.Q. (2004). Origins of mammalian hematopoiesis: in vivo paradigms and in 
vitro models. Curr Top. Dev Biol 60, 127-196. 
Letting,D.L., Chen,Y.Y., Rakowski,C., Reedy,S., and Blobel,G.A. (2004). Context-dependent regulation 
of GATA-1 by friend of GATA-1. Proc. Natl. Acad. Sci. U. S. A 101, 476-481. 
Liao,E.C., Paw,B.H., Oates,A.C., Pratt,S.J., Postlethwait,J.H., and Zon,L.I. (1998). SCL/Tal-1 
transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in 
zebrafish. Genes Dev 12, 621-626. 
Liao,E.C., Paw,B.H., Peters,L.L., Zapata,A., Pratt,S.J., Do,C.P., Lieschke,G., and Zon,L.I. (2000). 
Hereditary spherocytosis in zebrafish riesling illustrates evolution of erythroid beta-spectrin structure, 
and function in red cell morphogenesis and membrane stability. Development 127, 5123-5132. 
Liao,E.C., Trede,N.S., Ransom,D., Zapata,A., Kieran,M., and Zon,L.I. (2002). Non-cell autonomous 
requirement for the bloodless gene in primitive hematopoiesis of zebrafish. Development 129, 649-659. 
Lieschke,G.J., Oates,A.C., Crowhurst,M.O., Ward,A.C., and Layton,J.E. (2001). Morphologic and 
functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood 
98, 3087-3096. 
Lieschke,G.J., Oates,A.C., Paw,B.H., Thompson,M.A., Hall,N.E., Ward,A.C., Ho,R.K., Zon,L.I., and 
Layton,J.E. (2002). Zebrafish SPI-1 (PU.1) marks a site of myeloid development independent of 
primitive erythropoiesis: implications for axial patterning. Dev Biol 246, 274-295. 
Lin,C.S., Lim,S.K., D'Agati,V., and Costantini,F. (1996). Differential effects of an erythropoietin 
receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev. 10, 154-164. 
Liu,F. and Wen,Z. (2002). Cloning and expression pattern of the lysozyme C gene in zebrafish. Mech 
Dev 113, 69-72. 
Long,Q., Meng,A., Wang,H., Jessen,J.R., Farrell,M.J., and Lin,S. (1997). GATA-1 expression pattern 
can be recapitulated in living transgenic zebrafish using GFP reporter gene. Development 124, 
4105-4111. 
Lyons,S.E., Lawson,N.D., Lei,L., Bennett,P.E., Weinstein,B.M., and Liu,P.P. (2002). A nonsense 
mutation in zebrafish gata1 causes the bloodless phenotype in vlad tepes. Proc Natl Acad Sci U S A 99, 
5454-5459. 
Mackarehtschian,K., Hardin,J.D., Moore,K.A., Boast,S., Goff,S.P., and Lemischka,I.R. (1995). 
Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. 
Immunity. 3, 147-161. 
 144
Mak,S.K. and Kultz,D. (2004). Gadd45 proteins induce G2/M arrest and modulate apoptosis in kidney 
cells exposed to hyperosmotic stress. J Biol Chem 279, 39075-39084. 
Manley,N.R. (2000). Thymus organogenesis and molecular mechanisms of thymic epithelial cell 
differentiation. Semin. Immunol 12, 421-428. 
Manley,N.R. and Capecchi,M.R. (1995). The role of Hoxa-3 in mouse thymus and thyroid development. 
Development 121, 1989-2003. 
Marchio,A., Meddeb,M., Pineau,P., Danglot,G., Tiollais,P., Bernheim,A., and Dejean,A. (1997). 
Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic 
hybridization. Genes Chromosomes Cancer 18, 59-65. 
Matsuoka,S., Tsuji,K., Hisakawa,H., Xu,M., Ebihara,Y., Ishii,T., Sugiyama,D., Manabe,A., Tanaka,R., 
Ikeda,Y., Asano,S., and Nakahata,T. (2001). Generation of definitive hematopoietic stem cells from 
murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived 
stromal cells. Blood 98, 6-12. 
McCallum,C.M., Comai,L., Greene,E.A., and Henikoff,S. (2000). Targeted screening for induced 
mutations. Nat. Biotechnol. 18, 455-457. 
McKercher,S.R., Torbett,B.E., Anderson,K.L., Henkel,G.W., Vestal,D.J., Baribault,H., Klemsz,M., 
Feeney,A.J., Wu,G.E., Paige,C.J., and Maki,R.A. (1996). Targeted disruption of the PU.1 gene results in 
multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658. 
Medvinsky,A. and Dzierzak,E. (1996). Definitive hematopoiesis is autonomously initiated by the AGM 
region. Cell 86, 897-906. 
Medvinsky,A.L., Samoylina,N.L., Muller,A.M., and Dzierzak,E.A. (1993). An early pre-liver 
intraembryonic source of CFU-S in the developing mouse. Nature 364, 64-67. 
Michael,D. and Oren,M. (2002). The p53 and Mdm2 families in cancer. Curr Opin Genet Dev 12, 
53-59. 
Mombaerts,P., Iacomini,J., Johnson,R.S., Herrup,K., Tonegawa,S., and Papaioannou,V.E. (1992). 
RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877. 
Moore,M.A. and Metcalf,D. (1970). Ontogeny of the haemopoietic system: yolk sac origin of in vivo 
and in vitro colony forming cells in the developing mouse embryo. Br. J Haematol. 18, 279-296. 
Mucenski,M.L., McLain,K., Kier,A.B., Swerdlow,S.H., Schreiner,C.M., Miller,T.A., Pietryga,D.W., 
Scott,W.J., Jr., and Potter,S.S. (1991). A functional c-myb gene is required for normal murine fetal 
hepatic hematopoiesis. Cell 65, 677-689. 
Mukouyama,Y., Chiba,N., Mucenski,M.L., Satake,M., Miyajima,A., Hara,T., and Watanabe,T. (1999). 
Hematopoietic cells in cultures of the murine embryonic aorta-gonad-mesonephros region are induced 
by c-Myb. Curr Biol 9, 833-836. 
Muller,A.M., Medvinsky,A., Strouboulis,J., Grosveld,F., and Dzierzak,E. (1994). Development of 
hematopoietic stem cell activity in the mouse embryo. Immunity. 1, 291-301. 
Mullins,M.C., Hammerschmidt,M., Haffter,P., and Nusslein-Volhard,C. (1994). Large-scale 
mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol 4, 
189-202. 
Nasevicius,A. and Ekker,S.C. (2000). Effective targeted gene 'knockdown' in zebrafish. Nat Genet 26, 
216-220. 
Nehls,M., Kyewski,B., Messerle,M., Waldschutz,R., Schuddekopf,K., Smith,A.J., and Boehm,T. (1996). 
 145
Two genetically separable steps in the differentiation of thymic epithelium. Science 272, 886-889. 
Nehls,M., Pfeifer,D., Schorpp,M., Hedrich,H., and Boehm,T. (1994). New member of the winged-helix 
protein family disrupted in mouse and rat nude mutations. Nature 372, 103-107. 
Nerlov,C., Querfurth,E., Kulessa,H., and Graf,T. (2000). GATA-1 interacts with the myeloid PU.1 
transcription factor and represses PU.1-dependent transcription. Blood 95, 2543-2551. 
Neubauer,H., Cumano,A., Muller,M., Wu,H., Huffstadt,U., and Pfeffer,K. (1998). Jak2 deficiency 
defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93, 397-409. 
Nichogiannopoulou,A., Trevisan,M., Neben,S., Friedrich,C., and Georgopoulos,K. (1999). Defects in 
hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med 190, 1201-1214. 
Nishikawa,S.I., Nishikawa,S., Hirashima,M., Matsuyoshi,N., and Kodama,H. (1998). Progressive 
lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of 
endothelial and hemopoietic lineages. Development 125, 1747-1757. 
Nocka,K., Majumder,S., Chabot,B., Ray,P., Cervone,M., Bernstein,A., and Besmer,P. (1989). 
Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant 
mice--evidence for an impaired c-kit kinase in mutant mice. Genes Dev. 3, 816-826. 
North,T., Gu,T.L., Stacy,T., Wang,Q., Howard,L., Binder,M., Marin-Padilla,M., and Speck,N.A. (1999). 
Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 126, 
2563-2575. 
Ogata,K., Morikawa,S., Nakamura,H., Sekikawa,A., Inoue,T., Kanai,H., Sarai,A., Ishii,S., and 
Nishimura,Y. (1994). Solution structure of a specific DNA complex of the Myb DNA-binding domain 
with cooperative recognition helices. Cell 79, 639-648. 
Ollmann,M., Young,L.M., Di Como,C.J., Karim,F., Belvin,M., Robertson,S., Whittaker,K., Demsky,M., 
Fisher,W.W., Buchman,A., Duyk,G., Friedman,L., Prives,C., and Kopczynski,C. (2000). Drosophila 
p53 is a structural and functional homolog of the tumor suppressor p53. Cell 101, 91-101. 
Orkin,S.H. and Zon,L.I. (1997). Genetics of erythropoiesis: induced mutations in mice and zebrafish. 
Annu. Rev. Genet. 31, 33-60. 
Pal,S., Cantor,A.B., Johnson,K.D., Moran,T.B., Boyer,M.E., Orkin,S.H., and Bresnick,E.H. (2004). 
Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc Natl Acad Sci U S A 101, 
980-985. 
Palis,J., Robertson,S., Kennedy,M., Wall,C., and Keller,G. (1999). Development of erythroid and 
myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 126, 5073-5084. 
Palis,J. and Yoder,M.C. (2001). Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp 
Hematol. 29, 927-936. 
Pan,H. and Griep,A.E. (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic 
mice: implications for tumor suppressor gene function in development. Genes Dev 8, 1285-1299. 
Paw,B.H. (2001). Cloning of the zebrafish retsina blood mutation: a genetic model for 
dyserythropoiesis and erythroid cytokinesis. Blood Cells Mol Dis. 27, 62-64. 
Paw,B.H., Davidson,A.J., Zhou,Y., Li,R., Pratt,S.J., Lee,C., Trede,N.S., Brownlie,A., Donovan,A., 
Liao,E.C., Ziai,J.M., Drejer,A.H., Guo,W., Kim,C.H., Gwynn,B., Peters,L.L., Chernova,M.N., 
Alper,S.L., Zapata,A., Wickramasinghe,S.N., Lee,M.J., Lux,S.E., Fritz,A., Postlethwait,J.H., and 
Zon,L.I. (2003). Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 
deficiency. Nat Genet 34, 59-64. 
 146
Paw,B.H. and Zon,L.I. (2000). Zebrafish: a genetic approach in studying hematopoiesis. Curr Opin 
Hematol. 7, 79-84. 
Perkins,A.C., Sharpe,A.H., and Orkin,S.H. (1995). Lethal beta-thalassaemia in mice lacking the 
erythroid CACCC-transcription factor EKLF. Nature 375, 318-322. 
Peters,H., Neubuser,A., Kratochwil,K., and Balling,R. (1998). Pax9-deficient mice lack pharyngeal 
pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. Genes Dev. 12, 
2735-2747. 
Petrovick,M.S., Hiebert,S.W., Friedman,A.D., Hetherington,C.J., Tenen,D.G., and Zhang,D.E. (1998). 
Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of 
AML1. Mol Cell Biol 18, 3915-3925. 
Pevny,L., Lin,C.S., D'Agati,V., Simon,M.C., Orkin,S.H., and Costantini,F. (1995). Development of 
hematopoietic cells lacking transcription factor GATA-1. Development 121, 163-172. 
Pevny,L., Simon,M.C., Robertson,E., Klein,W.H., Tsai,S.F., D'Agati,V., Orkin,S.H., and Costantini,F. 
(1991). Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for 
transcription factor GATA-1. Nature 349, 257-260. 
Phillips,R.L., Ernst,R.E., Brunk,B., Ivanova,N., Mahan,M.A., Deanehan,J.K., Moore,K.A., 
Overton,G.C., and Lemischka,I.R. (2000). The genetic program of hematopoietic stem cells. Science 
288, 1635-1640. 
Plaster,N., Sonntag,C., Busse,C.E., and Hammerschmidt,M. (2006). p53 deficiency rescues apoptosis 
and differentiation of multiple cell types in zebrafish flathead mutants deficient for zygotic DNA 
polymerase delta1. Cell Death Differ 13, 223-235. 
Porcher,C., Swat,W., Rockwell,K., Fujiwara,Y., Alt,F.W., and Orkin,S.H. (1996). The T cell leukemia 
oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86, 47-57. 
Pui,J.C., Allman,D., Xu,L., DeRocco,S., Karnell,F.G., Bakkour,S., Lee,J.Y., Kadesch,T., Hardy,R.R., 
Aster,J.C., and Pear,W.S. (1999). Notch1 expression in early lymphopoiesis influences B versus T 
lineage determination. Immunity. 11, 299-308. 
Radomska,H.S., Huettner,C.S., Zhang,P., Cheng,T., Scadden,D.T., and Tenen,D.G. (1998). 
CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic 
development from bipotential myeloid progenitors. Mol Cell Biol 18, 4301-4314. 
Radtke,F., Wilson,A., and MacDonald,H.R. (2004). Notch signaling in T- and B-cell development. Curr. 
Opin. Immunol. 16, 174-179. 
Radtke,F., Wilson,A., Stark,G., Bauer,M., van,M.J., MacDonald,H.R., and Aguet,M. (1999). Deficient 
T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 10, 547-558. 
Ransom,D.G., Bahary,N., Niss,K., Traver,D., Burns,C., Trede,N.S., Paffett-Lugassy,N., Saganic,W.J., 
Lim,C.A., Hersey,C., Zhou,Y., Barut,B.A., Lin,S., Kingsley,P.D., Palis,J., Orkin,S.H., and Zon,L.I. 
(2004). The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an 
essential regulator of hematopoiesis. PLoS. Biol 2, E237. 
Ransom,D.G., Haffter,P., Odenthal,J., Brownlie,A., Vogelsang,E., Kelsh,R.N., Brand,M., van Eeden,F.J., 
Furutani-Seiki,M., Granato,M., Hammerschmidt,M., Heisenberg,C.P., Jiang,Y.J., Kane,D.A., 
Mullins,M.C., and Nusslein-Volhard,C. (1996). Characterization of zebrafish mutants with defects in 
embryonic hematopoiesis. Development 123, 311-319. 
Ratajczak,J., Marlicz,W., Machalinski,B., Pertusini,E., Czajka,R., and Ratajczak,M.Z. (1998). An 
improved serum free system for cloning human "pure" erythroid colonies. The role of different growth 
factors and cytokines on BFU-E formation by the bone marrow and cord blood CD34+ cells. Folia 
Histochem. Cytobiol. 36, 55-60. 
 147
Rebollo,A. and Schmitt,C. (2003). Ikaros, Aiolos and Helios: transcription regulators and lymphoid 
malignancies. Immunol. Cell Biol. 81, 171-175. 
Rekhtman,N., Radparvar,F., Evans,T., and Skoultchi,A.I. (1999). Direct interaction of hematopoietic 
transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev 13, 
1398-1411. 
Reya,T., Duncan,A.W., Ailles,L., Domen,J., Scherer,D.C., Willert,K., Hintz,L., Nusse,R., and 
Weissman,I.L. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 
423, 409-414. 
Robb,L., Elwood,N.J., Elefanty,A.G., Kontgen,F., Li,R., Barnett,L.D., and Begley,C.G. (1996). The scl 
gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J 
15, 4123-4129. 
Rodriguez,P., Bonte,E., Krijgsveld,J., Kolodziej,K.E., Guyot,B., Heck,A.J., Vyas,P., de,B.E., 
Grosveld,F., and Strouboulis,J. (2005). GATA-1 forms distinct activating and repressive complexes in 
erythroid cells. EMBO J. 24, 2354-2366. 
Rylski,M., Welch,J.J., Chen,Y.Y., Letting,D.L., Diehl,J.A., Chodosh,L.A., Blobel,G.A., and Weiss,M.J. 
(2003). GATA-1-mediated proliferation arrest during erythroid maturation. Mol. Cell Biol. 23, 
5031-5042. 
Sasaki,K. and Matsumura,G. (1988). Spleen lymphocytes and haemopoiesis in the mouse embryo. J 
Anat. 160, 27-37. 
Sasaki,K. and Sonoda,Y. (2000). Histometrical and three-dimensional analyses of liver hematopoiesis 
in the mouse embryo. Arch. Histol. Cytol. 63, 137-146. 
Sauvageau,G., Thorsteinsdottir,U., Eaves,C.J., Lawrence,H.J., Largman,C., Lansdorp,P.M., and 
Humphries,R.K. (1995). Overexpression of HOXB4 in hematopoietic cells causes the selective 
expansion of more primitive populations in vitro and in vivo. Genes Dev. 9, 1753-1765. 
Sawada,K., Krantz,S.B., Dessypris,E.N., Koury,S.T., and Sawyer,S.T. (1989). Human colony-forming 
units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth 
factor I and/or insulin for erythroid development. J. Clin. Invest 83, 1701-1709. 
Sawada,S. and Littman,D.R. (1993). A heterodimer of HEB and an E12-related protein interacts with 
the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell Biol. 13, 5620-5628. 
Schumacher,B., Hanazawa,M., Lee,M.H., Nayak,S., Volkmann,K., Hofmann,E.R., Hengartner,M., 
Schedl,T., and Gartner,A. (2005). Translational repression of C. elegans p53 by GLD-1 regulates DNA 
damage-induced apoptosis. Cell 120, 357-368. 
Scott,E.W., Fisher,R.C., Olson,M.C., Kehrli,E.W., Simon,M.C., and Singh,H. (1997). PU.1 functions in 
a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid 
progenitors. Immunity. 6, 437-447. 
Scott,E.W., Simon,M.C., Anastasi,J., and Singh,H. (1994). Requirement of transcription factor PU.1 in 
the development of multiple hematopoietic lineages. Science 265, 1573-1577. 
Shafizadeh,E., Paw,B.H., Foott,H., Liao,E.C., Barut,B.A., Cope,J.J., Zon,L.I., and Lin,S. (2002). 
Characterization of zebrafish merlot/chablis as non-mammalian vertebrate models for severe congenital 
anemia due to protein 4.1 deficiency. Development 129, 4359-4370. 
Shalaby,F., Ho,J., Stanford,W.L., Fischer,K.D., Schuh,A.C., Schwartz,L., Bernstein,A., and Rossant,J. 
(1997). A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89, 
981-990. 
Shalaby,F., Rossant,J., Yamaguchi,T.P., Gertsenstein,M., Wu,X.F., Breitman,M.L., and Schuh,A.C. 
 148
(1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 
62-66. 
Shi,Y., Lee,J.S., and Galvin,K.M. (1997). Everything you have ever wanted to know about Yin Yang 
1..... Biochim Biophys Acta 1332, F49-F66. 
Shivdasani,R.A., Mayer,E.L., and Orkin,S.H. (1995). Absence of blood formation in mice lacking the 
T-cell leukaemia oncoprotein tal-1/SCL. Nature 373, 432-434. 
Silverstein,R.A. and Ekwall,K. (2005). Sin3: a flexible regulator of global gene expression and genome 
stability. Curr Genet 47, 1-17. 
Smith,L.G., Weissman,I.L., and Heimfeld,S. (1991). Clonal analysis of hematopoietic stem-cell 
differentiation in vivo. Proc Natl Acad Sci U S A 88, 2788-2792. 
Socolovsky,M., Lodish,H.F., and Daley,G.Q. (1998). Control of hematopoietic differentiation: lack of 
specificity in signaling by cytokine receptors. Proc. Natl. Acad. Sci. U. S. A 95, 6573-6575. 
Solnica-Krezel,L., Schier,A.F., and Driever,W. (1994). Efficient recovery of ENU-induced mutations 
from the zebrafish germline. Genetics 136, 1401-1420. 
Souabni,A., Cobaleda,C., Schebesta,M., and Busslinger,M. (2002). Pax5 promotes B lymphopoiesis 
and blocks T cell development by repressing Notch1. Immunity. 17, 781-793. 
Spronk,C.A., Tessari,M., Kaan,A.M., Jansen,J.F., Vermeulen,M., Stunnenberg,H.G., and Vuister,G.W. 
(2000). The Mad1-Sin3B interaction involves a novel helical fold. Nat Struct. Biol 7, 1100-1104. 
Stainier,D.Y., Weinstein,B.M., Detrich,H.W., III, Zon,L.I., and Fishman,M.C. (1995). Cloche, an early 
acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development 121, 
3141-3150. 
Su,D.M. and Manley,N.R. (2000). Hoxa3 and pax1 transcription factors regulate the ability of fetal 
thymic epithelial cells to promote thymocyte development. J. Immunol. 164, 5753-5760. 
Sui,G., Affar,e.B., Shi,Y., Brignone,C., Wall,N.R., Yin,P., Donohoe,M., Luke,M.P., Calvo,D., 
Grossman,S.R., and Shi,Y. (2004). Yin Yang 1 is a negative regulator of p53. Cell 117, 859-872. 
Tenen,D.G., Hromas,R., Licht,J.D., and Zhang,D.E. (1997). Transcription factors, normal myeloid 
development, and leukemia. Blood 90, 489-519. 
Thomas,M.J. and Seto,E. (1999). Unlocking the mechanisms of transcription factor YY1: are 
chromatin modifying enzymes the key? Gene 236, 197-208. 
Thompson,M.A., Ransom,D.G., Pratt,S.J., MacLennan,H., Kieran,M.W., Detrich,H.W., III, Vail,B., 
Huber,T.L., Paw,B., Brownlie,A.J., Oates,A.C., Fritz,A., Gates,M.A., Amores,A., Bahary,N., 
Talbot,W.S., Her,H., Beier,D.R., Postlethwait,J.H., and Zon,L.I. (1998). The cloche and spadetail genes 
differentially affect hematopoiesis and vasculogenesis. Dev Biol 197, 248-269. 
Thorsteinsdottir,U., Sauvageau,G., and Humphries,R.K. (1999). Enhanced in vivo regenerative 
potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 94, 
2605-2612. 
Till,J.E.M.E.A.a.S.L. (1964). A stochastic model of stem cell proliferation, based on the growth of 
spleen colony-forming cells. Proc. Natl. Acad. Sci. U. S. A 51, 29-36. 
Ting,C.N., Olson,M.C., Barton,K.P., and Leiden,J.M. (1996). Transcription factor GATA-3 is required 
for development of the T-cell lineage. Nature 384, 474-478. 
Traver,D., Paw,B.H., Poss,K.D., Penberthy,W.T., Lin,S., and Zon,L.I. (2003). Transplantation and in 
 149
vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol 4, 1238-1246. 
Trede,N.S., Zapata,A., and Zon,L.I. (2001). Fishing for lymphoid genes. Trends Immunol 22, 302-307. 
Tsai,F.Y., Keller,G., Kuo,F.C., Weiss,M., Chen,J., Rosenblatt,M., Alt,F.W., and Orkin,S.H. (1994). An 
early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221-226. 
Tsang,A.P., Fujiwara,Y., Hom,D.B., and Orkin,S.H. (1998). Failure of megakaryopoiesis and arrested 
erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev 12, 1176-1188. 
Tsang,A.P., Visvader,J.E., Turner,C.A., Fujiwara,Y., Yu,C., Weiss,M.J., Crossley,M., and Orkin,S.H. 
(1997). FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in 
erythroid and megakaryocytic differentiation. Cell 90, 109-119. 
Uchida,N., Jerabek,L., and Weissman,I.L. (1996). Searching for hematopoietic stem cells. II. The 
heterogeneity of Thy-1.1(lo)Lin(-/lo)Sca-1+ mouse hematopoietic stem cells separated by counterflow 
centrifugal elutriation. Exp Hematol. 24, 649-659. 
van Eeden,F.J., Granato,M., Odenthal,J., and Haffter,P. (1999). Developmental mutant screens in the 
zebrafish. Methods Cell Biol 60, 21-41. 
Varnum-Finney,B., Xu,L., Brashem-Stein,C., Nourigat,C., Flowers,D., Bakkour,S., Pear,W.S., and 
Bernstein,I.D. (2000). Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by 
constitutive Notch1 signaling. Nat. Med. 6, 1278-1281. 
Vogelstein,B., Lane,D., and Levine,A.J. (2000). Surfing the p53 network. Nature 408, 307-310. 
Wagers,A.J., Christensen,J.L., and Weissman,I.L. (2002a). Cell fate determination from stem cells. 
Gene Ther. 9, 606-612. 
Wagers,A.J., Sherwood,R.I., Christensen,J.L., and Weissman,I.L. (2002b). Little evidence for 
developmental plasticity of adult hematopoietic stem cells. Science 297, 2256-2259. 
Wang,C.Y., Liang,Y.J., Lin,Y.S., Shih,H.M., Jou,Y.S., and Yu,W.C. (2004). YY1AP, a novel 
co-activator of YY1. J Biol Chem 279, 17750-17755. 
Wang,H., Clark,I., Nicholson,P.R., Herskowitz,I., and Stillman,D.J. (1990). The Saccharomyces 
cerevisiae SIN3 gene, a negative regulator of HO, contains four paired amphipathic helix motifs. Mol 
Cell Biol 10, 5927-5936. 
Wang,H., Long,Q., Marty,S.D., Sassa,S., and Lin,S. (1998). A zebrafish model for hepatoerythropoietic 
porphyria. Nat Genet 20, 239-243. 
Wang,Q., Stacy,T., Binder,M., Marin-Padilla,M., Sharpe,A.H., and Speck,N.A. (1996). Disruption of 
the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive 
hematopoiesis. Proc Natl Acad Sci U S A 93, 3444-3449. 
Wang,X., Kua,H.Y., Hu,Y., Guo,K., Zeng,Q., Wu,Q., Ng,H.H., Karsenty,G., de Crombrugghe,B., Yeh,J., 
and Li,B. (2006). p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent 
osteoclastogenesis, and bone remodeling. J Cell Biol 172, 115-125. 
Warren,A.J., Colledge,W.H., Carlton,M.B., Evans,M.J., Smith,A.J., and Rabbitts,T.H. (1994). The 
oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78, 
45-57. 
Weinstein,B.M., Schier,A.F., Abdelilah,S., Malicki,J., Solnica-Krezel,L., Stemple,D.L., Stainier,D.Y., 
Zwartkruis,F., Driever,W., and Fishman,M.C. (1996). Hematopoietic mutations in the zebrafish. 
Development 123, 303-309. 
 150
Weiss,M.J., Keller,G., and Orkin,S.H. (1994). Novel insights into erythroid development revealed 
through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev 8, 1184-1197. 
Weiss,M.J. and Orkin,S.H. (1995). Transcription factor GATA-1 permits survival and maturation of 
erythroid precursors by preventing apoptosis. Proc Natl Acad Sci U S A 92, 9623-9627. 
Westman,B.J., Mackay,J.P., and Gell,D. (2002). Ikaros: a key regulator of haematopoiesis. Int. J. 
Biochem. Cell Biol. 34, 1304-1307. 
Wienholds,E., Schulte-Merker,S., Walderich,B., and Plasterk,R.H. (2002). Target-selected inactivation 
of the zebrafish rag1 gene. Science 297, 99-102. 
Wienholds,E., van Eeden,F., Kosters,M., Mudde,J., Plasterk,R.H., and Cuppen,E. (2003). Efficient 
target-selected mutagenesis in zebrafish. Genome Res 13, 2700-2707. 
Willert,K., Brown,J.D., Danenberg,E., Duncan,A.W., Weissman,I.L., Reya,T., Yates,J.R., III, and 
Nusse,R. (2003). Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 
448-452. 
Willett,C.E., Cherry,J.J., and Steiner,L.A. (1997). Characterization and expression of the recombination 
activating genes (rag1 and rag2) of zebrafish. Immunogenetics 45, 394-404. 
Willett,C.E., Cortes,A., Zuasti,A., and Zapata,A.G. (1999). Early hematopoiesis and developing 
lymphoid organs in the zebrafish. Dev Dyn. 214, 323-336. 
Willett,C.E., Kawasaki,H., Amemiya,C.T., Lin,S., and Steiner,L.A. (2001). Ikaros expression as a 
marker for lymphoid progenitors during zebrafish development. Dev Dyn. 222, 694-698. 
Wilson,A., MacDonald,H.R., and Radtke,F. (2001). Notch 1-deficient common lymphoid precursors 
adopt a B cell fate in the thymus. J. Exp. Med. 194, 1003-1012. 
Wingert,R.A., Brownlie,A., Galloway,J.L., Dooley,K., Fraenkel,P., Axe,J.L., Davidson,A.J., Barut,B., 
Noriega,L., Sheng,X., Zhou,Y., and Zon,L.I. (2004). The chianti zebrafish mutant provides a model for 
erythroid-specific disruption of transferrin receptor 1. Development 131, 6225-6235. 
Winnier,G., Blessing,M., Labosky,P.A., and Hogan,B.L. (1995). Bone morphogenetic protein-4 is 
required for mesoderm formation and patterning in the mouse. Genes Dev 9, 2105-2116. 
Wong,N., Chan,A., Lee,S.W., Lam,E., To,K.F., Lai,P.B., Li,X.N., Liew,C.T., and Johnson,P.J. (2003). 
Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates 
candidate genes over-expression. J Hepatol. 38, 298-306. 
Wong,N., Lai,P., Lee,S.W., Fan,S., Pang,E., Liew,C.T., Sheng,Z., Lau,J.W., and Johnson,P.J. (1999). 
Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization 
analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 154, 37-43. 
Wu,H., Liu,X., Jaenisch,R., and Lodish,H.F. (1995). Generation of committed erythroid BFU-E and 
CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59-67. 
Xu,M.J., Matsuoka,S., Yang,F.C., Ebihara,Y., Manabe,A., Tanaka,R., Eguchi,M., Asano,S., Nakahata,T., 
and Tsuji,K. (2001). Evidence for the presence of murine primitive megakaryocytopoiesis in the early 
yolk sac. Blood 97, 2016-2022. 
Yamanaka,R., Barlow,C., Lekstrom-Himes,J., Castilla,L.H., Liu,P.P., Eckhaus,M., Decker,T., 
Wynshaw-Boris,A., and Xanthopoulos,K.G. (1997). Impaired granulopoiesis, myelodysplasia, and 
early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc. Natl. Acad. Sci. U. S. 
A 94, 13187-13192. 
Yoder,M.C. and Hiatt,K. (1997). Engraftment of embryonic hematopoietic cells in conditioned 
 151
newborn recipients. Blood 89, 2176-2183. 
Yoder,M.C., Hiatt,K., Dutt,P., Mukherjee,P., Bodine,D.M., and Orlic,D. (1997a). Characterization of 
definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity 7, 335-344. 
Yoder,M.C., Hiatt,K., and Mukherjee,P. (1997b). In vivo repopulating hematopoietic stem cells are 
present in the murine yolk sac at day 9.0 postcoitus. Proc Natl Acad Sci U S A 94, 6776-6780. 
Zan,Y., Haag,J.D., Chen,K.S., Shepel,L.A., Wigington,D., Wang,Y.R., Hu,R., Lopez-Guajardo,C.C., 
Brose,H.L., Porter,K.I., Leonard,R.A., Hitt,A.A., Schommer,S.L., Elegbede,A.F., and Gould,M.N. 
(2003). Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat. 
Biotechnol. 21, 645-651. 
Zhang,D.E., Zhang,P., Wang,N.D., Hetherington,C.J., Darlington,G.J., and Tenen,D.G. (1997). Absence 
of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer 
binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. U. S. A 94, 569-574. 
Zhang,P., Behre,G., Pan,J., Iwama,A., Wara-Aswapati,N., Radomska,H.S., Auron,P.E., Tenen,D.G., and 
Sun,Z. (1999). Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. 
Proc Natl Acad Sci U S A 96, 8705-8710. 
Zhang,P., Zhang,X., Iwama,A., Yu,C., Smith,K.A., Mueller,B.U., Narravula,S., Torbett,B.E., 
Orkin,S.H., and Tenen,D.G. (2000). PU.1 inhibits GATA-1 function and erythroid differentiation by 
blocking GATA-1 DNA binding. Blood 96, 2641-2648. 
Zhuang,Y., Cheng,P., and Weintraub,H. (1996). B-lymphocyte development is regulated by the 
combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell Biol. 16, 
2898-2905. 
Zon,L.I. (1995). Developmental biology of hematopoiesis. Blood 86, 2876-2891. 
 
 
